Press Releases

The information and content in this site has been released in the past by Express Scripts Holding Company or its predecessor and wholly-owned subsidiary, Express Scripts, Inc. (together, Express Scripts). These contents may no longer be current. The passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. On the date released, some of the contents in this site may have contained statements that were then "forward-looking statements," based upon then current expectations, forecasts and assumptions that involved risks and uncertainties, then enumerated by Express Scripts that could cause actual outcomes and results to differ materially. To the extent any information is forward-looking, it is intended to comply with the safe harbor for forward-looking information as of the date of issuance (for more information, view our forward-looking statement). Express Scripts disclaims any intention or obligation to update or revise the contents of this site, including but not limited to any forward-looking statements made at the time the information was first released, whether as a result of new information, future events or otherwise.

Keyword Search


Archived Press Releases
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009
07/06/2017Express Scripts Holding Company Announces Second Quarter 2017 Earnings Conference Call
St. Louis, July 06, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 second quarter financial results on Tuesday, July 25, 2017 after the market closes and will hold its quarterly conference call to discuss 2017 second quarter financial results on Wednesday, July 26, 2017, at 8:30 a.m. eastern time (7:30 a.m. central time).  The call will include a slide presentation and is being webcast via ... 
06/27/2017Express Scripts Elects Kathleen M. Mazzarella to Board of Directors
ST. LOUIS, June 27, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced the election of Kathleen M. Mazzarella to the company's Board of Directors effective June 27, 2017.  "We are honored that Kathy will be joining our Board, and we appreciate the wealth of expertise and experience she will bring to us," said George Paz, Chairman of the Board.  Ms. Mazzarella has served as Chairman, President and Chief Executive Officer o... 
06/22/2017A Nation in Pain: Focus on Medicaid
ST. LOUIS, June 22, 2017 /PRNewswire/ -- Our nation's unprecedented opioid epidemic has been called the worst drug crisis in American history. To highlight the severity of this issue, consider these few alarming statistics: Drug overdose now leads the cause of accidental deaths in the United States — more than 15,000 people fatally overdosed on prescription pain killers in 2016 — making drug overdoses the leading cause of accidental deaths in the United States. Nationwide, pharmacies rece... 
06/07/2017Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse
ST. LOUIS, June 7, 2017 /PRNewswire/ -- Building upon its history of industry-leading bold actions, Express Scripts (NASDAQ: ESRX) today announced a new Advanced Opioid ManagementSM solution that will better address our nation's opioid-addiction epidemic by working comprehensively with patients, prescribers and pharmacies to minimize early exposure while helping prevent progression to overuse and abuse. In a recent pilot study of just more than 100,000 Expre... 
06/05/2017Express Scripts Holding Company to Present at Upcoming Conferences
ST. LOUIS, June 5, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at two upcoming conferences: Goldman Sachs 38th Annual Global Healthcare Conference on Tuesday, June 13, 2017 at 9:20 a.m. pacific (12:20 p.m. eastern).  William Blair and Company's 37th Annual Growth Stock Conference on Wednesday, June 14, 2017 at 10:00 a.m. central (11:00 a.m. eastern). The presentations will be broadcast via the Inte... 
06/01/2017Express Scripts Expands SafeGuardRx® Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis
- Pulmonary Care Value Program addresses medication adherence through remote patient monitoring, patient engagement via Express Scripts' exclusive collaboration with Mango Health, and a quality pharmacy network. - Multiple Sclerosis Care Value Program shields payers from costs associated with discontinued therapy; leverages Accredo's specialist pharmacist support to deliver enhanced patient care and medication adherence. ST. LOUIS, June 1, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ES... 
05/18/2017Express Scripts Subsidiary to Join Walgreens Boots Alliance Development Group Purchasing Organization
ST. LOUIS, May 18, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX), through a wholly owned subsidiary, Innovative Product Alignment, LLC, today announced it will participate in Walgreens Boots Alliance Development GmbH (WBAD) group purchasing organization. In addition, Econdisc Contracting Solutions, a group purchasing organization that contracts with manufacturers to source generic pharmaceuticals on behalf of its participants, will have access to WBAD's sourcing efforts thr... 
05/17/2017Express Scripts and myMatrixx Combine To Offer Best-in-Class Pharmacy Services for Workers' Compensation Programs
ST. LOUIS, May 17, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced it is taking an important step in expanding its customized workers' compensation pharmacy solutions by acquiring myMatrixx, a pharmacy benefit solutions provider for the workers' compensation industry. The companies will merge core capabilities to deliver best-in-class clinical expertise, advanced analytics, and customized client experiences to serve workers' compensation clients and injured patients. ... 
05/08/2017Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, May 8, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16, 2017 at 11:20 a.m. pacific (2:20 p.m. eastern).  The presentation will be broadcast via the Internet and can be accessed at the Investor Relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to li... 
05/08/2017Cross-Industry Partnership Reduces The Cost Of Popular Diabetes, Asthma And Other Brand Name Drugs
Inside Rx, a new initiative from Express Scripts, partners with GoodRx, drug manufacturers and drug stores to save Americans an average of 34 percent at 40,000 pharmacies ST. LOUIS and SANTA MONICA, Calif., May 8, 2017 /PRNewswire/ -- Today, Express Scripts (NASDAQ: ESRX) announced the launch of  Inside Rx, a new, partially owned subsidiary that applies Express Scripts' purchasing power to expand affordable access to brand and generic medications for patients in need. Inside Rx has partnere... 
05/05/2017Express Scripts Recognized Among Most Diverse U.S. Companies by DiversityInc
ST. LOUIS, May 5, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) has been recognized by DiversityInc as a "Noteworthy" company for diversity, based on its hiring, retention, and promotion of women, minorities, people with disabilities, LGBT individuals, and veterans. "Express Scripts is proud to be recognized by DiversityInc for our commitment to diversity and providing an inclusive environment for our employees," said Express Scripts President and CEO T... 
04/24/2017Express Scripts Announces 2017 First Quarter Results; Provides Update on Anthem Relationship and Visibility into Core PBM Business Excluding Contribution from Anthem, Coventry and Catamaran
ST. LOUIS, April 24, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 first quarter net income of $546.3 million or $0.90 per diluted share.  The 2017 first quarter adjusted earnings per diluted share was $1.33.*   First Quarter 2017 Results The following compares first quarter 2017 and 2016 operating results: Adjusted claims of 351.7 million, down 1% – See Table 1 GAAP net income of $546.3 million, up 4% GAAP earnings per diluted share ... 
04/11/2017Express Scripts Holding Company Announces First Quarter 2017 Earnings Conference Call
St. Louis, April 11, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 first quarter financial results on Monday, April 24, 2017 after the market closes and will hold its quarterly conference call to discuss 2017 first quarter financial results on Tuesday, April 25, 2017, at 8:30 a.m. EDT (7:30 a.m. CDT).  The call will include a slide presentation and is being webcast via the Internet and c... 
04/04/2017U.S. Workers' Compensation Prescription Drug Spending Decreased 7.6% in 2016 Through Cost-Savings Solutions, Improved Care for Injured Workers
ST. LOUIS, April 4, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) lowered prescription drug spending for workers' compensation payers by 7.6 percent in 2016, according to the 11th edition of its Workers' Compensation Drug Trend Report. "In a year when many payers wrestled with drug price increases that dominated the news, Express Scripts protected clients from this impact," said Dr. Brigette Nelson, senior vice president of workers' compensation clinic... 
03/15/2017Mango Health Announces Partnership, Strategic Investment from Express Scripts
New daily health solution connects two industry leading platforms for improving health outcomes and reducing the cost of care.SAN FRANCISCO, March 15, 2017 /PRNewswire-USNewswire/ -- Mango Health, a mobile health company, today announced a long term operating partnership with Express Scripts (NASDAQ: ESRX) which will include a new daily health management platform to improve health outcomes. Through the partnership, Mango Health's innovative patient-facing mobile applications will be available to... 
03/07/2017Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference
ST. LOUIS, March 7, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 9:30 a.m. Eastern Daylight Time at the Loews Miami Beach Hotel in Miami Beach, FL.  At the meeting, the Company may make forward-looking statements, including but not limited to our 2017 full year and quarterly guidance and statements related to how the Company creates value fo... 
02/28/2017High Drug Prices Frustrate Government-Sponsored Health Programs, According to New Express Scripts Drug Trend Insights
ST. LOUIS, Feb. 28, 2017 /PRNewswire/ -- Health plans partnering with Express Scripts are delivering high-quality, affordable pharmacy care to millions of individuals enrolled in government-sponsored programs, but this record is at risk without decisive action to advance additional pro-patient and pro-payer policy changes, according to new research released today by Express Scripts (NASDAQ: ESRX). "Our country is engaged in an important dialogue about how bes... 
02/16/2017Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017
ST. LOUIS, Feb. 16, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was recognized today by Fortune Magazine as one of the World's Most Admired Companies within the Health Care: Pharmacy and Other Services category. "Express Scripts is honored to be named one of the World's Most Admired Companies," said Tim Wentworth, CEO and President, Express Scripts. "This recognition is driven by the commitment and passion of our 26,000 employees to make medicine more... 
02/14/2017Express Scripts Announces 2016 Fourth Quarter and Full Year Results
ST. LOUIS, Feb. 14, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 fourth quarter and full year net income of $1,434.7 million and $3,404.4 million, respectively, or $2.34 and $5.39 per diluted share, respectively.  2016 fourth quarter and full year adjusted earnings per diluted share, as detailed in Table 4, was $1.88 and $6.39, respectively.1 "We delivered another year of successful performance, not only through financial results, but by providing innovat... 
02/06/2017Express Scripts Fights Back Against Irresponsible Drug Pricing; Holds U.S. Drug Spending Increase to 3.8 Percent in 2016
- Patients' share of cost for prescription drugs declined for the second consecutive year - Despite brand-name list price increases of nearly 11 percent, Express Scripts kept unit cost increases for employers to just 2.5 percent across all prescription drugs - One-third of employers with pharmacy plans managed by Express Scripts spent less on prescription drugs in 2016 ST. LOUIS, Feb. 6, 2017 /PRNewswire/ -- Express Scripts' (NASDAQ: ESRX) efforts to put medicine within reach for paye... 
01/18/2017Express Scripts Holding Company Announces Fourth Quarter and Full Year 2016 Earnings Conference Call
ST. LOUIS, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) (“Express Scripts”) announced today its intention to release its 2016 fourth quarter and full year financial results on Tuesday, February 14, 2017 after the market closes and will hold its quarterly conference call to discuss 2016 fourth quarter and full year financial results on Wednesday, February 15, 2017, at 8:30 a.m. EST (7:30 a.m. CST).  The call includes a slide presentation and is being webcas... 
01/04/2017Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Jan. 4, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 11:30 a.m. Pacific Time (2:30 p.m. EST) at the Westin St. Francis in San Francisco, CA. The presentation will be broadcast via the Internet and can be accessed at the Investor Relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows M... 
12/14/2016Express Scripts Holding Company Announces 2017 Financial Guidance
ST. LOUIS, Dec. 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share1 for 2017 in the range of $6.82 to $7.02, representing growth of 7% to 10% from the midpoint of our 2016 adjusted EPS guidance range.  "Our value proposition is clear; our opportunities to help patients and payers contain healthcare costs and improve clinical outcomes have never been greater," said Tim Wentworth, CEO and President. "As we continue ... 
12/12/2016Express Scripts Announces Enhancements to Industry Leading SafeGuardRx(SM) Programs
- Hepatitis Cure Value Program® expands covered treatments to include both Viekira Pak™ and Harvoni® in 2017 - Oncology Care Value Program(SM) expands indication-based management to medications that make up nearly a quarter of all oncology spend - Cholesterol Care Value Program® demonstrates superior medication adherence for patients filling PCSK9 inhibitors via Accredo compared to other retail and specialty pharmacies ST. LOUIS, Dec. 12, 2016 /PRNewswire/ -- As part of its ongoing mi... 
12/05/2016Express Scripts Earns Top Marks in 2017 Corporate Equality Index
Human Rights Campaign Foundation Awards Perfect Score to Express Scripts for LGBT Workplace Equality ST. LOUIS, Dec. 5, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) received a perfect score of 100 percent on the 2017 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation.  The company joins the ranks of 517 major U.S. businesses which also ea... 
11/14/2016Express Scripts Holding Company Announces 2017 Financial Guidance Conference Call
ST. LOUIS, Nov. 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced its intention to release its 2017 financial guidance on Wednesday, December 14, 2016, via press release before the market opens, followed by a conference call to discuss the 2017 financial guidance at 9:00 a.m. Eastern Time (8:00 a.m. Central Time) on Wednesday, December 14, 2016.  The conference call will feature remarks by Tim Wentworth, CEO and President and Eric Slusser, CFO. The call i... 
11/03/2016Express Scripts Puts Medicine Within Reach with 4-Star Medicare Prescription Drug Programs
Express Scripts 2017 Choice and Value Plans Offer Coverage, Convenience, Care and Service for Beneficiaries Nationwide ST. LOUIS, Nov. 3, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced that Express Scripts Medicare® Prescription Drug Plan (PDP), contract S5660, has once again earned a 4-Star* quality rating from the Centers for Medicare and Medicaid Services (CMS). "As our country faces rising drug costs, Medicare beneficiaries need a plan they can rely on for medica... 
11/01/2016Express Scripts to Present at the Credit Suisse Healthcare Conference
ST. LOUIS, Nov. 1, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (the "Company" or "Express Scripts") today announced that it will present at the Credit Suisse Annual Healthcare Conference on Tuesday, November 8, 2016 at 9:30 a.m. MST (11:30 a.m. EST) at The Phoenician in Scottsdale, AZ. The presentation will be broadcast via the Internet and can be accessed at the Investor Relations section of Express Scripts' website at http://www.express-scripts.com.  RealPlayer or W... 
10/25/2016Express Scripts Announces 2016 Third Quarter Results
ST. LOUIS, Oct. 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 third quarter net income of $722.9 million, or $1.15 per diluted share.  2016 third quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.74.1 "The healthcare industry demands that we stay ahead of future trends and deliver solutions to emerging issues facing today's market," said Tim Wentworth, CEO and President.  "Doing so deepens the trusted relationships we have bui... 
10/04/2016Express Scripts Holding Company Announces Third Quarter Earnings Conference Call
ST. LOUIS, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its third quarter earnings on Tuesday, October 25, 2016 after the market closes and will hold its quarterly conference call to discuss third quarter results on Wednesday, October 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).  The call is being broadcast and can be accessed at the Investor Information section of Express Scripts’ web site at www.ex... 
09/08/2016Express Scripts Launches Inflammatory Conditions Care Value Program(SM), Making America's Costliest Medication Class More Affordable
New Value-Based Model Aligns Drug Payments to Specific Medical Conditions and Refunds Payers for Early Discontinuation of Expensive Medications ST. LOUIS, Sept. 8, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today launched its Inflammatory Conditions Care Value Program℠, a comprehensive approach to control costs and improve care for people with inflammatory conditions like rheumatoid arthritis, psoriasis and Crohn's Disease. Through the combination of indication-specific ... 
09/01/2016Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, Sept. 1, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (the "Company" or "Express Scripts") announced today that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at 1:00 p.m. Eastern Time (12:00 p.m. Central Time).  The presentation will be broadcast via the Internet and can be accessed at the Investor Relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media ... 
08/31/2016Express Scripts Launches Diabetes Care Value Program℠, Guaranteeing More Affordable, Higher-Quality Diabetes Care
Plans Adopting Novel Approach Will Cut Anticipated 2017 Diabetes Drug Trend in Half ST. LOUIS, Aug. 31, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced the launch of its Diabetes Care Value Program℠, the industry's most comprehensive approach to improve pharmacy care while controlling plan costs for people with diabetes. The new program – part of the Express Scripts SafeGuardRx℠ suite of pharmacy solutions – combines a novel quality-based pharmacy network, a holist... 
07/28/2016Express Scripts Announces Final Results of Maximum Tender Offers
ST. LOUIS, Mo., July 28, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the final tender results for its previously announced tender offers (the "Maximum Tender Offers") to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series") that will not result in an aggregate amount that all holders of any such series of Notes are entitled ... 
07/25/2016Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance
ST. LOUIS, July 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 second quarter net income of $720.7 million, or $1.13 per diluted share.  2016 second quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.57.1   "As the healthcare industry changes, a primary need of payers and patients remains the same: access to affordable medicine," said Tim Wentworth, CEO and President.  "An increase in our expected 2017 retention rate to a range ... 
07/23/2016Express Scripts Announces Early Tender Results and Upsizing of Maximum Tender Offers
ST. LOUIS, July 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the early tender results for its previously announced tender offers (the "Maximum Tender Offers") to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series") that will not result in an aggregate amount that all holders of any such series of Notes are entitled to re... 
07/14/2016Express Scripts Announces Pricing of Maximum Tender Offers
ST. LOUIS, July 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the consideration payable in connection with its previously announced tender offers (the "Maximum Tender Offers") to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series") that will not result in an aggregate amount that all holders of any series of Notes are ent... 
07/14/2016Express Scripts Announces Early Tender Results and Upsizing of Maximum Tender Offers
ST. LOUIS, July 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the early tender results for its previously announced tender offers (the "Maximum Tender Offers") to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series") that will not result in an aggregate amount that all holders of any such series of Notes are entitled to re... 
07/11/2016Express Scripts Holding Company Announces Second Quarter Earnings Conference Call
ST. LOUIS, July 11, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its second quarter earnings on Monday, July 25, 2016 after the market closes and will hold its quarterly conference call to discuss second quarter results on Tuesday, July 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investor Information section of Express Scripts’ web site at www.express-scri... 
07/06/2016Express Scripts Announces Pricing and Expiration of Any and All Tender Offer
ST. LOUIS, July 6, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the pricing and expiration of its previously announced tender offer (the "Tender Offer") to purchase for cash any and all of its outstanding 2.650% senior notes due 2017 (the "Notes"). Title of Security CUSIP Number Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Fixed ... 
06/29/2016Express Scripts Announces Tender Offers for Outstanding Debt Securities
ST. LOUIS, June 29, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced that it has commenced tender offers to purchase for cash the debt securities listed in the tables below (collectively, the "Securities" and each a "series"). Any and All of the Outstanding Securities Listed Below Title of Security CUSIP Number Principal Amount Outstanding U.S. Treasury Reference Security B... 
05/31/2016Express Scripts Holding Company to Present at Upcoming Conferences
ST. LOUIS, May 31, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the following conferences: Goldman Sachs 37th Annual Global Healthcare Conference on Thursday, June 9, 2016 at 9:20 a.m. pacific (12:20 p.m. eastern). William Blair and Company's 36th Annual Growth Stock Conference on Wednesday, June 15, 2016 at 10:00 a.m. central (11:00 a.m. eastern). These presentations will also be broadcast via the Internet and can be accessed... 
05/02/2016Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, May 2, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Wednesday, May 11, 2016 at 8:40 a.m. pacific (11:40 a.m. eastern). The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen to the Webcast... 
04/25/2016Express Scripts Announces 2016 First Quarter Results; Increases 2016 Guidance Range: Raises Mid-Point; Provides 2016 Second Quarter Guidance
ST. LOUIS, April 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 first quarter net income of $526.1 million, or $0.81 per diluted share.  2016 first quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.22.1   "Our strong financial results are built upon a foundation of client alignment, patient care and financial discipline," said George Paz, CEO.  "It has been a privilege to lead Express Scripts and I am proud of what we have acco... 
04/06/2016Express Scripts Holding Company Announces First Quarter Earnings Conference Call
ST. LOUIS, April 06, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its first quarter earnings on Monday, April 25, 2016 after the market closes and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investor Information section of Express Scripts’ web site at www.express-scr... 
04/05/2016U.S. Workers' Compensation Prescription Drug Spending Increased 2.2 Percent in 2015
Opioids Remain Costliest Therapy Class, Yet Express Scripts Management Programs Drove Down Utilization For Fifth Consecutive Year ST. LOUIS, April 5, 2016 /PRNewswire/ -- Rising drug prices contributed to a 2.2 percent growth in pharmacy spending for American workers' compensation payers in 2015, according to a new report released today by Express Scripts (NASDAQ: ESRX). Effective management programs helped lower injured workers' drug utilization by 2.6 percent last year, offsetting th... 
03/14/2016Increase in U.S. Drug Spending Slowed to 5.2 Percent in 2015 Through Cost-Saving Solutions, Specialized Care
- Express Scripts solutions slowed increases in overall drug spending despite price inflation of greater than 20 percent on more than one-third of brand-name medications in 2015 - For Express Scripts members, average monthly copayments decreased 3.2 percent - Change in drug spending was flat or negative for 30 percent of Express Scripts clients in 2015 - Express Scripts Hepatitis Cure Value Program® lowered the cost of therapy by 50 percent, saving payers $1 billion while providing cura... 
03/01/2016Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference
ST. LOUIS, March 1, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the Barclays Global Healthcare Conference on Tuesday, March 15, 2016 at 8:30 a.m. eastern at the Loews Miami Beach Hotel in Miami Beach, FL. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to t... 
02/26/2016Express Scripts Announces Pricing and Expiration of Tender Offer
ST. LOUIS, Feb. 26, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the pricing and expiration of its previously announced tender offer (the "Tender Offer") to purchase for cash any and all outstanding 3.125% senior notes due 2016 listed in the table below (the "Notes"). Title of Security CUSIP Number Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Refere... 
02/25/2016Express Scripts Announces Accelerated Share Repurchase Transaction
ST. LOUIS, Feb. 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (the "Company or "Express Scripts") announced that it has entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC. Under the terms of the ASR agreement the Company will receive an aggregate initial delivery of approximately 32.1 million shares of the Company's common stock in exchange for a prepayment of $2.8 billion. The final number of shares to be repurchased will be ... 
02/22/2016Express Scripts Announces a Tender Offer for Any and All of the Outstanding 3.125% Senior Notes due 2016
ST. LOUIS, Feb. 22, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced that it has commenced a tender offer (the "Tender Offer") to purchase for cash any and all outstanding 3.125% senior notes due 2016 listed in the table below (the "Notes"). Title of Security CUSIP Number Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread Hypothe... 
02/16/2016Express Scripts Announces 2015 4th Quarter and Full Year Results; Narrows 2016 Guidance Range: Raises Mid-Point
ST. LOUIS, Feb. 16, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 fourth quarter and full year net income of $773.5 million and $2,476.4 million, respectively, or $1.13 and $3.56 per diluted share.  2015 fourth quarter and full year adjusted earnings per diluted share, as detailed in Table 4, was $1.56 and $5.53, respectively.1   "Our business model of alignment, developed 30 years ago, has never been more relevant than it is today," said George Paz, Chair... 
02/04/2016Express Scripts Holding Company Announces Fourth Quarter and Full Year 2015 Earnings Conference Call
ST. LOUIS , Feb. 04, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its fourth quarter and full year earnings on Tuesday, February 16, 2016 after the market closes and will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 17, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investor Information section of Expre... 
01/04/2016Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Jan. 4, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the J.P. Morgan Healthcare Conference on Monday, January 11, 2016 at 3:30 p.m. Pacific (6:30 p.m. ET) at the Westin St. Francis in San Francisco, CA. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to li... 
12/22/2015Express Scripts Holding Company Announces 2016 Financial Guidance and Reaffirms 2015 Financial Guidance
ST. LOUIS, Dec. 22, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share for 2016 in the range of $6.08 to $6.28, representing growth of 10% to 14% over the mid-point of our previously issued 2015 guidance range – See table below. "Our focused model of alignment has positioned us uniquely in the healthcare services landscape to improve health outcomes and lower costs for our clients and patients," said George Paz, CEO a... 
12/14/2015Express Scripts Holding Company Announces 2016 Financial Guidance Webcast And Conference Call
ST. LOUIS, Dec. 14, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced today its intention to release its 2016 financial guidance on Tuesday, December 22, 2015, via press release before the market opens and prior to a conference call to discuss the 2016 financial guidance on Tuesday, December 22, 2015, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time).  The conference call will feature remarks by George Paz, CEO and chairman, Tim Wentworth, President and Eric Slusser,... 
12/03/2015Express Scripts Increases Authorization for Share Repurchase Program
ST. LOUIS, Dec. 3, 2015 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that on December 2, 2015, the Board of Directors of the Company approved an increase in the authorized number of shares that may be repurchased under the Company's share repurchase program by an additional 60 million shares, or a total authorization of 265 million shares, of the Company's common stock. About Express Scripts Express Scripts puts medicine within reach of tens of millions of people by aligning wi... 
12/01/2015Express Scripts Champions $1 per Pill Access to an Alternative for Daraprim
ST. LOUIS, Dec. 1, 2015 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced it will partner with Imprimis Pharmaceuticals (NASDAQ: IMMY) to drive access to a low-cost alternative to Daraprim (pyrimethamine), a drug for the treatment of toxoplasmosis that has been recently priced out of reach for people with HIV, pregnant women and others with weakened immune systems. Imprimis is offering a compounded oral formulation of pyrimethamine and leucovorin (a form of folic acid) for $1 p... 
11/30/2015Premera Blue Cross and Express Scripts Agree to Contract Extension
Agreement Secures Enduring Partnership in Healthcare Innovation and Affordability MOUNTLAKE TERRACE, Wash. and ST. LOUIS, Nov. 30, 2015 /PRNewswire/ -- Premera Blue Cross and Express Scripts (NASDAQ: ESRX) today announced an early renewal of the companies' long-standing pharmacy benefit agreement. The partnership, which began in 1999, will now extend through at least 2019. After evaluating pharmacy benefit manager capabilities during a competitive review and selection process, Premera... 
11/06/2015Express Scripts to Present at the Credit Suisse Healthcare Conference
ST. LOUIS, Mo., Nov. 6, 2015 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the Credit Suisse Annual Healthcare Conference on Wednesday, November 11, 2015 at 9:30 a.m. MST (11:30 a.m. EST) at The Phoenician in Scottsdale, AZ. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen to ... 
10/27/2015Express Scripts Announces 3rd Quarter Results; Increases 2015 Guidance Range
ST. LOUIS, Oct. 27, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 third quarter net income attributable to Express Scripts stockholders of $661.7 million, or $0.97 per diluted share.  Adjusted earnings per diluted share, as detailed in Table 4, were $1.45 for the third quarter. 1 "With the rising cost of prescription drugs, we are continuing our mission to make medicine more affordable and accessible for clients and patients," said George Paz, Chairman and... 
10/21/2015Quality, Care and Convenience: Express Scripts Presents 4-Star Medicare Prescription Drug Programs for 2016
Express Scripts Choice and Value Plans Continue Value-Driven Pharmacy Network Featuring Walgreens ST. LOUIS, Oct. 21, 2015 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced that its nationally available Express Scripts Medicare® Prescription Drug Plans (PDP) have earned a 4-Star* quality rating from the Centers for Medicare and Medicaid Services (CMS) for the second consecutive year. "Express Scripts Medicare prescription drug plans offer tremendous value to retirees, help... 
10/15/2015Express Scripts Holding Company Announces Third Quarter 2015 Earnings Conference Call
ST. LOUIS, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its third quarter earnings on Tuesday, October 27, 2015 after the market closes and will hold its quarterly conference call to discuss third quarter results on Wednesday, October 28, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investor Information section of Express Scripts' web site at www.expr... 
10/06/2015Express Scripts Includes Innovative Cholesterol-Lowering Drugs on National Preferred Formulary
- Both Praluent™ and Repatha™ Will Be Included on the Nation's Largest Drug Formulary - Express Scripts Uniquely Expands Affordable Access and Caps Future Cost Increases - Cholesterol Care Value Program Offers Superior Patient Care, Greater Payer Value Through the Accredo® Specialty Pharmacy ST. LOUIS, Oct. 6, 2015 /PRNewswire/ -- To ensure clinically appropriate, cost-effective use of two new cholesterol-lowering drugs, Express Scripts (NASDAQ: ESRX) today announced it will include b... 
09/10/2015Express Scripts Names Eric Slusser Chief Financial Officer
ST. LOUIS, Sept. 10, 2015 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced Eric Slusser has joined the company as Executive Vice President and Chief Financial Officer, effective September 9, 2015. Mr. Slusser joins Express Scripts with significant experience as a financial executive in healthcare, bringing executive-level and functional experience in all aspects of finance including strategy, capital markets, mergers and acquisitions, financial reporting, plan... 
09/09/2015Express Scripts Names Tim Wentworth Chief Executive Officer, Effective May 2016; George Paz to Retire and Remain as Chairman
ST. LOUIS, Sept. 9, 2015 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced George Paz will retire as Chief Executive Officer, effective following the company's annual meeting of stockholders currently scheduled for May 2016, and current company President Tim Wentworth will take on the role of CEO. Mr. Paz will remain on the Board as non-executive Chairman following his retirement, and Thomas Mac Mahon will continue as Lead Independent Director. Mr. Wentworth was... 
07/28/2015Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range
ST. LOUIS, July 28, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 second quarter net income attributable to Express Scripts stockholders of $600.1 million, or $0.88 per diluted share.  Adjusted earnings per diluted share, as detailed in Table 4, were $1.44 for the second quarter. 1  "It is clear many companies across healthcare are validating the need for size and scale," said George Paz, Chairman and Chief Executive Officer. "But, what matters most is how... 
07/06/2015Express Scripts Holding Company Announces Second Quarter 2015 Earnings Conference Call
ST. LOUIS, July 6, 2015 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its second quarter earnings on Tuesday, July 28, 2015 after the market closes and will hold its quarterly conference call to discuss second quarter results on Wednesday, July 29, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investor Information section of Express Scripts' web site at www.express-s... 
07/01/2015Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends
- Latest Express Scripts Exchange Pulse Report reveals new exchange enrollees in Q1 2015 were healthier and spent less on medications compared to exchange enrollees in Q1 2014, helping plans better balance their risk. - Full-year analysis of exchange plan specialty pharmacy spending reveals 24 percent growth - nearly three times the growth rate seen among traditional health plans. - Five percent of exchange plan patients with high annual medication costs accounted for 68 percent of total p... 
06/12/2015Express Scripts Elects Tim Wentworth to Board of Directors
ST. LOUIS, June 12, 2015 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that its Board of Directors has elected Tim Wentworth to the Board. Mr. Wentworth is currently the President of Express Scripts, a role he has held since 2014. He has management responsibility for all aspects of the company's core business, and reports directly to George Paz, Express Scripts' Chairman and CEO. "We are pleased to welcome Tim to the Express Scripts Board of Directors, an... 
06/02/2015Express Scripts to Present at the William Blair 35th Annual Growth Stock Conference
ST. LOUIS, June 2, 2015 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the William Blair 35th Annual Growth Stock Conference on Tuesday, June 9, 2015 at 10:10 a.m. CT (11:10 a.m. ET). The presentation will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen to the Webcast and free downloads of these players ar... 
05/13/2015Express Scripts Research Highlights $52 Billion Challenge for U.S. Healthcare System
- Nearly 600,000 Americans have annual medication costs above $50,000 - The number of U.S. patients taking at least $100,000 worth of prescription drugs tripled in 2014 - Majority of these patients take at least 10 medications, from at least 4 different prescribers - Express Scripts solutions address critical opportunities to improve care and reduce costs for patients with high medication costs ORLANDO, Fla., May 13, 2015 /PRNewswire/ -- As pharmaceutical companies introduce more h... 
05/05/2015SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health
Innovative Quality Network Program uses risk and reward design to promote patient health outcomes LONG BEACH, Calif. and ST. LOUIS, May 5, 2015 /PRNewswire/ -- Medicare beneficiaries with diabetes, high blood pressure or high cholesterol may achieve better health outcomes when using pharmacies that are part of performance-based networks, according to early results of a unique program conducted by SCAN Health Plan and Express Scripts (NASDAQ: ESRX). "Pharmacists are one of the most trus... 
04/29/2015Express Scripts Announces Accelerated Share Repurchase Transaction
ST. LOUIS, April 29, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it has entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC. Under the terms of the ASR agreement the Company will receive an aggregate initial delivery of approximately 55.1 million shares of the Company's common stock in exchange for a prepayment of $5.5 billion. The final number of shares to be repurchased will be based on the average of the daily v... 
04/28/2015Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point
ST. LOUIS, April 28, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 first quarter net income attributable to Express Scripts stockholders of $441.1 million, or $0.60 per diluted share.  Adjusted earnings per diluted share, as detailed in Table 4, were $1.10 for the first quarter.1   "As our industry evolves, and plan sponsors have more business models to choose from, it is increasingly clear that Express Scripts is the best choice to manage America's pharma... 
04/21/2015Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs
Rising Prescription Prices for Compounded Medications Still a Concern ST. LOUIS, April 21, 2015 /PRNewswire/ -- Workers' compensation pharmacy spending increased 1.9 percent in 2014, as a 5.4 percent decrease in utilization helped offset a 7 percent increase in the cost per prescription, according to new data released today by Express Scripts (NASDAQ: ESRX). The 2014 Express Scripts Workers' Compensation Drug Trend Report discusses the overall pharmacy trend as well as in-depth resear... 
04/08/2015Express Scripts Holding Company Announces First Quarter 2015 Earnings Conference Call
ST. LOUIS, April 8, 2015 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its first quarter earnings on Tuesday, April 28, 2015 after the market closes and will hold its quarterly conference call to discuss first quarter results on Wednesday, April 29, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investor Information section of Express Scripts' web site at www.express-... 
03/10/2015U.S. Prescription Drug Spending Increased 13.1 Percent in 2014, Driven by Hepatitis C and Compounded Medications
- The 2014 Express Scripts Drug Trend Report shows highest national spend increase over past decade. Excluding hepatitis C and compounded medications, drug spending increased 6.4 percent in 2014. - More than 15 percent of Express Scripts' clients spent less on prescription drugs in 2014 than in 2013. Closely managed pharmacy plans spent nearly 30 percent less per member on traditional medications, reduced annual specialty drug spend increases by 32 percent. - Express Scripts' hepatitis C s... 
02/23/2015Express Scripts Announces 4th Quarter Results; Provides Initial 2015 Earnings Guidance
ST. LOUIS, Feb. 23, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 fourth quarter and full year net income attributable to Express Scripts stockholders of $581.8 million and $2,007.6 million, or $0.79 and $2.64 per diluted share.  Adjusted earnings per diluted share, as detailed in Table 4, were $1.39 and $4.88 for the fourth quarter and full year, respectively. 1   "While we are proud of our heritage and the work we have done for clients, we are even more ... 
01/16/2015Express Scripts Announces Fourth Quarter 2014 Earnings Conference Call and Webcast of Investor Day Meeting
ST. LOUIS, Jan. 16, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced today its intention to release its fourth quarter and full year earnings and 2015 earnings guidance on Monday, February 23, 2015 after the market closes and will hold its quarterly conference call to discuss fourth quarter and full year results and 2015 earnings guidance on Tuesday, February 24, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).  The Company has scheduled an investor day ... 
01/06/2015Express Scripts to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Jan. 6, 2015 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 at 9:00 a.m. Pacific (12:00 p.m. EST) at the Westin St. Francis in San Francisco, CA. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the... 
12/22/2014Express Scripts and AbbVie Make Hepatitis C Cure Available to Millions of Patients in Need
- Viekira Pak® Will Be the Exclusive Option for Genotype 1 Hepatitis C Patients Covered by the Express Scripts National Preferred Formulary - Multi-Year Agreement Significantly Expands Affordable Access to a Curative Hepatitis C Therapy - Superior Patient Care, Greater Payer Value Available Through Accredo® Specialty Pharmacy ST. LOUIS, Dec. 22, 2014 /PRNewswire/ -- Offering an unprecedented solution to an unprecedented healthcare challenge, Express Scripts (NASDAQ: ESRX) today announ... 
12/15/2014Express Scripts Initiates Chief Financial Officer Transition Process; Increases Authorization of Share Repurchase Program; and Reaffirms 2014 Guidance
ST. LOUIS, Dec. 15, 2014 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) announced that it is initiating a Chief Financial Officer transition process.  Cathy R. Smith will be leaving the Company to pursue other interests and no longer serves in the role of Executive Vice President and Chief Financial Officer of the Company.  Ms. Smith will continue her employment into the first quarter of 2015 in order to facilitate a smooth and orderly transition.  Express Scripts also announced that James M... 
12/09/2014Many Americans on Long-Term Painkillers Take Potentially Fatal Drug Combinations
- New Express Scripts report provides nation's most comprehensive analysis of pain treatment trends. - Amount of pain medication taken increased significantly over the past five years while the number of Americans using pain medications long-term remained flat. - Use of pain medications most prevalent in small, Southeastern cities. - Nearly half of chronic pain medication users took short-acting medications on a long-term basis, thus increasing their risk for addiction. ST. LOUIS... 
11/05/2014Express Scripts to Present at the Credit Suisse Healthcare Conference
ST. LOUIS, Nov. 5, 2014 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the Credit Suisse Annual Healthcare Conference on Tuesday, November 11, 2014 at 9:30 a.m. MST (11:30 a.m. EST) at the Arizona Biltmore Hotel in Phoenix, AZ. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen t... 
10/28/2014Express Scripts Announces 3rd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
ST. LOUIS, Oct. 28, 2014 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 third quarter net income attributable to Express Scripts stockholders of $582.3 million, or $0.78 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, was $1.29 for the third quarter.1   "We have continually improved the pharmacy benefit over nearly three decades, and we're positioning ourselves to drive further advances," stated George Paz, chairman and chief exec... 
10/15/20142015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality and Performance Rating
Express Scripts Medicare Choice and Value plans offer America's seniors quality, value in Part D ST. LOUIS, Oct. 15, 2014 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) announced today that its 2015 Express Scripts Medicare® prescription drug plan S5660 (PDP) earned a 4-Star rating* from the Centers for Medicare & Medicaid Services (CMS). "Express Scripts Medicare is a high-quality Part D plan that offers seniors total value – affordability, choice, convenience, clinical care and ... 
10/09/2014Express Scripts Holding Company Announces Third Quarter 2014 Earnings Conference Call
ST. LOUIS, Oct. 9, 2014 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its third quarter earnings on Tuesday, October 28, 2014 after the market closes and will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2014, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Inv... 
10/08/2014New Express Scripts Analysis Reveals Trends Among Health Exchange Members
- Nearly half already using pharmacy benefit - Exchange members more likely to use generic medications - Specialty medications comprise 1.3% of prescriptions, 38% of expenditures ST. LOUIS, Oct. 8, 2014 /PRNewswire/ -- Nearly half of Americans enrolled in a Public Health Insurance Exchange plan, including those who waited until April 2014 to enroll, have already used their pharmacy benefit, according to new data published today by Express Scripts (NASDAQ: ESRX). This usage rate i... 
10/01/2014Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network
New Preferred Pharmacy Network to Offer Seniors $0 and $1 Copayments on Tier 1 Generics ST. LOUIS, Oct. 1, 2014 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced that its two nationally available 2015 Express Scripts Medicare® Prescription Drug Plans (PDP) will offer a preferred retail pharmacy network featuring Walgreens (NYSE: WAG) (NASDAQ: WAG), helping America's seniors obtain more value, choice and clinical support  for their Medicare dollars. Medicare beneficiaries w... 
09/12/2014Express Scripts Elects Roderick Palmore to Board of Directors
ST. LOUIS, Sept. 12, 2014 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that its Board of Directors has appointed Roderick Palmore to fill a vacancy on the Board. Mr. Palmore serves as executive vice president, general counsel, chief compliance and risk management officer and secretary of General Mills (retiring February 2015). He joined General Mills in 2008 from Sara Lee Corporation, where he served as executive vice president, general counsel and secretar... 
08/05/2014U.S. Will Waste $9 Billion on Non-Pharmacy Specialty Medications in 2015
Express Scripts' Medical Benefit Management Reduces Overall Specialty Drug Spend ST. LOUIS, Aug. 5, 2014 /PRNewswire/ -- Next year, U.S. health plan sponsors are projected to spend $9.07 billion on specialty medication services that provide no additional value, according to a new analysis released today by Express Scripts (NASDAQ: ESRX). This wasteful spending could be avoided if payers applied cost-saving techniques from the pharmacy benefit on medications that are administered through the... 
07/29/2014Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
ST. LOUIS, July 29, 2014 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 second quarter net income attributable to Express Scripts stockholders of $515.2 million, or $0.67 per diluted share.  Adjusted earnings per diluted share, as detailed in Table 4, was $1.23 for the second quarter.1 "We are well positioned to serve our clients with scale, alignment and innovative solutions to lower costs, manage trend and to improve the health outcomes of our members," stated... 
07/17/2014State Governments May Spend $55 Billion on Hepatitis C Medications
Unprecedented High Drug Costs to Force Major Financial Tradeoffs for State Budgets ST. LOUIS, July 17, 2014 /PRNewswire/ -- State legislatures will need to find billions in their budgets to purchase costly new hepatitis C therapy, according to a new state-by-state analysis released today by Express Scripts (NASDAQ: ESRX). More than 750,000 Americans with chronic hepatitis C receive state-funded healthcare through Medicaid or the prison system. Given the pricing that drug manufacturers... 
07/07/2014Express Scripts Holding Company Announces Second Quarter 2014 Earnings Conference Call
ST. LOUIS, July 7, 2014 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its second quarter earnings on Tuesday, July 29, 2014 after the market closes and will hold its quarterly conference call to discuss second quarter results on Wednesday, July 30, 2014, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investo... 
07/01/2014Express Scripts Names David Queller Senior Vice President, Sales and Account Management
ST. LOUIS, July 1, 2014 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that David Queller will join the company as Senior Vice President, Sales and Account Management, effective July 8, 2014. He will be responsible for the leadership, strategic direction and oversight of the company's portfolio of business divisions. Mr. Queller will join Express Scripts from Aetna, where he was Senior Vice President, National Accounts. He led Aetna's premier business unit th... 
06/09/2014Top 5 Percent of Opioid Prescribers Write 40 Percent of US Narcotic Prescriptions
New Express Scripts Research Identifies High Prescribers Among Peer Groups SAN DIEGO, June 9, 2014  /PRNewswire/ -- Forty percent of U.S. narcotic prescriptions in 2011-2012 were written by only five percent of opioid prescribers, according to a study Express Scripts (NASDAQ: ESRX) presented today at AcademyHealth's annual research meeting. The study identifies prescribers who prescribe opioids at a much higher rate than peers who are in the same specialty, treat patients of simi... 
05/05/2014Express Scripts to Present at Upcoming Conferences
ST. LOUIS, May 5, 2014 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences: Bank of America Merrill Lynch 2014 Healthcare Conference on Tuesday, May 13, 2014 at 8:40 a.m. pacific (11:40 a.m. eastern). Jefferies 2014 Global Healthcare Conference on Wednesday, June 4th at 8:00 a.m. eastern. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site a... 
04/29/2014Express Scripts Announces 1st Quarter Results
Adjusts 2014 Full Year Guidance ST. LOUIS, April 29, 2014 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 first quarter net income attributable to Express Scripts1 stockholders of $328.3 million, or $0.42 per diluted share.  Adjusted earnings per diluted share, as detailed in Table 4, was $0.99 for the first quarter.   "We have been focused on integration over the last several years, and as a result of this effort, we have successfully built a technology platf... 
04/18/2014Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract
ST. LOUIS, April 18, 2014 /PRNewswire/ -- The U.S. Department of Defense today awarded Express Scripts (NASDAQ: ESRX) administration of the TRICARE Pharmacy Program, Fourth Generation (TPharm4) contract serving approximately 10 million beneficiaries. "Express Scripts is proud to continue providing world-class service and specialized pharmacy care to our men and women in uniform, along with their dependents and also to military retirees," said George Paz, chairman and chief executive office... 
04/15/2014Express Scripts Holding Company Announces First Quarter 2014 Earnings Conference Call
ST. LOUIS, April 15, 2014 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its first quarter earnings on Tuesday, April 29, 2014 after the market closes and will hold its quarterly conference call to discuss first quarter results on Wednesday, April 30, 2014, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Investor... 
04/10/2014Cost Increases Drive Higher Drug Trend for Workers' Compensation
Spending on Compounded Medications More Than Doubled in 2013 ST. LOUIS, April 10, 2014 /PRNewswire/ -- Significant increases in cost per prescription drove drug trend for workers' compensation payers higher in 2013, according to research released this week by Express Scripts (NASDAQ: ESRX). Overall pharmacy spending for workers' compensation increased 9.5 percent, according to the Express Scripts Workers' Compensation Drug Trend Report, primarily from an 8.2 percent jump in cost per prescri... 
04/09/2014Express Scripts Analysis Reveals First Look at Medication Utilization Trends Among Public Health Insurance Exchange Enrollees
Early Data Shows Greater Use of Specialty Medications in Exchange Plans vs. Commercial Health Plans ORLANDO, Fla., April 9, 2014 /PRNewswire/ -- In a first look at pharmacy trends in Public Health Insurance Exchange plans, use of specialty medications was greater among Exchange enrollees versus patients enrolled in a commercial health plan, according to new research presented today by Express Scripts (NASDAQ: ESRX).  "This is a very early analysis that starts to tell the story of how ... 
04/08/2014U.S. Spending on Hepatitis C Medications to Skyrocket 1,800 Percent by 2016
Express Scripts Report Forecasts Unsustainable Increases in Specialty Drug Spend ORLANDO, Fla., April 8, 2014 /PRNewswire/ -- Expensive treatments for broad patient populations are driving unprecedented growth in U.S. spending on specialty drugs to treat complex conditions such as rheumatoid arthritis, multiple sclerosis and cancer, according to a new report issued today by Express Scripts (NASDAQ: ESRX). As it has for the past two decades, the Express Scripts Drug Trend Report quantif... 
03/20/2014Express Scripts Named as a 2014 World's Most Ethical Company by the Ethisphere Institute
ST. LOUIS, March 20, 2014 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) announced today that it has been recognized by the Ethisphere Institute, an independent center of research promoting best practices in corporate ethics and governance, as a 2014 World's Most Ethical Company®. The award recognizes organizations that continue to raise the bar on ethical leadership and corporate behavior. World's Most Ethical Company honorees understand the correlation between ethics, reputation and daily... 
03/12/2014ADHD Medication Use Continues to Climb, Biggest Gains Seen Among Adults
Express Scripts Report Shows More Women than Men Take ADHD Drugs ST. LOUIS, March 12, 2014 /PRNewswire/ -- The number of Americans who use medication to treat Attention Deficit Hyperactivity Disorder (ADHD) rose 36 percent in 5 years, totaling more than 4.8 million privately insured individuals in 2012, according to the most current and comprehensive analysis of these medications released today by Express Scripts (NASDAQ: ESRX). The new report, Turning Attention to ADHD, also shows tha... 
02/27/2014Express Scripts Workers' Compensation Solution Helps Payers Address the Rising Cost of Physician Dispensing
ST. LOUIS, Feb. 27, 2014 /PRNewswire/ -- Medications dispensed through a physician's office are often repackaged and priced as much as 60 to 300 percent higher than an identical drug dispensed at a pharmacy to workers receiving treatment due to on-the-job injuries. Today, Express Scripts (NASDAQ: ESRX) announced the launch of a new Physician-Dispensed Medication Solution to provide workers' compensation payers visibility into their true total pharmacy costs and help reduce costs resulting from  ... 
02/24/2014Express Scripts to Present at Upcoming Conferences
ST. LOUIS, Feb. 24, 2014 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences: Cowen and Company 34th Annual Healthcare Conference on Monday, March 3, 2014 at 2:50 p.m. eastern. Barclays Global Healthcare Conference on Wednesday, March 12, 2014 at 8:30 a.m. eastern. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-sc... 
02/20/2014Express Scripts Announces Record 4th Quarter Adjusted EPS of $1.12; Reported EPS of $0.64
Provides Initial 2014 Earnings Guidance ST. LOUIS, Feb. 20, 2014 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2013 fourth quarter and full year net income from continuing operations attributable to Express Scripts shareholders of $514.2 million and $1,898.2 million, or $0.64 and $2.31 per diluted share, respectively.  Adjusted earnings per diluted share from continuing operations attributable to Express Scripts, as detailed in Table 4, were $1.12 and $4.3... 
02/10/2014Express Scripts Unveils Industry-Leading Medicare Star Ratings Modeling Dashboard for Health Plans
ConstellationSM Ratings Advisor modeling program is first to link Star Rating improvements to projected CMS quality bonuses and total plan performance NEW ORLEANS, Feb. 10, 2014 /PRNewswire/ -- Presenting today at the Institute for International Research 11th Annual Medicare Congress, Express Scripts (NASDAQ: ESRX) is introducing a breakthrough modeling tool to help Medicare health plans simply and effectively navigate Centers for Medicare and Medicaid Services (CMS) Star Ratings, and ident... 
01/28/2014Tim Wentworth Named President of Express Scripts
ST. LOUIS, Jan. 28, 2014 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today appointed Tim Wentworth as President. He will have management responsibility for all aspects of the company's core business, and will report directly to chairman and CEO, George Paz. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) (Photo: http://photos.prnewswire.com/prnh/20140128/AQ54549) Mr. Wentworth, 53, most recently was Senior Vice President and President, Sales an... 
01/14/2014Express Scripts Names Cathy R. Smith Chief Financial Officer
ST. LOUIS, Jan. 14, 2014 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that Cathy R. Smith will join the company as Executive Vice President and Chief Financial Officer, effective February 10, 2014. (Logo:  http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) She will join Express Scripts from Walmart, where she has been executive vice president of strategy and chief financial officer for Walmart International since February 2010. Before joining ... 
01/03/2014Express Scripts to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Jan. 3, 2014 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the J.P. Morgan Healthcare Conference on January 15, 2014 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) at the Westin St. Francis in San Francisco, CA.   The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is ne... 
12/20/2013Express Scripts to Webcast Investor Day Meeting
ST. LOUIS, Dec. 20, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced today its intention to release its fourth quarter earnings and 2014 earnings guidance on Thursday, February 20, 2014 after the market closes and has scheduled an investor day meeting in New York City at 8:00 a.m. Eastern Time on February 21, 2014.  In addition to discussing fourth quarter earnings and 2014 earnings guidance, senior management will review the Company's strategies to deliver long-term... 
12/10/2013Express Scripts Announces Accelerated Share Repurchase Transaction
ST. LOUIS, Dec. 10, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it has entered into an accelerated share repurchase, or ASR, transaction with Bank of America, N.A. to purchase shares of Express Scripts' common stock for an aggregate purchase price of $1,500 million.  The ASR transaction is subject to customary terms and conditions and will be funded from cash on hand. Under the terms of the transaction, Express Scripts will initially receive approximately 2... 
11/04/2013Express Scripts to Present at the Credit Suisse Healthcare Conference
ST. LOUIS, Nov. 4, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the Credit Suisse Healthcare Conference on November 12, 2013 at 9:00 a.m. MST (11:00 a.m. EST) at the Phoenician Hotel in Scottsdale, AZ. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the W... 
10/29/2013Express Scripts Launches Workers' Compensation Program To Help Payers Reduce Narcotic Abuse
Express Scripts' Morphine Equivalent Dose Management Program Provides a Real-Time, Proactive Approach to Better Ensure Appropriate Use of Narcotics ST. LOUIS, Oct. 29, 2013 /PRNewswire/ -- Prescription narcotic overdoses cause more deaths than cocaine and heroin combined each year. Misuse and abuse of these powerful medications also result in significant extra expense for workers' compensation payers. Today, Express Scripts (NASDAQ: ESRX) announced the launch of its Morphine Equivalent Dose... 
10/24/2013Express Scripts Reports Third Quarter 2013 Results
Increases 2013 Earnings Guidance ST. LOUIS, Oct. 24, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2013 third quarter net income from continuing operations attributable to Express Scripts shareholders of $442.2 million, or $0.54 per diluted share.  Adjusted earnings per diluted share from continuing operations attributable to Express Scripts, as detailed in Table 4, were $1.08 for the third quarter.  The quarter reflects a reduction in the income tax rate to ad... 
10/10/2013Express Scripts Holding Company Announces Third Quarter 2013 Earnings Conference Call
ST. LOUIS, Oct. 10, 2013 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its third quarter earnings on Thursday, October 24, 2013 after the market closes and will hold its quarterly conference call to discuss third quarter results on Friday, October 25, 2013, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at the Inve... 
10/08/2013Express Scripts Presents 2014 Medicare Prescription Drug Plan Options, Including $0 Copay for Generics, 3,000 Covered Medications
New Preferred Pharmacy Network in "Choice" Plan Offers Greater Savings for Seniors ST. LOUIS, Oct. 8, 2013 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today unveiled two nationally available Medicare Part D plans through its Express Scripts Medicare™ Prescription Drug Plan (PDP), providing America's seniors with choice, value and clinical support that can help safeguard their health and their Medicare dollars. (Logo:  http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) ... 
09/17/2013New Research Finds Many Seniors Wrongly Think Public Health Insurance Exchanges Are Replacing Medicare Plans
Confusion about the Affordable Care Act Could Lead Seniors to Make Poor Medicare Enrollment, Health Decisions ST. LOUIS, Sept. 17, 2013 /PRNewswire/ -- As the nation approaches open enrollment for new public health insurance exchanges and Medicare, a new survey shows major misconceptions among seniors over how healthcare reform impacts Medicare benefits. This knowledge gap, coupled with fear about the affordability of healthcare, could lead seniors to make poor Medicare enrollment and healt... 
09/09/2013Express Scripts Acquires SmartD Medicare Prescription Drug Plan; Adds to Industry-Leading Medicare Offering
ST. LOUIS, Sept. 9, 2013 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced the strategic acquisition of the SmartD Medicare Prescription Drug Plan (PDP) which will add 87,000 covered Medicare lives. Terms of the deal were not disclosed. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) "Working together with independent and chain pharmacies, we look forward to serving SmartD members and we are pleased in the continued growth and enhancement of our Medicar... 
09/04/2013TRICARE Mail Order Pharmacy Program Demonstrates Safety, Cost-Effectiveness and Improved Health Outcomes
-- Accuracy rate of mail order prescriptions: 99.997 percent -- Mail order savings over retail pharmacy: 16.7 percent -- Beneficiary satisfaction: 96 percent ST. LOUIS, Sept. 4, 2013 /PRNewswire/ -- Working with Express Scripts (NASDAQ: ESRX), the Department of Defense (DoD) TRICARE® mail order pharmacy program cost the government and beneficiaries less money than retail pharmacies and is a safe, effective way to deliver prescription drugs, a new DoD Inspector General audit has found.... 
08/13/2013New Study Finds Anxiety Medication Use Higher Among Caregivers
Express Scripts Data Reveal 29% Greater Use of Anxiety Medications, Higher Prevalence of Other Stress-Related Conditions among Caregiver Population ST. LOUIS, Aug. 13, 2013 /PRNewswire/ -- According to a new report released today by Express Scripts (NASDAQ: ESRX), the stress associated with providing unpaid care for a sick or disabled adult can create additional detrimental effects on the caregiver's health, leading to a 29 percent greater use of anti-anxiety medications compared to non car... 
08/01/2013Express Scripts and Walgreens Offer New Solution to Improve Patient Health
ST. LOUIS & DEERFIELD, Ill.--(BUSINESS WIRE)--Aug. 1, 2013-- Express Scripts (NASDAQ:ESRX) and Walgreens (NYSE:WAG) (NASDAQ:WAG) today announced the launch of Smart90® Walgreens, a new option for Express Scripts clients interested in 90-day prescription drug programs that drive lower costs and improve health outcomes for people with chronic diseases who require long-term treatment. Under the new option, plan sponsors that choose to include Wa... 
07/29/2013Express Scripts Reports Second Quarter 2013 Results
Increases 2013 Earnings Guidance ST. LOUIS, July 29, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2013 second quarter net income from continuing operations attributable to Express Scripts shareholders of $558.3 million, or $0.67 per diluted share.  Adjusted earnings per diluted share from continuing operations attributable to Express Scripts, as detailed in Table 4, were $1.12 for the second quarter.   "Our second quarter results reflect the successful exec... 
07/25/2013Express Scripts To Discuss Outlook for Future Growth
ST. LOUIS, July 25, 2013 /PRNewswire/ -- As previously announced, Express Scripts Holding Company (Nasdaq: ESRX) will release its second quarter earnings on Monday, July 29, 2013 after the market closes and will hold its quarterly conference call to discuss second quarter earnings results on Tuesday, July 30, 2013, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed from the Investor Information section of Express Scripts' web site at www.expre... 
07/02/2013Express Scripts Holding Company Announces Second Quarter 2013 Earnings Conference Call
ST. LOUIS, July 2, 2013 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its second quarter earnings on Monday, July 29, 2013 after the market closes and will hold its quarterly conference call to discuss second quarter results on Tuesday, July 30, 2013, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at Express Scripts' ... 
06/06/2013Express Scripts to Present at the William Blair 33rd Annual Growth Stock Conference
ST. LOUIS, June 6, 2013 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the William Blair 33rd Annual Growth Stock Conference on Tuesday, June 11, 2013 at 7:30 a.m. central (8:30 a.m. eastern). The presentation will be broadcast via the internet and can be accessed through the Investor Relations section of the Express Scripts web site at http://www.express-scripts.com.  Following the presentation, both the slide deck and the webcast will remain availa... 
05/21/2013U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015
Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions ST. LOUIS, May 21, 2013 /PRNewswire/ -- U.S. spending on specialty prescription drugs -- those used to treat chronic, complex diseases such as cancer, multiple sclerosis and rheumatoid arthritis -- is projected to increase 67 percent by the end of 2015, according to a forecast released today by Express Scripts (NASDAQ: ESRX). "As we see what's on the horizon,... 
05/08/2013Express Scripts to Present at Upcoming Conferences
ST. LOUIS, May 8, 2013 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences: - Bank of America Merrill Lynch 2013 Healthcare Conference on Thursday, May 16, 2013 at 10:00 a.m. Pacific (1:00 p.m. Eastern). - UBS Global Healthcare Conference on Tuesday, May 21, 2013 at 1:30 p.m. Eastern. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http... 
04/29/2013Express Scripts Reports First Quarter 2013 Results
Increases 2013 Earnings Guidance ST. LOUIS, April 29, 2013 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) announced 2013 first quarter net income from continuing operations attributable to Express Scripts shareholders of $374 million, or $0.45 per diluted share. Adjusted earnings per diluted share from continuing operations attributable to Express Scripts, as detailed in Table 4, were $0.99 for the first quarter. "Our strong financial performance in the first quarter repre... 
04/23/2013Poorest U.S. States Rank Among Most Wasteful in Unnecessary Medication-Related Costs
Waste Needlessly Added $418 Billion to the Country's 2012 Healthcare Spend ORLANDO, Fla., April 23, 2013 /PRNewswire/ -- The United States wasted $418 billion in 2012 based on bad medication-related decisions, and the impact was most deeply felt in those states that could least afford it, according to new research from Express Scripts (NASDAQ: ESRX). (Photo: http://photos.prnewswire.com/prnh/20130423/AQ99646-INFO) (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSL... 
04/22/2013Express Scripts Holding Company Announces First Quarter 2013 Earnings Conference Call
ST. LOUIS, April 22, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its first quarter earnings on Monday, April 29, 2013 after the market closes and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 30, 2013, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is being webcast and can be accessed at Express Scrip... 
04/22/2013Express Scripts Research Shows Prescription Drug Utilization Declines for Payers of Workers' Compensation
Narcotics Still Remain Highest Cost Therapy Class; Comprehensive Fraud, Waste and Abuse Program Key to Reducing Waste ST. LOUIS, April 22, 2013 /PRNewswire/ -- Express Scripts' (NASDAQ: ESRX) industry-leading prescription management programs drove down utilization of prescription drugs for workers' compensation payers last year even though overall drug trend rose, according to new research released today in the Express Scripts 2012 Workers' Compensation Drug Trend Report. (Logo: h... 
04/09/2013Express Scripts Recommends Rejection of TRC Capital's "Mini-Tender" Offer
ST. LOUIS, April 9, 2013 /PRNewswire/ -- Express Scripts Holding Company ("Express Scripts") (NASDAQ: ESRX) today announced that it has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 2 million shares of Express Scripts common stock, or approximately 0.24 percent of shares outstanding, at $55.75 per share, which is approximately 2.7 percent below the closing share price of Express Scripts common stock on April 8, 2013 ($57.27). Express Scripts ... 
03/18/2013New National Survey Shows Majority of Americans Confident About Choosing Health Coverage
Public Exchanges: Survey Spotlights Role of Pharmacy in Purchasing Preferences ST. LOUIS, March 18, 2013 /PRNewswire via COMTEX/ --While complex changes are coming to healthcare next year, a majority of Americans — including those currently uninsured — are confident in their ability to choose health coverage, according to a national survey released today by Express Scripts (NASDAQ: ESRX). (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) With a new marketplace of hea... 
03/07/2013Express Scripts Study Reveals Keys to Controlling Specialty Drug Costs
Tightly Managed Specialty Pharmacy Benefits Can Cut Specialty Drug Trend in Half WASHINGTON, March 7, 2013 /PRNewswire via COMTEX/ --A study presented today at the National Business Group on Health's (NBGH) Business Health Agenda 2013 conference in Washington, D.C., showed that, on average, employers that use multiple cost management programs had a 50 percent lower specialty drug trend than employers that did not use any specialty management programs. (Logo: http://photos.prnewswire.com/p... 
03/05/2013US Spending on Traditional Prescription Drugs Fell in 2012 for First Time on Record
- Hepatitis C accounted for higher percentage drug spend increase than any other major disease in 2012. - Spending on medications to treat attention disorders increased 14.2 percent in 2012, due largely to increased utilization among adult patients. - Within the Medicaid population, the highest percentage drug spend increase was attributed to medications to treat alcohol and drug dependence. ST. LOUIS, March 5, 2013 /PRNewswire via COMTEX/ --For the first time in more than 20 years, there... 
02/20/2013Express Scripts to Present at Upcoming Conferences
ST. LOUIS, Feb. 20, 2013 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences: Citi 2013 Global Healthcare Conference on Wednesday, February 27, 2013 at 9:35 a.m. eastern. Cowen and Company 33rd Annual Healthcare Conference on Wednesday, March 6, 2013 at 9:20 a.m. eastern. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site a... 
02/18/2013Express Scripts Reports Fourth Quarter and Full Year Results
Provides Initial 2013 Earnings Guidance ST. LOUIS, Feb. 18, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2012 fourth quarter and full year net income attributable to Express Scripts shareholders from continuing operations of $515.9 million and $1,340.5 million, or $0.62 and $1.79 per diluted share, respectively. Adjusted earnings per share attributable to Express Scripts from continuing operations, as detailed in Table 4 were $1.05 and $3.74 per diluted share ... 
01/17/2013Express Scripts Holding Company Announces Fourth Quarter 2012 Earnings Conference Call
ST. LOUIS, Jan. 17, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its fourth quarter earnings on Monday, February 18, 2013 at approximately 4:00 p.m. Eastern Time (3:00 p.m. Central Time) and will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 19, 2013, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is b... 
01/09/2013Express Scripts Extends Exchange Offer with Respect to Certain of Its Senior Notes
ST. LOUIS, Jan. 9, 2013 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company") today announced that it has extended until January 11, 2013 at 5:00 p.m., New York City time, the expiration date of its offer to exchange: an aggregate principal amount of up to $900,000,000 of its 2.750% Senior Notes due 2014 and the related subsidiary guarantees, which have been registered under the Securities Act of 1933, as amended (the "Securities Act"), for a like principal ... 
12/21/2012Express Scripts to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Dec. 21, 2012 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX) announced that Jeff Hall, CFO, will present at the J.P. Morgan 2013 Healthcare Conference on January 8, 2013 at 9:00 a.m. PST (12:00 p.m. EST) at the Westin St. Francis in San Francisco, CA. As announced on its third quarter earnings conference call, in order to improve clarity, the Company will provide guidance and outlook information for 2013 in conjunction with its fourth quarter earnings release. Fourth quar... 
11/28/2012Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
-The Express Scripts Prescription Price Index shows that since September 2011, price inflation for the most highly utilized brand-name medications was more than six times greater than overall economic price inflation for consumer goods. -The price gap between brand-name and generic medications widened an additional 35.2 percentage points from September 2011 to September 2012, the largest one-year increase Express Scripts has recorded. -Year-to-date spending on specialty medications is up 22.... 
11/07/2012Express Scripts to Present at Investor Conferences in November
ST. LOUIS, Nov. 7, 2012 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the following investor conferences in November: Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 8:30 a.m. eastern. Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, 2012 at 10:00 a.m. mountain (12:00 p.m. eastern). These presentations will also be broadcast via the Internet and can be accessed on the In... 
11/05/2012Express Scripts Reports Third Quarter Results
Raises Full Year Earnings Guidance ST. LOUIS, Nov. 5, 2012 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX) announced 2012 third quarter net income of $391.4 million, or $0.47 per diluted share. Adjusted earnings per share, as detailed in Table 4 were $1.02 per diluted share for the third quarter. "Our solid third quarter results demonstrate our continued success as a combined organization," stated George Paz, chairman and chief executive officer. "Integration continues on track ... 
10/30/2012The Growing Cost of Aging: Express Scripts Study Shows Medication Use for Normal Aging Conditions Overtakes Costs of Treating Most Chronic Diseases
ST. LOUIS, Oct. 30, 2012 /PRNewswire via COMTEX/ --Prescription-drug treatment regimens for conditions that are a normal part of aging are now costing the nation more than many serious and potentially life-threatening diseases, according to new research from Express Scripts (NASDAQ: ESRX). (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) A study, presented today at the annual meeting of the American Public Health Association (APHA) in San Francisco, finds that in 2011 ... 
10/23/2012Express Scripts Holding Company Announces Third Quarter 2012 Earnings Conference Call
ST. LOUIS, Oct. 23, 2012 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Monday, November 5, 2012 after the market closes and will hold its quarterly conference call to discuss third quarter results on Tuesday, November 6, 2012, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). The Company expects to provide 2013 guidance in co... 
10/18/2012New Express Scripts Workers' Compensation Product Helps Payers Address Cost Impact of Physician Dispensing
ST. LOUIS, Oct. 18, 2012 /PRNewswire via COMTEX/ --Express Scripts (NASDAQ: ESRX) is applying its understanding of behavioral science to a new program to help workers' compensation payers save money on costly medications. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) The new product is based on the findings of a pilot study designed to encourage injured workers to use clinically equivalent generic medications. For example, the pilot found that injured workers who we... 
10/17/2012Express Scripts Unveils 2013 Medicare Prescription Drug Plan Options, Including $0 Copay for Generics and Broad Pharmacy Network
Express Scripts Medicare™ (PDP) has been awarded 4 out of 5 stars for service and quality excellence by CMS ST. LOUIS, MO., October 17, 2012 -- Express Scripts (NASDAQ: ESRX) unveiled two Medicare Part D plans through its Express Scripts Medicare™ Prescription Drug Plan (PDP), formerly Medco Medicare Prescription Plan, to help America’s seniors save money on prescription drug costs as generic versions of popular brand name drugs become available. Enrollment for the 2013 plan year begins Octob... 
09/25/2012Express Scripts Announces Federal Pharmacy Services Division
ST. LOUIS, Sept. 25, 2012 /PRNewswire via COMTEX/ --With 10 years of experience in making the use of prescription drugs safer and more affordable for millions of military beneficiaries, Express Scripts (NASDAQ: ESRX) is today doing even more to serve other entities through its newly rebranded Federal Pharmacy Services division. (Logo: http://photos.prnewswire.com/prnh/20120925/AQ79760LOGO) (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) For the past decade, Express... 
08/31/2012Consumer-Directed Healthcare Leader ConnectYourCare Emerging as Private Company
Growth Equity Firm ABS Capital to Assume Majority Ownership HUNT VALLEY, Md., Aug. 31, 2012 /PRNewswire via COMTEX/ --ConnectYourCare, a leading consumer-directed healthcare (CDH) account administrator, announced today that its parent company, Express Scripts Holding Company (Nasdaq: ESRX), has entered into a definitive agreement to divest ConnectYourCare. Effective upon the closing of the transaction, which is subject to customary closing conditions, ConnectYourCare will operate independentl... 
08/16/2012Express Scripts Launches Virtual Coaching To Help Patients Better Understand Therapy
ST. LOUIS, Aug. 16, 2012 /PRNewswire via COMTEX/ --A new online tool, Virtual Coaching, helps patients -- especially those with complex health conditions -- better understand their disease and how their medication works. Express Scripts is making Virtual Coaching available through HealthBridge Pharma & Biotech, now part of United BioSource Corporation, which offers a full range of integrated services to assist pharmaceutical and biotech companies in providing specialty prescription produc... 
08/07/2012Express Scripts Reports Second Quarter Results
Raises Full Year Earnings Guidance ST. LOUIS, Aug. 7, 2012 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX) announced 2012 second quarter net income of $170.9 million, or $0.21 per diluted share. Adjusted earnings per share, as detailed in Table 4 were $0.88 per diluted share for the second quarter. "Our strong second quarter results, the first as a combined organization, demonstrate the continued execution of our business model of alignment," stated George Paz, chairman and chief... 
07/19/2012Express Scripts and Walgreens Announce New Pharmacy Network Agreement
ST. LOUIS & DEERFIELD, Ill., Jul 19, 2012 (BUSINESS WIRE) --Express Scripts (NASDAQ: ESRX) and Walgreens (NYSE: WAG) (NASDAQ: WAG) today announced the companies have reached a multi-year pharmacy network agreement that includes rates and terms under which Walgreens will participate in the broadest Express Scripts retail pharmacy network available to new and existing clients. The companies are not disclosing the terms of the new contract. Walgreens will be part of the broadest network of pharma... 
07/10/2012Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
ST. LOUIS, July 10, 2012 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Tuesday, August 7, 2012 after the market closes and will hold its quarterly conference call to discuss second quarter results on Wednesday, August 8, 2012, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed a... 
06/06/2012Express Scripts to Present at William Blair Growth Stock Conference
ST. LOUIS, June 6, 2012 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the William Blair Growth Stock Conference on June 12, 2012 at 11:30 a.m. Central (12:30 p.m. Eastern) at the Four Seasons Hotel in Chicago, Illinois. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts' web site at http://www.express-scripts.com  RealPlayer or Windows Media Player is needed to listen to ... 
05/17/2012Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers
ST. LOUIS, May 17, 2012 /PRNewswire via COMTEX/ -- "9 Trends" Report Identifies What's On the Minds of Employers and Health Plans: Helping Members Make Healthier Decisions Using Social Media and Apps to Engage Members and Improve Behaviors Developing New Ways to Comprehensively Manage Specialty Care Improving Convenience and Adherence through Home Delivery Poor health choices add billions in cost to the companies, unions, health plans and government agencies that ... 
05/11/2012Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
ATLANTA, May 11, 2012 /PRNewswire via COMTEX/ --Older patients with high cholesterol or high blood pressure are at particular risk for unnecessary hospitalizations if they don't follow doctor's orders on taking their medications, according to new research from Express Scripts (NASDAQ: ESRX) presented this week. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) Data from two studies show that patients 65 and older who did not take their medicines as prescribed had around a... 
05/10/2012Express Scripts Reports First Quarter Results
ST. LOUIS, May 10, 2012 /PRNewswire via COMTEX/ --Express Scripts Holding Company (Nasdaq: ESRX) announced 2012 first quarter net income of $267.8 million, or $0.55 per diluted share. These results reflect those of Express Scripts, Inc. prior to the completion of the merger with Medco Health Solutions, Inc. ("Medco"), on April 2, 2012. Adjusted earnings per share, as detailed in Table 4 were $0.73 per diluted share for the first quarter. "With the close of the Medco acquisition, Express Scr... 
05/04/2012Express Scripts to Present at Bank of America Merrill Lynch Conference
ST. LOUIS, May 4, 2012 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Bank of America Merrill Lynch 2012 Healthcare Conference on May 16, 2012 at 1:00 p.m. PDT (4:00 p.m. EDT) at the Encore at the Wynn in Las Vegas, Nevada. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts' web site at http://www.express-scripts.com  RealPlayer or Windows Media Player is needed to lis... 
04/17/2012Waste Adds $2.1 Billion to Workers' Compensation Pharmacy Costs, Express Scripts Reports
Unnecessary Use of Higher-Priced Medications Leading Cause of Waste; Lower-Cost, Clinically Equivalent Alternatives Would Save Billions for Workers' Compensation Payers ST. LOUIS, April 17, 2012 /PRNewswire via COMTEX/ --Unnecessary use of higher-priced medications resulted in nearly all of the $2.1 billion in wasted pharmacy-related spending last year for workers' compensation payers, according to research published in the 2011 Express Scripts Workers' Compensation Drug Trend Report. About 1... 
04/16/2012Express Scripts Launches ScreenRx(SM), Industry's First Solution Combining Early Detection and Tailored Interventions to Address Nation's $317 Billion Problem of Medication Nonadherence
- ScreenRx leverages predictive models and clinical expertise to help patients take their medication as prescribed. - New Drug Trend Report shows that eliminating medication nonadherence would cover the cost of healthcare for 44.8 million uninsured Americans. - In 2011, United States spending on prescription drugs increased 2.7 percent, the lowest annual drug trend Express Scripts has ever recorded. ST. LOUIS, April 16, 2012 /PRNewswire via COMTEX/ --Express Scripts (NASDAQ: ESRX) today a... 
04/06/2012Notice of Redemption and Withdrawal of Class of Securities from Listing on the NYSE
ST. LOUIS, April 6, 2012 /PRNewswire via COMTEX/ --On April 6, 2012, Medco Health Solutions, Inc., a wholly owned subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), issued a notice of redemption to the holders of its 7.25% Senior Notes due August 15, 2013 (Cusip No. 58405UAC6) (the "Notes"), which were issued under the Indenture, dated as of August 12, 2003, between Medco and U.S. Bank Trust National Association, as trustee. As indicated in the notice of redemption, Medco intends to ... 
04/05/2012Express Scripts Announces First Quarter 2012 Earnings Conference Call
ST. LOUIS, April 5, 2012 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Thursday, May 10, 2012 after the market closes and will hold its quarterly conference call to discuss first quarter results on Friday, May 11, 2012, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is being webcast and can be accessed at Express Scripts W... 
04/02/2012Express Scripts and Medco Health Solutions Complete Merger; Will Address National Mandate for More Affordable, Higher Quality Healthcare
ST. LOUIS, April 2, 2012 /PRNewswire via COMTEX/ --Express Scripts (NASDAQ: ESRX) completed its previously announced $29.1 billion acquisition of Medco Health Solutions today, creating the country's leading healthcare services company. (Photo: http://photos.prnewswire.com/prnh/20120402/AQ80316) (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) The new Express Scripts combines best-in-class clinical expertise and innovative applications of behavioral science to improve p... 
03/19/2012Express Scripts Research Shows Choosing Appropriate Medications Could Save Workers' Compensation Payers More than $23.7 Million Annually
ST. LOUIS, March 19, 2012 /PRNewswire/ -- Choosing clinically equivalent, lower-cost narcotic medications could cut more than $23 million a year in pharmacy-related costs for workers' compensation claims, according to an Express Scripts, Inc. (NASDAQ: ESRX) analysis. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) Express Scripts researchers examined workers' compensation prescription data for 402,000 injured workers who had filled at least one narcot... 
02/27/2012Express Scripts Unveils Comprehensive Fraud, Waste and Abuse Program for Workers' Compensation Clients
New suite of services will detect and deter fraud in workers' compensation prescriptions, saving tens of millions of dollars annually ST. LOUIS, Feb. 27, 2012 /PRNewswire/ -- Express Scripts, Inc. (NASDAQ:ESRX) announced today it has established a comprehensive Fraud, Waste and Abuse (FWA) detection program for workers' compensation payers, which can help stem the rising costs associated with the widespread abuse of prescription narcotics. (Logo: http://photos.prnewswir... 
02/22/2012Express Scripts Reports Fourth Quarter Results
ST. LOUIS, Feb. 22, 2012 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced 2011 fourth quarter and full year net income from continuing operations of $290.4 million and $1,275.8 million, or $0.59 and $2.53 per diluted share, respectively.  Adjusted earnings per share, as detailed in Table 4 were $0.82 and $2.97 per diluted share for the fourth quarter and full year, respectively. "Through our unwavering focus on innovation, service and alignment, we achieved a historically high ... 
02/07/2012Express Scripts Announces Fourth Quarter 2011 Earnings Conference Call
ST. LOUIS, Feb. 7, 2012 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Wednesday, February 22, 2012 after the market closes and will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 23, 2012, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is being webcast and can be accessed at Exp... 
02/06/2012Express Scripts, Inc. Announces Pricing of $3.5 Billion Senior Notes Offering
ST. LOUIS, Feb. 6, 2012 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that its wholly owned subsidiary, Aristotle Holding, Inc., a Delaware corporation ("Aristotle"), has successfully priced a private offering of senior notes consisting of $1.0 billion aggregate principal amount of 2.10% senior notes due 2015, $1.5 billion aggregate principal amount of 2.65% senior notes due 2017 and $1.0 billion aggregate principal amount of 3.90% senior notes due 2022. The o... 
02/06/2012Express Scripts, Inc. Launches Senior Notes Offering
ST. LOUIS, Feb. 6, 2012 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that its wholly owned subsidiary, Aristotle Holding, Inc., a Delaware corporation ("Aristotle"), has commenced a private offering of senior notes of a benchmark amount.  The net proceeds from the offering will be used to pay a portion of the cash consideration payable to stockholders of Medco Health Solutions, Inc. ("Medco") in connection with the previously announced merger pursuant to which Express S... 
01/04/2012Express Scripts HealthBridge Pharma & Biotech to Provide Specialty Pharmacy and Specialty Distribution Services for EYLEA(TM) (aflibercept) Injection
ST. LOUIS, Jan. 4, 2012 /PRNewswire via COMTEX/ --Express Scripts now provides services for EYLEA, a product of Regeneron, through its HealthBridge Pharma & Biotech services. CuraScript, a wholly owned subsidiary of Express Scripts and part of the HealthBridge suite of services, will be among a limited number of specialty pharmacies and specialty distributors for EYLEA. EYLEA (aflibercept) Injection was approved by the Food and Drug Administration on Nov. 18 and is indicated for the treat... 
12/29/2011Express Scripts to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Dec. 29, 2011 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the 30th Annual J.P. Morgan Healthcare Conference on January 9, 2012 at 9:00 a.m. PST (12:00 p.m. EST) at the Westin St. Francis in San Francisco, CA. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen t... 
12/06/2011Combining Express Scripts and Medco Health Solutions Will Help Protect Americans From the Rising Costs of Prescription Medicine
- Merger will accelerate the ability to drive out wasteful spending, lower cost of medicine, detect and close gaps in care, and increase safety and affordability for consumers - Complementary innovative approaches to patient care align with needs of business, labor, health plan and government clients to preserve and enhance the pharmacy benefit WASHINGTON, Dec. 6, 2011 /PRNewswire via COMTEX/ --Bringing together innovative pharmacy benefit managers Express Scripts, Inc. (NASDAQ: ESRX) and Me... 
12/05/2011Express Scripts and Medco Save Americans Tens of Billions in Healthcare Costs, New Economic Report Shows
- Pharmacy Benefit Managers tackle one of America's great economic challenges: the skyrocketing cost of healthcare - Innovative solutions drive out waste, lower costs and improve health outcomes - Merger of Express Scripts and Medco will help make prescription drugs more affordable for American families WASHINGTON, Dec. 5, 2011 /PRNewswire via COMTEX/ --Pharmacy benefit managers Express Scripts and Medco save employers, the federal government, labor unions, and consumers between $51 billion... 
11/14/2011Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering
ST. LOUIS, Nov. 14, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that its wholly owned subsidiary, Aristotle Holding, Inc., a Delaware corporation ("Aristotle"), has successfully priced a private offering of senior notes consisting of $900.0 million aggregate principal amount of 2.750% senior notes due 2014, $1.25 billion aggregate principal amount of 3.500% senior notes due 2016, $1.25 billion aggregate principal amount of 4.750% senior notes due 2021 an... 
11/14/2011Express Scripts, Inc. Launches Senior Notes Offering
ST. LOUIS, Nov. 14, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that its wholly owned subsidiary, Aristotle Holding, Inc., a Delaware corporation ("Aristotle"), has commenced a private offering of senior notes of a benchmark amount. The net proceeds from the offering will be used to pay a portion of the cash consideration payable to stockholders of Medco Health Solutions, Inc. ("Medco") in connection with the previously announced merger pursuant to which... 
10/27/2011Express Scripts to Present at Investor Conferences in November
ST. LOUIS, Oct. 27, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following investor conferences in November: Credit Suisse 2011 Healthcare Conference on Wednesday, November 9, 2011 at 7:30 a.m. mountain (9:30 a.m. eastern). Lazard Capital Markets' 8th Annual Healthcare Conference on Wednesday, November 16, 2011 at 10:00 a.m. eastern. These presentations will also be broadcast via the Internet and can be accessed on the investor... 
10/25/2011Express Scripts Reports Third Quarter Results
Reaffirms 2011 Earnings Guidance ST. LOUIS, Oct. 25, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter 2011 net income from continuing operations of $324.7 million, or $0.66 per diluted share. Adjusted earnings per share, as detailed in Table 4 was $0.79 per diluted share for the third quarter, representing a 22% increase over last year. "Our third quarter results reflect the continued execution of our business model and the value of fully aligning... 
10/17/2011Express Scripts Announces Third Quarter 2011 Earnings Conference Call
ST. LOUIS, Oct. 17, 2011 /PRNewswire via COMTEX/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Tuesday, October 25, 2011 after the market closes and will hold its quarterly conference call to discuss third quarter results on Wednesday, October 26, 2011, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). This call is being webcast and can be accessed at Expr... 
10/13/2011Express Scripts HealthBridge Pharma & Biotech to Provide Exclusive Specialty Pharmacy Services and Limited Distribution Services for Solesta®
ST. LOUIS, Oct. 13, 2011 /PRNewswire via COMTEX/ -- CuraScript, Inc., a wholly owned subsidiary of Express Scripts, Inc., is now the exclusive specialty pharmacy for patients using Solesta®, a product of Oceana Therapeutics Inc., under an agreement announced today. Part of Express Scripts HealthBridge Pharma & Biotech services, CuraScript SD Specialty Distribution will be one of two national distributors responsible for delivering Solesta to healthcare providers. Solesta is the only non... 
10/06/2011Express Scripts Announces Revised 2011 Financial Guidance
ST. LOUIS, Oct. 6, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) has historically provided annual guidance with respect to anticipated future financial results. This guidance is based on a variety of assumptions, plans and expectations, and, as stated in the Company's various filings and releases, actual results may differ significantly from those originally projected or suggested in such guidance for a variety of reasons. In October of 2010, Express Scripts provided ... 
09/29/2011Express Scripts Announces Single-Solution Approach to Pharma Services Through HealthBridge Pharma & Biotech
ST. LOUIS [September 29, 2011] – Express Scripts has launched a suite of services for pharmaceutical and biotech companies through HealthBridge Pharma & Biotech, providing a single-solution approach to patient care. HealthBridge Pharma & Biotech offers a full range of integrated services to assist pharmaceutical and biotech companies in providing prescription products and services to patients, physicians and pharmacists. These services include: CuraScript Specialty Pharmacy, CuraScript Specialt... 
09/20/2011Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
-- Accelerates ability to drive out wasteful pharmacy spending, lower costs of prescription medicine, improve health outcomes and increase safety and affordability for consumers, employers and taxpayers -- Advances healthcare with innovation while aligning with business, labor, health plan and government clients WASHINGTON, Sept. 20, 2011 /PRNewswire via COMTEX/ -- The proposed combination of Express Scripts, Inc. (NASDAQ: ESRX) and Medco Health Solutions, Inc. (NYSE: MHS) will bring clear ... 
08/25/2011Express Scripts to Present at Investor Conferences in September
ST. LOUIS, Aug. 25, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following investor conferences in September: Stifel Nicolaus 2011 Healthcare Conference on September 8, 2011 at 2:40 p.m. EDT at the Four Seasons Hotel in Boston, MA. Morgan Stanley 2011 Global Healthcare Conference on September 14, 2011 at 11:30 a.m. EDT at the Grand Hyatt Hotel in New York. These presentations will also be broadcast via the Internet and can be ac... 
07/21/2011Express Scripts Reports Second Quarter Results
Reaffirms 2011 Earnings Guidance ST. LOUIS, July 21, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter 2011 net income from continuing operations of $334.2 million, or $0.66 per diluted share. Adjusted earnings per share, as detailed in Table 4, was $0.71 per diluted share for the second quarter, representing an 18% increase over last year. "Our second quarter results reflect the success of our business model of alignment," stated George Paz, chief... 
07/21/2011Express Scripts and Medco Health Solutions Sign Definitive Merger Agreement; Medco Shareholders to Receive $29.1 Billion
Combined company will lead the effort to lower costs of prescription medicines for American families and provide benefits to businesses in a globally-competitive marketplace -- Addresses the national mandate for more affordable, higher quality healthcare -- Merged company will advance healthcare through innovation and an unwavering alignment with clients ST. LOUIS and FRANKLIN LAKES, N.J., July 21, 2011 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (NASDAQ: ESRX) and Medco Health Solutio... 
07/06/2011Express Scripts Announces Second Quarter 2011 Earnings Conference Call
ST. LOUIS, July 6, 2011 /PRNewswire via COMTEX/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 27, 2011 after the market closes and will hold its quarterly conference call to discuss second quarter results on Thursday, July 28, 2011, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at Express... 
06/23/2011Express Scripts to Present at the 11th Annual Oppenheimer & Co. Consumer Conference
ST. LOUIS, June 23, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the 11th Annual Oppenheimer & Co. Consumer Conference on June 28, 2011 at 1:00 p.m. eastern at the Four Seasons Hotel in Boston. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com RealPlayer or Windows Media Player is needed to listen to the Web... 
06/21/2011Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families
Company Shocked that Walgreens Prematurely Walks Away from Negotiations ST. LOUIS, June 21, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (NASDAQ: ESRX) said today it is open to continued negotiations with Walgreens to make prescription drugs affordable and accessible for American families. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO "In these challenging economic times, it is critical that we all work together to keep medicines affordable and accessible... 
06/06/2011Express Scripts to Present at the William Blair 2011 Growth Stock Conference
ST. LOUIS, June 6, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the William Blair 2011 Growth Stock Conference on June 16, 2011 at 11:20 a.m. central (12:20 p.m. eastern) at the Four Seasons Hotel in Chicago. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com RealPlayer or Windows Media Player is needed to listen... 
05/27/2011Express Scripts Announces Accelerated Share Repurchase Transactions
ST. LOUIS, May 27, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it has entered into two accelerated share repurchase, or ASR, transactions with Morgan Stanley to purchase shares of Express Scripts' common stock for an aggregate purchase price of $1,750 million. Under the terms of the transactions, the Company will initially receive approximately 29.4 million shares of its stock. At the end of the respective valuation periods for the ASR transactions, the C... 
04/27/2011Express Scripts Announces Increase in Share Repurchase Authorization
ST. LOUIS, April 27, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced today that its Board of Directors approved an increase in the number of shares authorized and available for repurchase by adding 50 million shares to its existing 15.1 million of residual shares under the prior authorization. Therefore, a total of 65.1 million shares are available under the repurchase program. The increase in the share repurchase program was subject to the completion of the previou... 
04/27/2011Express Scripts Announces Pricing of Senior Notes
ST. LOUIS, April 27, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it has successfully priced its $1.5 billion underwritten public offering of 3.125% senior notes due 2016 to yield 3.212%, which was consistent with the expectations discussed in Monday's earnings release. The offering was made pursuant to the Company's registration statement and prospectus filed with the Securities and Exchange Commission ("SEC"). The Company will pay interest on the notes sem... 
04/25/2011Express Scripts Reports First Quarter Results
Reaffirms 2011 Earnings Guidance ST. LOUIS, April 25, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter 2011 net income from continuing operations of $326.5 million, or $0.61 per diluted share. Adjusted earnings per share, as detailed in Table 4 was $0.66 per diluted share for the first quarter, representing a 20% increase over last year. "Our recent Drug Trend Report details over $400 billion of pharmacy-related waste in healthcare spend by Amer... 
04/25/2011Express Scripts Announces Intention to Commence a Debt Offering
ST. LOUIS, April 25, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that the Company currently intends to commence a public offering of a benchmark amount of senior notes sometime within the next few weeks, subject to market and business conditions and other prevailing factors. The Company indicated that it currently intends to use the net proceeds from the debt offering to repurchase its common stock pursuant to its existing share repurchase program, or for other ... 
04/22/2011Express Scripts to Present at Investor Conferences in May
ST. LOUIS, April 22, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Deutsche Bank 36th Annual Healthcare Conference on May 2, 2011 at 1:30 p.m. EDT at the InterContinental Hotel in Boston. BofA Merrill Lynch 2011 Healthcare Conference on May 12, 2011 at 8:30 a.m. PDT (11:30 a.m. EDT) at the Encore at the Wynn in Las Vegas, Nevada. These presentations will also be broadcast via the Internet and can be acc... 
04/15/2011Express Scripts Announces First Quarter 2011 Earnings Conference Call
ST. LOUIS, April 15, 2011 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Monday, April 25, 2011 after the market closes and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 26, 2011, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at Express Scr... 
04/06/2011Harnessing Patients' Good Intentions Can Cut 33% of America's Pharmacy-Related Waste
Express Scripts Report Upends Conventional Thinking on Effective Pharmacy Care ST. LOUIS, April 6, 2011 /PRNewswire via COMTEX/ -- The U.S. can eliminate 33 percent of its annual pharmacy-related waste simply by activating patients' good intentions to improve common behaviors linked to their prescription drugs, according to a groundbreaking research report released today. In a break with traditional views on pharmacy care, the Express Scripts 2010 Drug Trend Report shows a significant gap bet... 
04/05/2011Express Scripts Injects $226 Million Into Arizona Economy, Study Finds
PHOENIX, April 5, 2011 /PRNewswire via COMTEX/ --Express Scripts contributed more than $226 million to Arizona's economy in 2010, according to an economic analysis of the company's data by a university professor. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) The economic impact study, presented today to state economic development officials and legislators, showed that the company's operations support 2,665 direct and indirect jobs in the state. The analysis was... 
03/14/2011New Application Offers Express Scripts Members Convenient Account Access Across a Broad Range of Mobile Phone Platforms
ST. LOUIS, March 14, 2011 /PRNewswire via COMTEX/ --Members served by Express Scripts (Nasdaq: ESRX) can now access their pharmacy benefits account on their smart phones using a new application launched today. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) Members can download the Express Rx app from the Apple App store or the Android Market. Other users, including those on BlackBerry devices, can access the mobile-optimized website at http://m.esrx.com. The Exp... 
03/01/2011Generics Superior First-Line Antidepressant Therapy, Express Scripts Study Confirms
ST. LOUIS, March 1, 2011 /PRNewswire via COMTEX/ --Patientswho start on generic antidepressants are as likely to keep taking their medication as prescribed as those who start on brand-name drugs, an Express Scripts (Nasdaq: ESRX) study shows. The company's analysis provides further proof that greater use of generics could significantly reduce wasteful healthcare spending while maintaining positive health outcomes. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) The ... 
02/22/2011Express Scripts to Present at Investor Conferences in March
ST. LOUIS, Feb. 22, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences in March: 2011 Citi Global Healthcare Conference on March 3, 2011 at 10:30 a.m. EST at the New York Hilton in New York, NY. 2011 Barclays Capital Global Healthcare Conference on March 16, 2011 at 8:00 a.m. EDT at the Lowes Miami Hotel in Miami, FL These presentations will also be broadcast via the Internet and can be accessed on the investor... 
02/16/2011Express Scripts Reports Strong Fourth Quarter and Full Year 2010 Results
ST. LOUIS, Feb. 16, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced 2010 fourth quarter and full year net income from continuing operations of $329.6 million and $1,204.6 million, or $0.62 and $2.21 per diluted share, respectively. Adjusted earnings per share, as detailed in Table 4 were $0.71 and $2.50 per diluted share for the fourth quarter and full year, respectively. "2010 was a transformational year for Express Scripts," stated George Paz, chief executive... 
01/26/2011Express Scripts Announces Fourth Quarter 2010 Earnings Conference Call
ST. LOUIS, Jan. 26, 2011 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Wednesday, February 16, 2011 after the market closes and will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 17, 2011, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at... 
01/03/2011Express Scripts to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Jan. 3, 2011 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the 29th Annual J.P. Morgan Healthcare Conference on January 10, 2011 at 8:30 a.m. PST (11:30 a.m. EST) at the Westin St. Francis in San Francisco, CA. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to li... 
12/17/2010Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus
With Expansion, Company's Economic Benefit to Missouri Tops $10 Billion over Next Decade, Independent Study Finds ST. LOUIS, Dec. 17, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX), today announced plans to build a 227,000-square-foot structure in the NorthPark development area -- the third office building and fourth facility at its headquarters campus in North St. Louis County. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) The company also... 
11/18/2010Express Scripts Establishes Industry's Most Comprehensive Specialty Benefits Organization; Enhances Patient Care and Guarantees Cost Savings
ST. LOUIS, Nov. 18, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX), today announced the formation of Express Scripts Specialty Benefit Services, the industry's most comprehensive specialty benefits organization. Express Scripts now delivers plan sponsors a first-in-the-industry offering that enhances patient care across the pharmacy-medical spectrum, and guarantees savings on the specialty medical drug spend. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRI... 
10/27/2010Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance
ST. LOUIS, Oct 27, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced 2010 third quarter net income from continuing operations of $307.1 million, or $0.57 per diluted share. Third quarter adjusted earnings per share, as detailed in Table 4, was $0.65 per diluted share, an increase of 55% over 2009. Third Quarter 2010 Review (2010 data reflected on an adjusted basis. See Tables 2 and 3) Total adjusted claims of 186.9 million, up 48% from 2009 Gros... 
10/25/2010Express Scripts to Present at Investor Conferences in November
ST. LOUIS, Oct 25, 2010 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following investor conferences in November: Oppenheimer 21st Annual Healthcare Conference on Wednesday, November 3, 2010 at 1:35 p.m. eastern. Credit Suisse 2010 Healthcare Conference on Wednesday, November 10, 2010 at 8:30 a.m. mountain (10:30 a.m. eastern). Lazard Capital Markets' 7th Annual Healthcare Conference on Tuesda... 
10/13/2010Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
ST. LOUIS, Oct 13, 2010 /PRNewswire via COMTEX/ --At the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference taking place in St. Louis this week, Express Scripts (Nasdaq: ESRX) will present research findings that spotlight new opportunities for driving down healthcare costs and providing increased value for health plan sponsors and patients. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20080827/EXPRESSSCR... 
10/12/2010Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
ST. LOUIS, Oct 12, 2010 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings and 2011 earnings guidance on Wednesday, October 27, 2010 after the market closes and will hold its quarterly conference call to discuss third quarter results and 2011 earnings guidance on Thursday, October 28, 2010, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). T... 
10/11/2010Express Scripts Accurately Predicts Which Patients Are Likely to Ignore Doctors' Orders
First PBM to Apply Custom Interventions to Prevent Non-Adherent Behavior ST. LOUIS, Oct 11, 2010 /PRNewswire via COMTEX/ -- Through a set of proprietary computer models, Express Scripts, Inc. (Nasdaq: ESRX), is now able to accurately predict up to a year in advance which patients are most at risk of falling off their physician-prescribed drug therapy -- and to intervene in customized ways to improve those patients' adherence. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPT... 
10/05/2010Express Scripts Completes Spinoff of Rx Outreach
New nonprofit addresses growing medical needs of low-income Americans ST. LOUIS, Oct 05, 2010 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX) has completed the spinoff of its Rx Outreach business unit to create a new independent, nonprofit charitable organization with the mission of improving access to prescription medicines for low-income, uninsured Americans and working families. Michael Holmes, former executive vice president of Express Scripts, leads the new national organiz... 
09/07/2010Express Scripts to Present at Investor Conferences in September
ST. LOUIS, Sept 07, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following investor conferences in September: Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 8:00 a.m. eastern at the Grand Hyatt New York. Stifel Nicolaus Healthcare Conference on Wednesday, September 15, 2010 at 1:30 p.m. eastern at the Four Seasons Hotel in Boston. These presentations will also be broadcast via the Internet and ... 
07/28/2010Express Scripts' Strong Operating Fundamentals Drive Record Earnings
ST. LOUIS, July 28, 2010 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced 2010 second quarter net income from continuing operations of $307.3 million, or $0.56 per diluted share. Second quarter adjusted earnings per share, as detailed in Table 4, was $0.60 per diluted share, an increase of 33% over 2009. All per share amounts have been adjusted to reflect the Company's 2-for-1 stock split which occurred in the second quarter. Second Quarter 2010 Review (2010 data ref... 
07/13/2010Express Scripts Announces Second Quarter 2010 Earnings Conference Call
ST. LOUIS, July 13, 2010 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 28, 2010 after the market closes and will hold its quarterly conference call to discuss second quarter results on Thursday, July 29, 2010, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at Express... 
06/09/2010Saint Louis University and Express Scripts Researchers Find Gender Differences Impact Management of MS
Study suggests separate communications approach and support would benefit men with MS ST. LOUIS, June 9, 2010 /PRNewswire via COMTEX/ --New research co-published by Saint Louis University and Express Scripts, Inc., (Nasdaq: ESRX) suggests that men with multiple sclerosis (MS) may require more education and support to manage their disease and therapy than women with MS. Men also may benefit from more targeted adherence interventions. The study found that female MS patients report better aware... 
06/03/2010Express Scripts to Present at Investor Conferences in June
ST. LOUIS, June 3, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following investor conferences in June: Goldman Sachs 31st Annual Global Healthcare Conference on Tuesday, June 15, 2010 at 11:30 a.m. PDT (2:30 p.m. EDT) at the Century Plaza Hyatt Regency in Los Angeles. William Blair Growth Stock Conference on Thursday, June 17, 2010 at 10:40 a.m. CDT (11:40 a.m. EDT) at the Four Seasons Hotel in Chicago. These presentations wi... 
06/03/2010Express Scripts Technology & Innovation Center Opens, Bringing 300 Jobs to North St. Louis County
Best-in-Class Facility Advances Safety and Cost Efficiency in Prescription Drugs ST. LOUIS, June 3, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX), today officially opened its new Technology & Innovation Center, a high-tech facility near its world headquarters campus that brings 300 jobs to the St. Louis region. The 224,000-square-foot facility features industry-leading technology for accuracy, patient safety and driving down the cost of healthcare. "The Express Sc... 
06/01/2010Ex-Dividend Date Set For Express Scripts Stock Split
ST. LOUIS, June 1, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) today announced that NASDAQ has established June 8, 2010 as the ex-dividend date for the previously announced two-for-one stock split, which will be effected in the form of a stock dividend. As Express Scripts announced last month, the stock split is for shareholders of record on May 21, 2010, and will be payable on June 7, 2010. The ex-dividend date is the date on or after which shares are traded without ... 
05/05/2010Express Scripts Declares 2-For-1 Stock Split
ST. LOUIS, May 5, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) today announced that its Board of Directors has approved a two-for-one stock split to be effected in the form of a stock dividend. The stock split is for shareholders of record as of May 21, 2010, and will be effective on June 7, 2010. "Our stock split reflects further proof of the strength of our business model of alignment and our unwavering focus on improving health outcomes for members while driving out... 
04/28/2010Express Scripts Reports Strong First Quarter Earnings
Increases Midpoint of 2010 Earnings Guidance Range ST. LOUIS, April 28, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced 2010 first quarter net income of $260.2 million, or $0.94 per diluted share. First quarter adjusted earnings per share, as detailed in Table 4, was $1.10 per diluted share, an increase of 25% over 2009. First Quarter 2010 Review (2010 data reflected on an adjusted basis. See Tables 2 and 3) Cash flow from continuing operations o... 
04/26/2010Express Scripts to Present at Investor Conferences
ST. LOUIS, April 26, 2010 /PRNewswire via COMTEX/ --Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Deutsche Bank 35th Annual Healthcare Conference on May 3, 2010 at 11:20 a.m. EDT at the InterContinental Hotel in Boston. BofA Merrill Lynch 2010 Healthcare Conference on May 13, 2010 at 8:40 a.m. EDT at the Grand Hyatt in New York City. These presentations will also be broadcast via the Internet and can be accessed on the investor relatio... 
04/20/2010Individuals' Behavior Costs United States $163 Billion Annually in Pharmacy-Related Waste
Express Scripts First to Quantify Hidden Pharmaceutical Cost of Common Behaviors ST. LOUIS, April 20, 2010 /PRNewswire via COMTEX/ --Express Scripts is the first organization ever to quantify the hidden healthcare costs of very common behaviors related to prescription drugs, such as forgetfulness and procrastination, estimating the annual wasteful spending at $163 billion. The Express Scripts 2009 Drug Trend Report, released today, quantifies changes in drug spend on a year-to-year basis... 
04/02/2010Express Scripts Announces First Quarter 2010 Earnings Conference Call
ST. LOUIS, April 2, 2010 /PRNewswire via COMTEX/ --Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Wednesday, April 28, 2010 after the market closes and will hold its quarterly conference call to discuss first quarter results on Thursday, April 29, 2010, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at Express S... 
03/31/2010Express Scripts Diabetes Study Shows Switch to Mail-Order Pharmacy Increases Medication Adherence and Lowers Healthcare Costs
ST. LOUIS, March 31, 2010 /PRNewswire via COMTEX/ --Diabetes patients had higher rates of medication adherence and lower general medical costs after switching to mail delivery of their prescriptions for at least 12 months, according to results of a study released today by Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America. The study examined diabetes medication adherence and healthcare costs in patients using mail-order services vers... 
03/16/2010Express Scripts to Present at Barclays 2010 Global Healthcare Conference
ST. LOUIS, March 16, 2010 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Barclays 2010 Global Healthcare Conference on March 23, 2010 at 1:30 p.m. eastern at the Loews Hotel in Miami, Florida. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com/. RealPlayer or Windows Media Player is needed to listen to the Webcast and f... 
02/24/2010Express Scripts Reports Strong Fourth Quarter Earnings
Provides 2010 Earnings Per Share GuidanceST. LOUIS, Feb 24, 2010 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced 2009 fourth quarter and full year net income from continuing operations of $222.9 million and $826.5 million, or $0.80 and $3.11 per diluted share, respectively. Adjusted earnings per share, as detailed in Table 3, were $0.97 and $3.58 per diluted share for the fourth quarter and full year, respectively. "2009 was an excellent year for Express Scripts. Du... 
02/05/2010Express Scripts Supports Red Cross Haiti Relief Efforts
ST. LOUIS, Feb 05, 2010 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, today announced that employees have donated more then $97,000 to the Red Cross for its emergency relief and recovery efforts to help those affected by the earthquake in Haiti. With a dollar for dollar match by the Express Scripts Foundation, the total donation was more then $194,000. "Express Scripts and its employees are deeply s... 
01/27/2010Express Scripts Announces Fourth Quarter 2009 Earnings Conference Call
ST. LOUIS, Jan 27, 2010 /PRNewswire via COMTEX/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings and 2010 guidance on Wednesday, February 24, 2010 after the market closes and will hold its quarterly conference call to discuss these results on Thursday, February 25, 2010, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is being webcast and can be access... 
01/26/2010Express Scripts to Spin-off Rx Outreach to Create Nonprofit Offering Prescription Medicines
New organization to address growing needs of low-income Americans ST. LOUIS, Jan. 26 /PRNewswire/ -- Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, today announced it will create a new independent, nonprofit charitable organization to improve access to prescription medicines for low-income, uninsured Americans and working families. Express Scripts will donate Rx Outreach, a for-profit business unit, to establish the new organization, which will... 
01/04/2010Express Scripts to Present at Investor Conferences
ST. LOUIS, Jan 04, 2010 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following investor conferences in January: 28th Annual J.P. Morgan Healthcare Conference on January 11, 2010 at 8:30 a.m. PST (11:30 a.m. EST) at the Westin St. Francis in San Francisco, CA. Jefferies 2010 Global Healthcare Conference on January 26, 2010 at 11:15 a.m. EST at the Mandarin Oriental Hotel in New York, NY. The presentations will also be broadc... 
12/17/2009Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity
ST. LOUIS, Dec 17, 2009 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased eme... 
12/03/2009Express Scripts Is the First Company to Achieve URAC Accreditation for Workers' Compensation and Property and Casualty Pharmacy Benefit Management Program
ST. LOUIS, Dec. 3 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced it has earned URAC accreditation for Workers' Compensation Pharmacy Benefit Management under URAC's Pharmacy Quality Management program. Express Scripts is the first organization to have earned this URAC accreditation. "As a leader in the pharmacy benefit management industry with a focus on quality of healthcare and drug safety, Express Scripts is proud to be the first to achieve URAC accreditation for Wo... 
12/01/2009Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries
Long-term strategic alliance presents transformative opportunity to advance healthcare in America Click here for PDF version ST. LOUIS and INDIANAPOLIS, December 1, 2009 – Express Scripts, Inc. (Nasdaq: ESRX), and WellPoint, Inc. (NYSE:WLP), announced today the closing of Express Scripts’ acquisition of WellPoint’s NextRx subsidiaries. The transaction includes a 10-year agreement under which Express Scripts, one of the largest pharmacy benefits management companies in North Americ... 
11/12/2009Express Scripts to Build High Volume Filler Pharmacy in St. Louis
ST. LOUIS, Nov. 12 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefits management companies in North America, announced today that its new high volume filler (HVF) pharmacy will be built in St. Louis. (Logo: http://www.newscom.com/cgi-bin/prnh/20080827/EXPRESSSCRIPTSLOGO) "This expansion of our operations aligns with Express Scripts' strategy to optimize service and cost savings for our clients and patients," said George Paz... 
11/06/2009Express Scripts to Present at Credit Suisse Healthcare Conference
ST. LOUIS, Nov. 6 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Credit Suisse 18th Annual Healthcare Conference on November 12, 2009 at 7:30 a.m. MST (9:30 a.m. EST) at the Arizona Biltmore Hotel in Phoenix, Arizona. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media ... 
11/03/2009Express Scripts and Greatwater Software Announce Partnership to Provide New Service in Physician Offices
Service to support medication adherence and provide Express Scripts members with cost- and time-saving options ORLANDO, Fla., Nov. 3 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), a provider of integrated pharmacy benefit management (PBM) services, and Greatwater Software, Inc., a provider of patient self-service solutions for the healthcare industry, today announced a program that will enable patients to review options for reducing prescription costs when checking in for... 
10/28/2009Express Scripts Reports Strong Third Quarter Earnings
ST. LOUIS, Oct. 28 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income from continuing operations of $196.9 million, or $0.71 per diluted share. Excluding non-recurring items in the quarter, including a legal settlement and items related to the previously announced acquisition of WellPoint's pharmacy benefit management business ("NextRx"), earnings was $0.81 per diluted share. These earnings for the quarter include $0.18 per share of dilution relat... 
10/28/2009Key Influencers Convene in Chicago to Advance Behavioral Economics in Healthcare and Improve Health Outcomes and Lower Costs
Chicagoans Spend the Third-Highest on Healthcare in the United States CHICAGO, Oct. 28 /PRNewswire-USNewswire/ -- Express Scripts (Nasdaq: ESRX) Center for Cost-Effective Consumerism, the American Benefits Council and Hewitt Associates along with other leading health and policy organizations are continuing the momentum of the ignite09 symposium, a groundbreaking series of symposiums on the convergence of behavioral economics and healthcare, by bringing the conversation to Chicago. This invit... 
10/07/2009Key Influencers Convene in San Francisco to Advance Behavioral Economics and Healthcare
Thought Leaders Unite to Improve Health Outcomes and Lower Costs as California Grapples with State Budget Cuts in Healthcare SAN FRANCISCO, Oct. 7 /PRNewswire-USNewswire/ -- Express Scripts (Nasdaq: ESRX) Center for Cost-Effective Consumerism, the American Benefits Council and Hewitt Associates along with other leading health and policy organizations are bringing the ignite09 symposium, a groundbreaking series of symposiums on the convergence of behavioral economics and healthcare, to San Fra... 
10/01/2009Express Scripts Announces Third Quarter 2009 Earnings Conference Call
ST. LOUIS, Oct. 1 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Wednesday, October 28, 2009 after the market closes and will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2009, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at Expres... 
09/01/2009Express Scripts to Present at Investor Conferences
ST. LOUIS, Sept. 1 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following investor conferences in September: Thomas Weisel Partners Healthcare Conference 2009 on September 9, 2009 at 2:40 pm eastern at The Four Seasons Hotel in Boston, MA. Morgan Stanley Global Healthcare Conference on September 15, 2009 at 1 pm eastern at the Grand Hyatt Hotel in New York, NY. These presentations will also be broadcast via the Internet and can... 
07/29/2009Express Scripts Reports Strong Second Quarter Earnings
--2009 Earnings Guidance IncreasedST. LOUIS, July 29, 2009 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter net income from continuing operations of $192.0 million, or $0.74 per diluted share. Excluding non-recurring items in the quarter, primarily related to the previously announced acquisition of WellPoint's pharmacy benefit management business ("NextRx"), earnings per diluted share was $0.88, up 16% from $0.76 for the same period last year. T... 
07/06/2009Express Scripts Announces Second Quarter 2009 Earnings Conference Call
ST. LOUIS, July 6 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 29, 2009 after the market closes and will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2009, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at Expre... 
06/05/2009Express Scripts to Present at William Blair Growth Stock Conference
ST. LOUIS, June 5 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the William Blair Growth Stock Conference on Thursday, June 11, 2009 at 8:00 a.m. CT at the Four Seasons Hotel in Chicago. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the Webcasts ... 
06/05/2009Express Scripts Announces Pricing of Acquisition Financing Transactions
ST. LOUIS, June 5 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has successfully priced its public offerings of common stock and senior notes. The offerings were made pursuant to the Company's registration statement and prospectuses filed with the Securities and Exchange Commission ("SEC"). The Company announced that it has agreed to sell 23 million shares of its common stock at a public offering price of $61 per share. The Company has al... 
06/04/2009Express Scripts Launches Senior Notes Offering to Finance Acquisition
ST. LOUIS, June 4 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it is commencing a public offering of senior notes of a benchmark size pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC"). The Company intends to use the net proceeds from this offering of senior notes, along with the net proceeds from its previously announced public offering of 23,000,000 shares of its common stock (or 26,450,000... 
06/04/2009ConnectYourCare Cited as a CDHP Platform Leader by Independent Research Firm
Leaders have a “proven ability to serve multiple stakeholders well and to deliver a subscriber experience that stands out from the rest.” (Hunt Valley, MD) June 4, 2009 – ConnectYourCare was among the select companies that Forrester Research invited to participate in its May 29, 2009, Forrester Wave report, The Forrester WaveTM: CDHP Platforms, Q2 2009. ConnectYourCare was among those that received top scores in consumer access to funds, integration with payers and financial institutions, and... 
06/02/2009Express Scripts Launches Equity Offering to Finance Acquisition
ST. LOUIS, June 2, 2009 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it is commencing a public offering of 23,000,000 shares of its common stock pursuant to an automatic shelf registration statement on Form S-3 filed today with the Securities and Exchange Commission ("SEC"). The Company will grant the underwriters an option for 30 days to purchase up to 3,450,000 additional shares of common stock to cover over-allotments, if any. The Company estimate... 
05/28/2009Express Scripts Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of WellPoint's NextRx Subsidiaries
Deal Passes Regulatory Hurdle ST. LOUIS, May 28 /PRNewswire-FirstCall/ -- Today, Express Scripts, Inc. (Nasdaq: ESRX), announced that the waiting period required under the Hart-Scott-Rodino Act in connection with its premerger notification filing relating to its previously announced proposed acquisition of WellPoint, Inc.'s (NYSE: WLP) NextRx subsidiaries expired at 11:59 p.m. on May 27, 2009. This represents a significant step forward towards completion of the transaction. The tr... 
05/27/2009Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare
Innovative Thought Leaders Launch ignite09 to Improve Health Outcomes and Lower Costs WASHINGTON, May 27 /PRNewswire-USNewswire/ -- Express Scripts Center for Cost-Effective Consumerism, the American Benefits Council and Hewitt Associates along with other leading health and policy organizations are bringing together leaders in innovation from across the country at ignite09, a groundbreaking symposium on the convergence of behavioral economics and healthcare. This exclusive event is being h... 
05/13/2009Express Scripts to Present at Deutsche Bank Health Care Conference
ST. LOUIS, May 13 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009 at 10:10 a.m. EDT at the InterContinental Hotel in Boston. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the Webc... 
05/08/2009Express Scripts to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
ST. LOUIS, May 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Bank of America and Merrill Lynch 2009 Healthcare Conference on May 13, 2009. The presentation will begin at 8:00 a.m. EDT at the Palace Hotel in New York City. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com/ RealPlayer or Windows Media Pl... 
04/29/2009Express Scripts Reports First Quarter EPS of $0.86, up 23%
Raises 2009 EPS Guidance ST. LOUIS, April 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income from continuing operations of $214.7 million, or $0.86 per diluted share, which reflects 23% growth over $0.70 for the first quarter of 2008. The Company reported first quarter cash flow from continuing operations of $286.4 million, up 15% from $248.3 million last year. "It has been a strong start to 2009 for Express Scripts. Our diff... 
04/20/2009Express Scripts Pharmacy Cost Trends Lowest in Over a Decade
$42 Billion Savings Opportunity Still Remains for Nation ST. LOUIS, April 20 /PRNewswire-FirstCall/ -- In the midst of the financial crisis and skyrocketing healthcare costs, greater use of generic drugs and lower-cost brand drugs led to a record-low spending trend for 2008 according to data from Express Scripts (Nasdaq: ESRX), one of the nation's largest pharmacy benefit managers. Overall pharmacy cost trend for Express Scripts clients was 3.0 percent for 2008, down 2.5 percentag... 
04/14/2009Express Scripts Announces First Quarter 2009 Earnings Conference Call
ST. LOUIS, Apr 14, 2009 (BUSINESS WIRE) -- Express Scripts (Nasdaq:ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Wednesday, April 29, 2009 after the market closes and will hold its quarterly conference call to discuss first quarter results on Thursday, April 30, 2009, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and... 
04/13/2009Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion
Alliance Provides Game-Changing Capabilities to Tackle the Nation's Priorities to Improve Health Outcomes and Reduce Waste ST. LOUIS and INDIANAPOLIS, April 13 - Express Scripts, Inc. (Nasdaq: ESRX), and WellPoint, Inc. (NYSE:WLP), announced today that they have signed a definitive agreement under which Express Scripts, one of the largest pharmacy benefits management (PBM) companies in North America, will acquire WellPoint's NextRx subsidiaries for $4.675 billion, which includes considerati... 
03/18/2009Lowe's Leads First Wave of Companies Partnering With Express Scripts to Apply Behavioral Economics to Healthcare
Innovative Model Drives Millions of Dollars in Savings for Employers and Patients ST. LOUIS, March 18 /PRNewswire-FirstCall/ -- Lowe's, the second-largest home improvement retailer in the world, is among more than two dozen companies on track to save millions in 2009 through a pilot program with pharmacy benefit manager Express Scripts (Nasdaq: ESRX). One of the first marketplace innovations to apply behavioral economics principles to enhance health care, the Select Home Delivery... 
03/03/2009Express Scripts to Present At Barclays Global Healthcare Conference
ST. LOUIS, March 3, 2009 (GLOBE NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the Barclays Capital Global Healthcare Conference on March 11, 2009 at 3:15 p.m. EDT at the Lowes Miami Beach Hotel in Miami, Florida. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of the Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the Webc... 
02/25/2009Express Scripts Reports Full Year EPS of $3.10, Up 30%
Fourth Quarter EPS of $0.83, Up 20% ST. LOUIS, Feb. 25, 2009 (GLOBE NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced fourth quarter and full year net income from continuing operations of $206.4 million and $779.6 million, or $0.83 and $3.10 per diluted share, respectively. These results include $11.3 million ($7.3 million after tax) for charges related to a previously disclosed security incident. Fourth quarter and full year EPS grew 20% and 30%, respectively, over adjusted 2007 resul... 
02/03/2009Express Scripts Announces Fourth Quarter 2008 Earnings Conference Call
ST. LOUIS, Feb. 3 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Wednesday, February 25, 2009 after the market closes and will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 26, 2009, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed ... 
01/15/2009Express Scripts Elects Frank Mergenthaler to Board of Directors
ST. LOUIS, Jan. 15, 2009 (GLOBE NEWSWIRE) -- Express Scripts, Inc., (Nasdaq:ESRX) today announced that its Board of Directors has elected Frank Mergenthaler as a director and member of the Board. Mr. Mergenthaler is executive vice president and chief financial officer for the Interpublic Group (NYSE:IPG), one of the world's leading organizations of advertising agencies and marketing services companies with in excess of 40 thousand employees around the world. At IPG, Mr. Mergenthaler has res... 
01/05/2009Express Scripts to Present At the JP Morgan Healthcare Conference
ST. LOUIS, Jan. 5, 2009 (GLOBE NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the 27th Annual JP Morgan Healthcare Conference on January 12, 2009 at 11:30 a.m. PST (2:30 p.m. EST) at The Westin St. Francis in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to l... 
12/17/2008Behavioral Economics Emerge in Express Scripts Study On Medication Compliance
ST. LOUIS, Dec. 17, 2008 (GLOBE NEWSWIRE) -- A new study from pharmacy benefit manager Express Scripts (Nasdaq:ESRX) published in the current issue of American Journal of Managed Care suggests that financial incentives are not enough to encourage greater compliance with chronic medication. Researchers found that decreasing copayments resulted in only a modest 2.5 percentage point increase in patients' compliance with their medication. The study focused on examining the effect on medication ... 
12/02/2008Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines
ST. LOUIS, Dec. 2 /PRNewswire-FirstCall/ -- While many Americans are struggling to cope amid growing economic challenges including rising costs of basic necessities, unemployment and home foreclosures, Express Scripts (Nasdaq: ESRX) has expanded Rx Outreach to help lower-income consumers get their prescription medicines. Lower-income consumers can now receive a six-month supply of their prescription medicines for $20 through Rx Outreach, a low-cost, mail-order prescription drug ... 
11/11/2008Express Scripts Reports New Threats Tied to Data Security Breach
Company Announces $1 Million Reward Company Hires Kroll to Offer Data Security Consultation, Investigation and Restoration to Its Members ST. LOUIS, Nov. 11, 2008 (GLOBE NEWSWIRE) -- Express Scripts (Nasdaq:ESRX), one of the largest pharmacy benefit management companies in North America, announced today that a small number of its clients have received letters threatening to expose the personal information of its members. The threats are believ... 
11/06/2008Express Scripts Warns of Potential Large Data Breach Tied to Threat
ST. LOUIS, Nov 6, 2008 (GlobeNewswire via COMTEX News Network) -- Express Scripts (Nasdaq:ESRX), one of the largest pharmacy benefit management companies in North America, today announced that it has received a letter from an unknown person or persons trying to extort money from the company by threatening to expose millions of the company's patients' records. The letter included personal information of 75 members, including their names, dates of birth, social security numbers, and in some cases... 
11/03/2008Tweens and Teens Double Use of Diabetes Drugs
Study: More Children Taking Medications for Blood Pressure, Cholesterol, Asthma, ADD/ADHD, Depression and Diabetes ST. LOUIS, Nov. 3 /PRNewswire-FirstCall/ -- America's tweens and teens more than doubled their use of type 2 diabetes medications between 2002 and 2005, with girls between 10 and 14 years of age showing a 166 percent increase. One likely cause: Obesity, which is closely associated with type 2 diabetes. The finding is included in a study of chro... 
11/03/2008Express Scripts to Present At Credit Suisse Health Care Conference
ST. LOUIS, Nov 3, 2008 (GlobeNewswire via COMTEX News Network) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the Credit Suisse Phoenix Health Care Conference on November 13, 2008 at 9:00 a.m. mountain (11:00 a.m. eastern) at the Arizona Biltmore in Phoenix, AZ. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com RealPlayer or Windows Media Player is... 
10/30/2008Express Scripts Reports a 33 Percent Increase in Third Quarter Earnings Per Share
Company Raises 2008 Earnings Per Share Guidance Provides 2009 Earnings Per Share Guidance ST. LOUIS, Oct. 30, 2008 (GLOBE NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced third quarter net income from continuing operations of $203.0 million, or $0.81 per diluted share, representing a 33% increase over $0.61 on an adjusted basis for the same quarter last year. The Company reported year to date cash flow from continuing operations of $727.1 m... 
10/15/2008Express Scripts Announces Third Quarter 2008 Earnings Conference Call
ST. LOUIS, Oct. 15 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Thursday, October 30, 2008 after the market closes and will hold its quarterly conference call to discuss third quarter results on Friday, October 31, 2008, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is being webcast and can be accessed at Ex... 
09/18/2008New Studies Find Home Delivery Pharmacy Customers More Likely to Take Their Medicine and Choose Money-Saving Generic Drugs, According to Express Scripts
Home Delivery a Gateway for Better Health and Value Billions in Savings at StakeST. LOUIS, Sept 18, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Consumers are more likely to take their medications as directed and choose a money-saving generic drug when using a home delivery pharmacy instead of a retail pharmacy, according to results of two new studies from pharmacy benefit manager Express Scripts (Nasdaq: ESRX). In one study, compliance, or taking a medication as prescribed by y... 
09/03/2008Express Scripts to Present At Bank of America Conference
ST. LOUIS, Sep 3, 2008 (GlobeNewswire via COMTEX News Network) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the Bank of America 38th Annual Investment Conference on September 15, 2008 at 2:00 p.m. pacific (5:00 p.m. eastern) at Ritz-Carlton Hotel in San Francisco, CA. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media ... 
07/30/2008Express Scripts Reports a 33 Percent Increase in Second Quarter Earnings Per Share
Company Raises 2008 Earnings Per Share and Cash Flow Guidance Announces Increase in Share Repurchase Authorization ST. LOUIS, July 30, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced second quarter net income from continuing operations of $191.9 million, or $0.76 per diluted share, representing a 33% increase over $0.57 on an adjusted basis for the same quarter last year. The Company reported second quarter cash flow from continuing operatio... 
07/29/2008Express Scripts Settles New York Lawsuit
ST. LOUIS, July 29, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced today that it has settled a lawsuit by the State of New York relating to contracts that it and CIGNA had to provide pharmacy benefit management services for the New York State employee health plan, called the Empire Plan. The plan serves New York state and local government employees, retirees and their dependents. In the settlement, Express Scripts does not admit any of the assertions made by the Stat... 
07/22/2008Express Scripts Completes Acquisition of Medical Services Company's Pharmacy Services Division
Transaction Offers Expanded PBM Services to Workers' Compensation ClientsST. LOUIS, Jul 22, 2008 (PrimeNewswire via COMTEX News Network) -- Express Scripts announced today the closing of its acquisition of the workers' compensation pharmacy benefit management (PBM) business of privately held Medical Services Company (MSC) from Monitor Clipper Partners, a private equity investment firm. Express Scripts is one of the nation's leading managers of pharmacy benefits for employers, governments, unions... 
07/21/2008Generics Slow Growth in Workers' Compensation Drug Spending in 2007
ST. LOUIS--(BUSINESS WIRE)--July 21, 2008--Growth in spending by workers' compensation plans on prescription drugs slowed to a 6.0% increase over 2006, according to the annual Express Scripts Workers' Compensation Drug Trend Report. The increase in 2006 over 2005 was 11.4%. Contributing significantly to the 2007 spending slow-down was a record-setting, fourth quarter generic utilization rate of 68.9% by workers' compensation plans. "We slowed the upward trend in prescription drug ... 
07/09/2008Express Scripts Second Quarter 2008 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--July 9, 2008--Express Scripts (NASDAQ:ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 30, 2008 after the market closes and will hold its quarterly conference call to discuss second quarter results on Thursday, July 31, 2008, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at Express... 
06/27/2008Express Scripts Awarded TRICARE Pharmacy Program Contract
ST. LOUIS, June 27, 2008 (PRIME NEWSWIRE) -- The U.S. Department of Defense (DoD) has selected Express Scripts as the contractor for the DoD's TRICARE Pharmacy Program serving 9.1 million DoD beneficiaries. It is a great honor to continue serving our men and women in uniform, along with their dependents and military retirees -- to work on their behalf making the use of prescription drugs safer and more affordable. We look forward to continuing to meet beneficiaries' needs with outstanding s... 
06/13/2008Express Scripts Agrees to Acquire Medical Services Company's Pharmacy Services Division
Expands PBM Services to Workers' Compensation Pharmacy Clients ST. LOUIS, June 13, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced today that it has reached an agreement to acquire the workers' compensation pharmacy benefit management (PBM) business of Medical Services Company (MSC) from Monitor Clipper Partners, a private equity investment firm, for an undisclosed amount. The transaction is expected to close at the expiration of the Hart-Scott-Rodino waiting period, and ... 
06/10/2008Express Scripts Announces Sale of Infusion Pharmacy Business
ST. LOUIS, Jun 10, 2008 (PrimeNewswire via COMTEX News Network) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it has signed a definitive agreement to sell its Infusion Pharmacy business to Option Care, Enterprises, Inc. a wholly-owned subsidiary of Walgreen Co. (NYSE:WAG) (Nasdaq:WAG) for an undisclosed amount. "We previously announced that the infusion business was not a strategic fit with our core PBM and specialty pharmacy operations," stated George Paz, president, chief executive of... 
06/02/2008Express Scripts to Present At Investor Conferences
ST. LOUIS, June 2, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the following conferences in June 2008: Goldman Sachs 29th Annual Global Healthcare Conference on June 11, 2008 at 1:20 p.m. pacific (4:20 p.m. eastern) at the Ritz Carlton in Laguna Nigel, CA. William Blair 28th Annual Growth Stock Conference on June 19, 2008 at 7:30 a.m. central (8:30 a.m. eastern) at the Four Seasons Hotel in Chicago, IL. These presentations w... 
05/27/2008Express Scripts in Voluntary Agreement with State Attorneys General
ST. LOUIS--(BUSINESS WIRE)--May 27, 2008--Express Scripts, Inc., announced today that the Company and the Attorneys General of 28 states and the District of Columbia entered into an Assurance of Voluntary Compliance and Discontinuance (AVC). The agreement resolves an investigation initiated in 2004 and which did not result in litigation by the Attorneys General against the Company. The AVC precludes future litigation against the Company by the Attorneys General under state consume... 
04/29/2008Express Scripts Reports a 35 Percent Increase in First Quarter Earnings Per Share
2008 Earnings Per Share and Cash Flow Guidance Increased ST. LOUIS, April 29, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced first quarter net income from continuing operations of $178.3 million, or $0.70 per diluted share representing a 35% increase over $0.52 on an adjusted basis for the same quarter last year. The Company reported record first quarter cash flow from continuing operations of $248.3 million compared to $158.9 million for the same period last year. ... 
04/28/2008Express Scripts to Present At Investor Conferences
ST. LOUIS, April 28, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the following conferences: Deutsche Bank 33rd Annual Health Care Conference on May 7, 2008 at 11:30 a.m. eastern at the InterContinental Hotel in Boston, MA. Bank of America 2008 Healthcare Conference on May 14, 2008 at 1:20 p.m. pacific (4:20 p.m. eastern) at the Four Seasons Hotel in Las Vegas, NV. Citigroup Healthcare Conference on May 22, 2008 at 10:00 a.m. easte... 
04/16/2008CORRECTING and REPLACING Consumers' Average Prescription Drug Copay Drops as Generic Drug Use Grows
ST. LOUIS--(BUSINESS WIRE)--April 16, 2008--In BW6584 issued April 15, 2008: Third graph, first sentence of release should read: We process more than one million prescriptions every day and 63.7% are now for a generic drug versus 42% in 2002 (sted We process more than one million prescriptions every day and 67.3% are now for a generic drug versus 42% in 2002). The corrected release reads: CONSUMERS' AVERAGE PRESCRIPTION DRUG COPAY DROPS AS GENERIC DRUG USE GROWS La... 
04/15/2008Express Scripts Announces Major Consumer Health Initiative Inspired by $600 Million Savings as Consumers Drive Generic Statin Use to 53%; Nation's Leading Experts Join in Launching ''Center for Cost-Effective Consumerism''
ST. LOUIS, Apr 15, 2008 (BUSINESS WIRE) -- Express Scripts today announced a major initiative to advance consumer communications in health care, inspired by $600 million in savings, a six-fold increase for generics in a single drug category and new research results. "We know that innovative communications and an advanced understanding of the consumer were critical in helping us save plan sponsors and consumers over half a billion dollars in the anti-cholesterol category alone," said Georg... 
04/09/2008Express Scripts Announces First Quarter 2008 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--April 9, 2008--Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Tuesday, April 29, 2008 after the market closes and will hold its quarterly conference call to discuss first quarter results on Wednesday, April 30, 2008, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at Expr... 
04/08/2008Express Scripts Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards
ST. LOUIS--(BUSINESS WIRE)--April 8, 2008--URAC, an independent health accreditation and education organization, has selected Express Scripts as one of three pharmacy benefit managers honored in the first-ever nationwide competition recognizing health management programs that empower and protect consumers. Express Scripts was recognized for "Express Scripts Generics Today," a consumer campaign designed to advance the opportunity for patients and plan sponsors to save millions of d... 
03/11/2008Express Scripts to Present At Lehman Brothers Global Healthcare Conference
ST. LOUIS, March 11, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the Eleventh Annual Lehman Brothers Global Healthcare Conference on March 18, 2008 at 10:45 a.m. EDT at the Loews Miami Beach Hotel in Miami, Florida. This presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts website at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen... 
03/03/2008Express Scripts Names Jeffrey L. Hall Chief Financial Officer
ST. LOUIS, March 3, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) today announced that Jeffrey L. Hall will join the Company on April 1, 2008, as Executive Vice President and Chief Financial Officer. He will succeed Edward J. Stiften who had previously announced his retirement. Mr. Hall comes to Express Scripts from KLA-Tencor, where he has been Chief Financial Officer since January 2006. KLA-Tencor (Nasdaq:KLAC) is a leading supplier of process control and yield management... 
02/29/2008Generic Drugs Slow Rise in Prescription Drug Costs, Saving $5.2 Billion in 2007
ST. LOUIS, Feb 29, 2008 (BUSINESS WIRE) -- Greater use of generic drugs dramatically slowed the growth in prescription drug costs during 2007, saving an estimated $5.2 billion for commercially insured Americans and benefit plan sponsors. During 2007, the average cost of a prescription increased by only $1.09 to $54.34, up from $53.25 in 2006, according to pharmacy benefit manager Express Scripts. Otherwise, without the "generic effect," the cost per prescription would have increased $3.58 ... 
02/21/2008Express Scripts Reports a 42 Percent Increase in Full-Year 2007 Adjusted Earnings Per Share
Fourth Quarter Adjusted Earnings Per Share Up 33 Percent 2008 Earnings Per Share Guidance Increased ST. LOUIS, Feb. 21, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced fourth quarter net income of $138.5 million, or $0.54 per diluted share. Excluding non recurring items in both years, earnings per diluted share was a record $0.68, a 33 percent increase over $0.51 per diluted share last year. All per share amounts have been adjusted to reflect the Co... 
02/13/2008More Americans Are Using More Prescription Drugs
New State-by-State Data Correlates Increase with Rising State Obesity Rates ST. LOUIS--(BUSINESS WIRE)--Feb. 13, 2008--More U.S. adults are taking prescription drugs than ever before, fueling $12 billion in additional spending during 2006 alone. The number of people with at least one prescription increased from 67% to 74% between 2000 and 2006, according to a new Geographic Variation in Prescription Utilization study by pharmacy benefit manager Express... 
02/11/2008Express Scripts, Inc. Fourth Quarter 2007 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--Feb. 11, 2008--Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Thursday, February 21, 2008 after the market closes and will hold its quarterly conference call to discuss fourth quarter results on Friday, February, 22, 2008, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcast and can be accessed at... 
01/03/2008Consumers Using a Home Delivery Pharmacy More Likely to Choose Lower-Cost Therapies
-- Study Suggests Education, Outreach and Assistance as Crucial Drivers of Change --ST. LOUIS, Jan 03, 2008 (BUSINESS WIRE) -- Consumers using home delivery for their prescriptions were more likely to choose a lower-cost preferred therapy after a formulary change, than those using a retail pharmacy, according to a study appearing in the December 2007 issue of the Annals of Pharmacotherapy. The study by pharmacy benefit manager Express Scripts evaluated consumer behavior after the company re... 
01/02/2008Express Scripts to Present At the JP Morgan Healthcare Conference
ST. LOUIS, Jan. 2, 2008 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the 26th Annual JP Morgan Healthcare Conference on January 7, 2008 at 11:30 a.m. PST (2:30 p.m. EST) at The Westin St. Francis in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to li... 
11/27/2007Express Scripts Provides 2008 Earnings Per Share Guidance
Reflects Growth of 22% to 25% ST. LOUIS--(BUSINESS WIRE)--Nov. 27, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced today that it believes its financial performance will continue to benefit from the growth in generic utilization, home delivery, and specialty pharmacy management; lower retail and home delivery drug purchasing costs; increased productivity; and capital structure improvements. As a result, the Company expects its 2008 diluted earnings per share will be in the ra... 
11/20/2007Express Scripts Announces 2008 Earnings Guidance Conference Call
ST. LOUIS--(BUSINESS WIRE)--Nov. 20, 2007--Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its 2008 earnings guidance on Tuesday, November 27, 2007 before the market opens and hold a conference call on this day to discuss this guidance at 8:30 a.m. Central (9:30 a.m. Eastern). This call is being webcast and can be accessed at Express Scripts' web site at http://www.express-scr... 
11/20/2007Express Scripts to Expand at University of Missouri-St. Louis
ST. LOUIS--(BUSINESS WIRE)--Nov. 20, 2007--Express Scripts Inc. announced today it will build a second office building at University Place/NorthPark, the Business, Technology and Research Park of the University of Missouri-St. Louis (UMSL). Construction is expected to be completed in December 2008. The new building will be adjacent to Express Scripts' Headquarters, which was completed in May 2007. Criteria for selecting the UMSL campus for the recently built headquarters location ... 
11/06/2007Express Scripts to Present at Investor Conferences
ST. LOUIS--(BUSINESS WIRE)--Nov. 6, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Credit Suisse Health Care Conference on November 14, 2007 at 8:00 a.m. MST (10:00 a.m. EST) at the Arizona Biltmore Hotel in Phoenix, Arizona. Merrill Lynch Health Services Conference on November 28, 2007 at 10:45 a.m. EST at the Merrill Lynch World Financial Center Headquarters in New York, NY. These presentations will also be broad... 
10/24/2007Express Scripts Reports a 43 Percent Increase in Adjusted Earnings Per Share
2007 Earnings Per Share Guidance Increased -- Midpoint Reflects 39 Percent Growth Record Third Quarter Cash Flow From Operations of $247 million ST. LOUIS, Oct. 24, 2007 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced third quarter net income of $142.9 million, or $0.56 per diluted share, which includes non-recurring charges totaling $0.04 per diluted share discussed below. Excluding these charges, diluted earnings per share was $0.60, a 43... 
10/11/2007Express Scripts Acquires Industry Leading CDHP Account Administrator
ConnectYourCare Aids Strategy of Enabling Better Health and Value at the Consumer Level ST. LOUIS--(BUSINESS WIRE)--Oct. 11, 2007--Pharmacy benefit manager Express Scripts, Inc., (NASDAQ: ESRX) today announced the acquisition of ConnectYourCare, L.L.C., one of the nation's leading consumer directed health plan (CDHP) account administrators, from privately-held Revolution Health. Terms of the transaction were not disclosed. ConnectYourCare, based near Baltimore,... 
10/03/2007Express Scripts Earns New URAC Accreditation
ST. LOUIS--(BUSINESS WIRE)--Oct. 3, 2007--Express Scripts today announced it has earned accreditation under the new pharmacy benefit management (PBM) accreditation program established by URAC, the Washington D.C.-based independent accreditor of health care management organizations. URAC launched the new accreditation program to create standards that promote PBM industry best practices, encourage quality improvement, and protect and empower consumers. The accreditation standar... 
09/27/2007Express Scripts, Inc. Third Quarter 2007 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--Sept. 27, 2007--Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Wednesday, October 24, 2007 after 4:00 p.m. Eastern (3:00 p.m. Central Time) and will hold its quarterly conference call to discuss third quarter results on Thursday, October 25, 2007, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcas... 
09/12/2007Express Scripts to Present at Bank of America Conference
ST. LOUIS--(BUSINESS WIRE)--Sept. 12, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Bank of America 37th Annual Investment Conference on September 19, 2007 at 9:30 a.m. pacific (12:30 p.m. eastern) at Ritz-Carlton Hotel in San Francisco, CA. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Playe... 
09/05/2007Express Scripts to Webcast Investor Meeting
ST. LOUIS--(BUSINESS WIRE)--Sept. 5, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it has scheduled an investor meeting in New York beginning at 9:00 a.m. eastern on Thursday, October 4, 2007, at which management will make presentations regarding the Company. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is ne... 
07/30/2007Express Scripts Participates in New PBM Accreditation Program
ST. LOUIS--(BUSINESS WIRE)--July 30, 2007--Express Scripts announced today its participation in the beta testing process for a new program to establish accreditation standards for pharmacy benefit managers. URAC, the Washington, D.C.-based independent accreditor of health care management organizations, is launching the program with the goal of creating standards that promote the pharmacy benefit management (PBM) industry best practices; encourages quality improvement; and protects and... 
07/25/2007Express Scripts Reports Strong Second Quarter Earnings
Company Raises 2007 Earnings Per Share Guidance; Announces Increase in Share Repurchase AuthorizationST. LOUIS, Jul 25, 2007 (PrimeNewswire via COMTEX News Network) -- Express Scripts, Inc. (Nasdaq:ESRX) announced second quarter net income of $152.7 million, or $0.57 per diluted share. Excluding a non-recurring gain on the sale of stock that is discussed below, earnings per diluted share was $0.56, a 47 percent increase over $0.38 per diluted share for the same quarter last year. All per share a... 
07/12/2007Express Scripts Study Links Use of Generic Drugs to Generic-Brand Copay Differentials
ST. LOUIS, Jul 12, 2007 (BUSINESS WIRE) -- In the first study of its kind, pharmacy benefit manager Express Scripts' researchers have established a link between encouraging the use of more generic drugs and the copay differential between generics and brand drugs. Plans with a generic vs. brand copayment differential of $21 or more used generic drugs at a rate 5.2 percentage points higher than plans with a $0 to $5 differential. "The findings in this study show that getting plan design rig... 
07/03/2007Express Scripts, Inc. Second Quarter 2007 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--July 3, 2007--Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 25, 2007, after 3:00 p.m. Central Time. In addition, management will holds its quarterly conference call to discuss second quarter results on Thursday, July 26, 2007 at 9:00 a.m. Central Time. This call is being webcast by Thomson Financial a... 
06/07/2007Express Scripts to Present at Investor Conferences
ST. LOUIS--(BUSINESS WIRE)--June 7, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences in June 2007: Goldman Sachs 28th Annual Global Healthcare Conference on June 14, 2007 at 8:00 a.m. pacific (11:00 a.m. eastern) at the Ritz Carlton in Laguna Nigel, CA. William Blair 27th Annual Growth Stock Conference on June 19, 2007 at 9:50 a.m. central (10:50 a.m. eastern) at the Four Seasons Hotel in Chicago, IL. Jeffries Healthc... 
05/23/2007Express Scripts Declares 2-For-1 Stock Split
ST. LOUIS--(BUSINESS WIRE)--May 23, 2007--Express Scripts, Inc. (NASDAQ: ESRX) today announced that its Board of Directors has approved a two-for-one stock split to be effected in the form of a stock dividend. The stock split is for shareholders of record as of June 8, 2007, and will be effective on or about June 22, 2007. "Our stock split reflects the successful execution of our business model, which is built around the alignment of interests with plan sponsors and patients," sta... 
05/17/2007Express Scripts to Present at Investor Conferences
ST. LOUIS, May 17, 2007 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Citigroup Healthcare Conference on May 24, 2007 at 12:00 p.m. eastern at The New York Hilton Hotel in New York, NY. Bank of America 2007 Health Care Conference on May 30, 2007 at 10:00 a.m. pacific (1:00 p.m. eastern) at the Four Seasons Hotel in Las Vegas, NV. These presentations will also be broadcast via the Internet and can be accessed on th... 
04/26/2007Consumer Outreach Boosts Generic Cholesterol-Fighting Drugs
Generic Use Up 500%, Saving $230 Million Since January '06 ST. LOUIS--(BUSINESS WIRE)--April 26, 2007--Benefit plan sponsors and patients have saved $230 million on cholesterol-fighting drugs since January 2006, when Express Scripts (Nasdaq: ESRX) began encouraging consumers to discuss generic alternatives with their physicians. The company, one of the nation's largest pharmacy benefit managers, reported the savings at its annual Outcomes Conference today. Use of generic chol... 
04/25/2007Nearly One Quarter of Seniors Could Have Avoided Medicare ''Doughnut Hole''
Analysis Uncovers Opportunity to Steer Clear of Prescription Coverage Gap and Cut Overall Medicare Part D Costs by 13 Percent Through Increased Use of Generic Drugs ST. LOUIS--(BUSINESS WIRE)--April 25, 2007--Express Scripts (Nasdaq: ESRX), a leading pharmacy benefit manager, today announced results of an analysis examining the 2006 prescription claims history of 220,000 non-low-income seniors with Medicare drug plans that have a standard coverage gap, "doug... 
04/25/2007Biotech Drug Spending Increases 21 Percent Even as Growth in Rx Expenditure Slows
Study Predicts Category Will Account for $99 Billion by 2010 ST. LOUIS--(BUSINESS WIRE)--April 25, 2007--Express Scripts (Nasdaq: ESRX), a leading pharmacy benefit manager, today announced spending on high-cost biotech drugs increased 21 percent in 2006. This increase excludes spending for biotech drugs within the medical benefit, such as those administered in physician offices or other therapies that traditionally fall into the medical benefit. Spending increased 25 percent in 20... 
04/23/2007Express Scripts Reports Strong First Quarter Earnings
Company Raises 2007 Guidance for Both Earnings Per Share and Cash Flow ST. LOUIS--(BUSINESS WIRE)--April 23, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $133.7 million, or $0.97 per diluted share. Excluding non-recurring items that are discussed below, earnings per diluted share was $1.04, a 49 percent increase over $0.70 per diluted share for the same quarter last year. Express Scripts reported first quarter cash ... 
04/23/2007Express Scripts Nominates Woodrow A. Myers to Board of Directors
ST. LOUIS--(BUSINESS WIRE)--April 23, 2007--Express Scripts, Inc., today announced the nomination of Woodrow A. Myers, M.D., M.B.A., for election to the company's Board of Directors at its May 23, 2007, annual meeting. Currently managing director of Myers Ventures LLC, Dr. Myers most recently served as executive vice president and chief medical officer of Wellpoint Health Networks, Inc., from 2000 to 2005. Previously, he served as director, healthcare management for Ford Motor Com... 
04/20/2007Express Scripts' Workers' Compensation Program Increases Use of Generic Drugs
ST. LOUIS--(BUSINESS WIRE)--April 20, 2007--ExpressComp, a workers' compensation offering by Express Scripts, increases the use of generic medications and reduces clients' costs. Express Scripts is one of the largest pharmacy benefit managers (PBM) in North America. Express Scripts is a leader in consumer behavioral changes involving the use of generic drugs. Since 2001, generic drug utilization for Express Scripts' workers' compensation clients has grown from 52 percent of all pr... 
04/17/2007Study Shows CDHP Financial Incentives Not Enough to Change Consumer Behavior
Better Communications, Tools Needed to Help Consumers Save Money, Promote Health ST. LOUIS--(BUSINESS WIRE)--April 17, 2007--Consumer-Directed Health Plans (CDHP) require more than financial incentives to help consumers make smart choices about their health and prescription use, according to a new study by pharmacy benefit manager Express Scripts. CDHP participants were, in fact, less likely than traditional health plan enrollees to change behavior an... 
04/04/2007Online COB Program for DoD Receives Innovation Award
ST. LOUIS--(BUSINESS WIRE)--April 4, 2007--The U.S. Department of Defense (DoD) TRICARE Retail Pharmacy (TRRx) program received the Pharmacy Benefit Management Institute's 2007 Rx Benefit Innovation award for its online, real-time coordination of benefits (COB) program, which is managed by Express Scripts and other DoD contractors. Express Scripts is one of the nation's largest pharmacy benefit management companies. "We congratulate the DoD on receiving this recognition and we are... 
03/23/2007Express Scripts Schedules First Quarter 2007 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--March 23, 2007--Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Monday, April 23, 2007 after 3:00pm Central Time and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 24, 2007, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at Express... 
03/16/2007Express Scripts Positioned for Strong Growth After Caremark Vote
Innovation and Execution Delivers Value for Stockholders, Plan Sponsors and Patients ST. LOUIS, March 16 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement from president, chief executive officer and chairman George Paz commenting on the approval by Caremark Rx, Inc. (NYSE: CMX) stockholders of Caremark's acquisition by CVS Corporation (NYSE: CVS). "First of all, I want to thank the stockhol... 
03/15/2007Express Scripts Reiterates Commitment to Raising Offer if Additional Synergies Identified
Advisory Services, Analysts, Stockholders Support Express Scripts Position Company Urges Caremark Stockholders to Vote GOLD Proxy Card AGAINST The Flawed Caremark Merger ProcessST. LOUIS, March 15, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement of commitment to an acquisition of Caremark Rx, Inc. (NYSE: CMX): Express Scripts is firmly committed to increasing the cash portion of our offer if we identify addition... 
03/14/2007Express Scripts Urges Caremark Stockholders Not to Leave Money on the Table
Urges Caremark Stockholders to Vote GOLD Proxy Card AGAINST The Flawed Caremark Merger Process ST. LOUIS, March 14 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued an open letter to Caremark Rx, Inc. (NYSE: CMX) stockholders urging them to vote against the proposed acquisition of Caremark by CVS Corporation (NYSE: CVS). Dear Caremark Stockholder: If you want more money, you should vote against the CVS transaction. ... 
03/14/2007Express Scripts to Present at the Lehman Brothers 2007 Global Healthcare Conference
ST. LOUIS--(BUSINESS WIRE)--March 14, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Lehman Brothers 2007 Global Healthcare Conference on March 19, 2007 at 8:30 a.m. EDT at the Loews Miami Beach Hotel in Miami, FL. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the ... 
03/14/2007Glass Lewis Reiterates Caremark Stockholders Should Vote Against CVS Acquisition
ST. LOUIS, March 14 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that Glass, Lewis & Co. ("Glass Lewis"), a leading independent voting advisory service, reiterated to its clients that Caremark stockholders should vote AGAINST the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on March 16, 2007. In its recommendation, Glass Lewis stated*: "As discus... 
03/13/2007PROXY Governance Recommends Caremark Stockholders Vote Against Acquisition By CVS
ST. LOUIS, March 13 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that PROXY Governance, Inc., a leading independent voting advisory service, recommends that its clients vote AGAINST the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on March 16, 2007. In its report, PROXY Governance noted: "We question whether Caremark's management and board negotiated the ... 
03/13/2007Express Scripts Comments on ISS Recommendation
ST. LOUIS, March 13 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement in response to the recommendation issued by Institutional Shareholder Services (ISS) regarding the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on March 16, 2007: "It is unfortunate that ISS has chosen not to support a disciplined and stockholder centric approach to this... 
03/12/2007Express Scripts Declares Current Offer to Acquire Caremark 'Best and Only' Offer Without Confirmatory Due Diligence
Identification of Additional Value Could Result in Higher Offer Price Caremark Stockholders Urged to Vote Against Flawed Merger Process with CVSST. LOUIS, March 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that the flawed merger process pursued by the Caremark Rx, Inc. (NYSE: CMX) Board of Directors, specifically the Board's refusal to permit confirmatory due diligence by Express Scripts, prevents Caremark stockholders from r... 
03/07/2007Express Scripts Improves Offer to Acquire Caremark
Raises 2007 Earnings Per Share Guidance Reflecting 26% to 29% GrowthST. LOUIS, March 7, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced an enhancement of its offer to acquire Caremark Rx, Inc (NYSE: CMX). The Express Scripts offer is to acquire all outstanding shares of Caremark for $29.25 in cash and 0.426 shares of Express Scripts stock for each share of Caremark stock. The Company will now pay additional cash consideration of ... 
03/06/2007Study Shows Specialty Pharmacy High Touch Model is Better for Patients
ST. LOUIS--(BUSINESS WIRE)--March 6, 2007--Patients using a specialty pharmacy for biotech medicines are more likely to report they are better able to manage their condition than those using a retail pharmacy by 42 percent versus 33 percent, according to a new study released by Express Scripts, a pharmacy benefit manager. Better results achieved by specialty pharmacy CuraScript can be attributed to its "high touch" care model. With the high touch care model, a patient's purchase o... 
02/28/2007Study Shows Incentive Program Increases Generic Drug Use
ST. LOUIS--(BUSINESS WIRE)--Feb. 28, 2007--A program that promotes greater use of generic medications, by waiving patient copayments for a limited time, is proven effective, according to a report released by Express Scripts, a leading pharmacy benefit manager. The report validates the effectiveness of the program - known as Zero Dollar Copay - in moving a significant number of plan members to lower cost, equally effective generics. Julayna Meyer, vice president of research and tre... 
02/23/2007Express Scripts Comments on Delaware Court of Chancery Ruling
Court Again Enjoins Caremark Vote on Acquisition by CVS, This Time for at Least 20 Days Recognizes Caremark Stockholders Have Appraisal Rights ST. LOUIS, Feb. 23 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today commented on the ruling by the Court of Chancery of the State of Delaware that it has again enjoined Caremark Rx, Inc. (NYSE: CMX) from holding a stockholder vote regarding the CVS acquisition, this time un... 
02/15/2007Generic Biotech Medicines Could Save Plan Sponsors and Patients $71 Billion
ST. LOUIS, Feb 15, 2007 (BUSINESS WIRE) -- Generic biotech medicines could save U.S. plan sponsors and patients $71 billion over ten years, with $3.5 billion of the savings occurring the first year, according to a report issued by Express Scripts, one of the nation's largest managers of pharmacy benefit plans. Savings for plan sponsors could amount to $1,900 in the first year for a multiple sclerosis patient with a therapy treatment that includes biotech medicines. "Given the savings p... 
02/13/2007Express Scripts Comments on Delaware Court of Chancery Order
ST. LOUIS, Feb 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today noted the order by the Court of Chancery of the State of Delaware in support of an independent stockholder's motion to enjoin the Caremark Rx, Inc., (NYSE: CMX) February 20, 2007 special meeting of stockholders until at least March 9, 2007. The company commented: "This is the right decision for Caremark stockholders. It is unfortunate that it was necessary for a court to e... 
02/13/2007Express Scripts Comments on Revised CVS Offer
Urges Stockholders to Vote GOLD Proxy Card AGAINST Proposed CVS Transaction Now Express Scripts Extends Tender Offer to March 16, 2007 ST. LOUIS, Feb. 13 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today commented on CVS Corporation's (NYSE: CVS) revised offer to acquire Caremark Rx, Inc., (NYSE: CMX). The Company stated: "Today's announcement can't paper over a flawed process, weaker currency, and unproven strat... 
02/12/2007Generic Anti-Cholesterol Drugs Save $126 Million for Plan Sponsors, Patients
Shift to Generics Biggest in History for America's Most Used Drug Class ST. LOUIS, Feb. 12 /PRNewswire-FirstCall/ -- Generic anti-cholesterol drugs helped pharmacy benefit manager Express Scripts save $126 million for its plan sponsors and patients in 2006. The cholesterol fighting drug Zocor(R) became available as generic simvastatin on June 23, 2006. By that time, Express Scripts had already succeeded in giving its clients and patients a big head start on saving money with th... 
02/12/2007ISS Recommends Caremark Stockholders Vote Against Acquisition by CVS
Four Proxy Advisory Firms Recommend Caremark Stockholders Vote Against CVS TransactionST. LOUIS, Feb 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that Institutional Shareholder Services (ISS), a leading independent voting advisory service, recommends that its clients vote AGAINST the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on February... 
02/09/2007Express Scripts Urges Caremark Board to Negotiate
Mails Letter to Caremark BoardST. LOUIS, Feb 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today mailed the following letter to the Board of Caremark Rx, Inc. (NYSE: CMX): February 9, 2007 Board of Directors Caremark Rx, Inc. 211 Commerce Street, Suite 800 Nashville, Tennessee 37201 Ladies and Gentlemen: Since our initial proposal to you more than seven weeks ago, setting out the terms of... 
02/09/2007Express Scripts Urges Caremark Stockholders to Vote the GOLD Proxy Card AGAINST the Proposed CVS/Caremark Transaction Today
Mails Letter to Caremark Stockholders ST. LOUIS, Feb. 9 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today mailed the following letter to the stockholders of Caremark Rx, Inc. (NYSE: CMX): February 9, 2007 PROTECT YOUR CAREMARK INVESTMENT VOTE AGAINST THE PROPOSED CVS MERGER TODAY Dear Caremark Stockholder: For nearly eight weeks, Caremark's Board and management have stonewalled Express ... 
02/08/2007Express Scripts Reports Record Fourth Quarter and Full-year 2006 Earnings
Company Raises 2007 Guidance for Both Earnings Per Share and Cash Flow Announces Increase In Share Repurchase Authorization ST. LOUIS--(BUSINESS WIRE)--Feb. 8, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced record fourth quarter net income of $147.2 million, or $1.07 per diluted share, compared to $0.75 per diluted share for the same quarter last year. Excluding non-recurring items in both quarters that are discussed below, ear... 
02/05/2007Express Scripts Urges Caremark Stockholders to Ignore CVS and Caremark's Scare Tactics
Vote the GOLD Proxy Card AGAINST the Proposed CVS/Caremark Transaction TodayST. LOUIS, Feb 05, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today urged Caremark (NYSE: CMX) stockholders to reject the desperate scare tactics set forth in the CVS (NYSE: CVS) letter this morning. The letter represents a continuation of the attempts by both CVS and Caremark to distract attention from the real issue at stake -- to maximize value for Caremark stockho... 
02/02/2007Express Scripts Urges Caremark Stockholders to Reject Value Destruction of Proposed Acquisition by CVS
ST. LOUIS, Feb. 2 /PRNewswire-FirstCall/ -- In an advertisement published today in The Wall Street Journal, Express Scripts, Inc. (Nasdaq: ESRX) urged Caremark Rx, Inc. (NYSE: CMX) stockholders to consider the enhanced value that an Express Scripts/Caremark combination offers to stockholders, plan sponsors and patients. By contrast, the proposed acquisition of Caremark by CVS Corporation (NYSE: CVS) is strategically and financially flawed. The text of the advertisement follows: ... 
02/01/2007Express Scripts Mails Letter to Caremark Stockholders
Urges Caremark Stockholders to Vote AGAINST CVS Proposal ST. LOUIS, Feb. 1 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today mailed the following letter to the stockholders of Caremark Rx, Inc. (NYSE: CMX): February 1, 2007 PROTECT YOUR CAREMARK INVESTMENT VOTE AGAINST THE PROPOSED CVS MERGER Dear Caremark Stockholder: As the Caremark Special Meeting approaches, we urge you to carefully con... 
01/31/2007Express Scripts Comments on Caremark's Attempts to Defend Lavish Payments to its Senior Management
ST. LOUIS, Jan 31, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today commented on the statement made by Caremark Rx, Inc. (NYSE: CMX) in an advertisement published today. "It is outrageous that Caremark would spend stockholder money attempting to defend the lavish payments that its senior management would receive in a combination with CVS. We have trouble understanding how a 'merger of equals' could possibly warrant... 
01/31/2007Express Scripts Intends to Re-File Hart-Scott-Rodino Premerger Notification
ST. LOUIS, Jan. 31 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it intends to voluntarily withdraw on February 2, 2007, and will re-file on February 6, 2007, its notification under the Hart-Scott-Rodino Antitrust Improvements Act in connection with the proposed acquisition of Caremark Rx, Inc. (NYSE: CMX) by Express Scripts. Express Scripts has determined to withdraw its Hart-Scott-Rodino filing and re-file it, which will provide the Federal T... 
01/30/2007Express Scripts Schedules Fourth Quarter Earnings Release and Conference Call
ST. LOUIS--(BUSINESS WIRE)--Jan. 30, 2007--Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, will report its fourth quarter 2006 results and comment on its 2007 earnings guidance prior to the market opening on Thursday, February 8, 2007. Express Scripts will hold its quarterly conference call to discuss these results on that same day, beginning at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). The conference call can... 
01/24/2007Express Scripts to Distribute Definitive Proxy Materials to Caremark Stockholders
Express Scripts Urges Caremark Stockholders to Vote the GOLD Proxy Card Against the Acquisition By CVS ST. LOUIS, Jan. 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will commence distributing its definitive proxy materials to all Caremark Rx, Inc. (NYSE: CMX) stockholders in connection with Caremark's special meeting of stockholders to be held on February 20, 2007. Express Scripts also announced that it will distri... 
01/16/2007Express Scripts Comments on CVS-Caremark Announcement
The Express Scripts Offer for Caremark Remains Superior ST. LOUIS, Jan. 16 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement in response to the announcement by Caremark Rx, Inc., (NYSE: CMX) and CVS Corporation (NYSE: CVS). The Express Scripts offer for Caremark remains superior. Express Scripts noted that the recent steps taken by Caremark and CVS are no more than a desperate attempt to save a flawed transaction: ... 
01/16/2007Express Scripts Announces Exchange Offer for Caremark
ST. LOUIS, Jan. 16 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it is commencing an exchange offer for all outstanding shares of Caremark Rx, Inc., (NYSE: CMX) in furtherance of Express Scripts' previously announced proposal to acquire Caremark. The complete terms, conditions and other details of the Exchange Offer are set forth in the offering documents that Express Scripts will file later today with the Securities and Exchange Commission. ... 
01/08/2007Express Scripts Nominates Four Directors for the Caremark Board of Directors
Express Scripts Offer for Caremark is Superior ST. LOUIS, Jan. 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it provided notice to Caremark Rx, Inc., (NYSE: CMX) of its intention to nominate four candidates for election to the Caremark Board of Directors at the Company's upcoming Annual Meeting of Stockholders. On December 18, 2006, Express Scripts announced its proposal to acquire Caremark for $29.25 in cash and 0.426 shares... 
01/08/2007Express Scripts Offer for Caremark is Superior
ST. LOUIS, Jan. 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement in response to the announcement by Caremark Rx, Inc. (NYSE: CMX) that its Board of Directors has rejected the Express Scripts offer: "Our offer represents a superior proposal. Caremark stockholders and the marketplace as a whole have demonstrated their strong support for our offer, which clearly provides Caremark stockholders with superior value to the proposed ac... 
01/04/2007Express Scripts Sends Letter to Caremark Stockholders
ST. LOUIS, Jan 04, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today sent the following letter to Caremark Rx, Inc. (NYSE: CMX) stockholders: January 4, 2007 PROTECT YOUR CAREMARK INVESTMENT VOTE AGAINST THE PROPOSED CVS MERGER Dear Caremark Stockholder: On November 1, 2006, Caremark Rx, Inc. and CVS Corporation announced a transaction whereby CVS would acquire all of the outstan... 
12/20/2006Express Scripts Comments on Caremark/CVS HSR Announcement
ST. LOUIS, Dec. 20 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement related to the announcement by Caremark Rx, Inc., (NYSE: CMX): "As we expected, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired for CVS Corporation (NYSE: CVS). We said on December 18th that we anticipate the Express Scripts transaction with Caremark would be completed in the third quarter of 2007. The super... 
12/18/2006Express Scripts Proposes to Acquire Caremark for $58.50 Per Share in Cash and Stock
Transaction Valued at Approximately $26 Billion Premium Approximately 22% Combination to Create World's Preeminent Pharmacy Benefit Management Company Annual Cost Synergies Expected to be Approximately $500 Million ST. LOUIS, Dec. 18 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it is proposing to acquire all of the outstanding shares of Caremark Rx, Inc., (NYSE: CMX) for $29.25 in cash and 0.426 shares of E... 
12/14/2006Express Scripts to Present at the JP Morgan Healthcare Conference
ST. LOUIS, Dec. 14 /PRNewswire-FirstCall/ -- David Myers, Vice President Investor Relations of Express Scripts, Inc. (Nasdaq: ESRX) is scheduled to present at the 25th Annual JP Morgan Healthcare Conference on January 8, 2007 at 1:30 p.m. PST (4:30 p.m. EST) at The Westin St. Francis in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . ... 
11/14/2006Express Scripts Provides 2007 Earnings Guidance
Reflects Growth of 20% to 24% ST. LOUIS, Nov. 14 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced today that it believes its financial performance will continue to benefit from growth in generic utilization, home delivery, and specialty pharmacy management; lower retail and home delivery drug purchasing costs; improved formulary compliance with preferred, lower-cost brand drugs; increased productivity; and capital structure improvements. As a ... 
11/10/2006Express Scripts, Inc. Announces 2007 Earnings Guidance Conference Call
ST. LOUIS, Nov. 10 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its 2007 earnings guidance on Tuesday, November 14, 2006 before the market opens and hold a conference call on this day to discuss this guidance at 8:30 a.m. Central (9:30 a.m. Eastern). This call is being webcast and can be accessed at Express Scripts' web site at http://www.express-s... 
11/08/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, Nov. 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Credit Suisse Health Care Conference on November 16, 2006 at 11:00 a.m. MST (1:00 p.m. EST) at The Arizona Biltmore Hotel in Phoenix, Arizona. Merrill Lynch Health Services Investor Conference on November 28, 2006 at 10:15 a.m. EST at the Waldorf Astoria Hotel in New York, NY. These presentations will also be broadcast via the Interne... 
10/24/2006Express Scripts Reports Record Third Quarter 2006 Earnings
2.5 Million Shares Repurchased During the Quarter Earnings Guidance Increased for 2006 ST. LOUIS, Oct. 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income of $114.7 million, or $0.83 per diluted share. This represents a 24 percent increase over $0.67 per diluted share last year, adjusted to exclude a $0.01 per diluted share non- recurring tax benefit. During the quarter, Express Scripts repu... 
09/28/2006New Web Tool Helps Consumers Uncover Generic Drug Alternatives
ST. LOUIS, Sept. 28 /PRNewswire-FirstCall/ -- With more than $10 billion in brand drugs going generic this year, consumers and health plans are cutting drug costs by as much as $60 on each prescription where a new generic is available. Consumers using brand drugs that aren't available as a generic can also get in on the savings. Potential alternatives to brand medications are often available and achieve a comparable therapeutic result to the brand at a lower cost. Uncovering ... 
09/27/2006Express Scripts, Inc. Announces Third Quarter 2006 Earnings Conference Call
ST. LOUIS, Sept. 27 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Tuesday, October 24, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss third quarter results on Wednesday, October 25, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accesse... 
09/18/2006Prescription Assistance Program Helps with Medicare Part D Doughnut Hole
ST. LOUIS, Sept. 18 /PRNewswire-FirstCall/ -- Nine months into the new Medicare Part D program, many beneficiaries are finding themselves in the program's "doughnut hole" coverage gap. Rx Outreach(SM), a patient assistance program (PAP) offered by pharmacy benefit manager Express Scripts, can help Medicare Part D beneficiaries in the "doughnut hole." Rx Outreach's PAP offers 90-day supplies of 110 primarily generic medications from more than 40 therapeutic classes to treat mos... 
08/29/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, Aug. 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Thomas Weisel Partners Healthcare Conference 2006 on September 6, 2006 at 10:55 a.m. EDT at the Four Seasons Hotel in Boston, MA. Bank of America 36th Annual Investment Conference on September 18, 2006 at 8:30 a.m. PDT (11:30 a.m. EDT) at the Ritz Carlton in San Francisco, CA. These presentations will be broadcast via the Inter... 
08/02/2006Express Scripts' CEO to Adopt 10b5-1 Plan
Reiterates 2006 Earnings GuidanceST. LOUIS, Aug 02, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that George Paz, the Company's president, chief executive officer and chairman, plans to adopt a new prearranged trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934. Rule 10b5-1 permits officers and directors of public companies to adopt predetermined plans for selling specified amounts of stock. No transactio... 
07/26/2006Express Scripts Reports Second Quarter 2006 Earnings
9.5 Million Shares Repurchased During the Quarter Earnings Guidance Increased for 2006 ST. LOUIS, July 26 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter net income of $107.8 million, or $0.75 per diluted share. This represents a 25 percent increase over $0.60 per diluted share last year, adjusted to exclude an $0.08 per diluted share non- recurring tax benefit. During the quarter, Express Scripts re... 
06/29/2006Express Scripts, Inc. Announces Second Quarter 2006 Earnings Conference Call
ST. LOUIS, June 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 26, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss second quarter results on Thursday, July 27, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accessed a... 
06/07/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, June 7, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Goldman Sachs 27th Annual Global Healthcare Conference on June 15, 2006 at 9:20 a.m. PDT (12:20 p.m. EDT) at the Ritz-Carlton in Dana Point, CA. William Blair 26th Annual Growth Stock Conference on June 27, 2006 at 9:50 a.m. CDT (10:50 a.m. EDT) at the Four Seasons Hotel in Chicago, IL. These presentations will be... 
06/07/2006Specialty Biotech Drug Spending Skyrockets
Cost Control Strategies Begin to Show Success ST. LOUIS, June 7, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Spending on America's most popular class of biotech drugs -- those used to treat inflammatory diseases -- increased 33.9 percent in 2005, according to the 2006 Express Scripts Specialty Drug Trend Report. The company is one of the nation's largest managers of pharmacy benefit plans, serving more than 55 million people. Although the class includes only four drugs -- th... 
06/06/2006$24.7 Billion in Generic Savings Available This Year
Driven by Blockbuster Brands Going Generic ST. LOUIS, June 6 /PRNewswire/ -- Generic drugs could save U.S. consumers $24.7 billion this year alone, according to a report issued today by Express Scripts, one of the nation's largest managers of pharmacy benefit plans. The report examined the clinical potential for greater generic drug use in six major drug-therapy classes used to treat common conditions like stomach ulcers, inflammation, depression, high blood press... 
05/24/2006Generic Drugs First for Millions
ST. LOUIS, May 24 /PRNewswire-FirstCall/ -- For millions of Americans, getting a new prescription increasingly means first trying a lower cost generic medicine before using a more expensive brand drug. Today, Express Scripts reported that 14 million consumers in pharmacy benefit plans it manages are now covered by programs that support using a generic as a first treatment option. The company said the figure represents a five-fold increase in the number of pharmacy benefit plan... 
05/09/2006Express Scripts to Present at the Bank of America Health Care Conference
ST. LOUIS, May 9, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Bank of America Health Care Conference on May 17, 2006 at 8:00 a.m. PDT (11:00 a.m. EDT) at The Four Seasons Hotel in Las Vegas, Nevada. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Play... 
05/01/2006Savings to Follow Generic Zocor Court Ruling
Express Scripts Reaffirms 2006 Earnings GuidanceST. LOUIS, May 1, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) commented today on the court's decision granting 180-day exclusivity for the generic version of Zocor, or simvastatin. During the 180-day exclusive period there will be two competing suppliers of simvastatin, which includes an authorized generic manufacturer. "Our clients will realize a significant reduction in the price of Zocor wh... 
04/26/2006Express Scripts Reports Solid First Quarter 2006 Earnings
ST. LOUIS, April 26 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $104.7 million, or $0.70 per diluted share. This compares to first quarter 2005 diluted earnings per share of $0.57, which included a $0.01 per diluted share non-recurring tax benefit. All per share amounts have been adjusted to reflect the Company's 2-for-1 stock split, which was effective June 24, 2005. "Our first quarter results reflect our continued focus ... 
04/25/2006Express Scripts' Research Earns Excellence Award
ST. LOUIS, April 25 /PRNewswire-FirstCall/ -- Express Scripts' "Effect of Patient Notification of Formulary Change on Formulary Adherence" research was selected as one of the three best articles published in the Journal of Managed Care Pharmacy (JMCP) in 2005. This honor marks the third year in a row Express Scripts has been recognized by the Academy of Managed Care Pharmacy for producing research ranked among the best scholarly work in managed care pharmacy. The randomized co... 
04/04/2006National Study Reveals Doubling in Type 2 Diabetes Prescriptions Among Children
-- Dramatic Four-Year-Increase a Leading Indicator of Future Health Care Cost Growth -- ST. LOUIS, April 4 /PRNewswire-FirstCall/ -- Express Scripts today announced results of a study of prescription claims for millions of U.S. children ages 5 to 19 revealing a four-year doubling in those taking medication typically used to treat or prevent Type 2 diabetes. This rapid increase, a rise from about 0.3 to 0.6 per thousand from 2002 to 2005, represents en... 
03/30/2006Express Scripts, Inc. Announces First Quarter 2006 Earnings Conference Call
ST. LOUIS, March 30 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Wednesday, April 26, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss first quarter results on Thursday, April 27, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accessed a... 
03/15/2006Express Scripts to Webcast Investor Meeting
ST. LOUIS, March 15 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will webcast its investor meeting beginning at 8:30 a.m. Mountain Time (11:30 a.m. Eastern Time) on Friday, April 7, 2006, at which management will make presentations regarding the Company followed by a tour of its Tempe Home Delivery Pharmacy. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at ht... 
03/03/2006Express Scripts' CEO Adopts 10b5-1 Plan
ST. LOUIS, March 3 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that George Paz, the Company's president and chief executive officer, has adopted a prearranged trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934. Rule 10b5-1 permits officers and directors of public companies to adopt predetermined plans for selling specified amounts of stock. "While I believe we are well-positioned in the PBM sector and am excited about our p... 
02/28/2006Lower Cost Generic Drugs for Lower Income Consumers
ST. LOUIS, Feb. 28 /PRNewswire-FirstCall/ -- Lower income consumers now can pay less for more generic medications, with a doubling of the number of generic medications available through Rx Outreach, a generic patient assistance program. The broader coverage will increase the number of generic drugs offered to 107, effective March 1. The program offers drugs in 19 of the top 25 therapeutic classes. Rx Outreach saved 267,000 patients more than $61 million while filling 771,000 pre... 
02/22/2006Express Scripts Reports Record Fourth Quarter and Full Year 2005 Earnings
EBITDA Per Adjusted Claim up 37% to $1.53ST. LOUIS, Feb 22, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced record fourth quarter net income of $111 million, or $0.75 per diluted share. Excluding a fourth quarter charge of $0.02 per diluted share for the early retirement of debt, earnings per diluted share was $0.77, a 45% increase over $0.53 per diluted share reported for the same quarter last year. All per share amounts have been adj... 
02/20/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, Feb. 20 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences. These presentations will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . Citigroup 2006 Healthcare Conference on March 1, 2006 at 2:30 p.m. EST at the Mayflower Hotel in Washington, DC. SG Cowen Healthcare Conference on March 7, 2006 at 1... 
02/09/2006Study: Set Pharmacy Copays to Reduce Costs, Avoid Cost-Shifting with Generic Drugs
ST. LOUIS, Feb. 9 /PRNewswire-FirstCall/ -- Express Scripts research reveals how changes to prescription benefit copayments can reduce healthcare costs through greater use of generic drugs without shifting costs to consumers. "A study released today, based on an analysis of 2004 prescription claims, indicates a pharmacy benefit plan design that increases the differential between brand and generic copayments by $10 can expect to achieve a 3 to 4 percentage point increase in the gen... 
01/19/2006Express Scripts, Inc. Announces Fourth Quarter 2005 Earnings Conference Call
ST. LOUIS, Jan. 19 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today its intention to release its fourth quarter earnings on Wednesday, February 22, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 23, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accessed at Express Scripts' web site at http://www.express-scripts.com/ in th... 
01/18/2006Generic Drug Info/Interview Resource for Journalists
Generic drugs promise to be one of the biggest, continuing health stories of 2006, with more than $11.3 billion (in sales) of brand drugs going generic. The biggest of these will be Zocor (simvastatin) at more than $3 billion in sales. For comprehensive background information on the generics opportunity and the billions that can be saved by using more generic drugs visit: http://www.express-scripts.com/pr/generics Our physician and pharmacy experts are also available to an... 
01/05/2006Express Scripts to Present at the JP Morgan Healthcare Conference - Note Change of Time
ST. LOUIS, Jan. 5 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the 24th Annual JP Morgan Healthcare Conference on January 9, 2006 at 11:00 a.m. PST (2:00 p.m. EST) at The Westin St. Francis in San Francisco, California. The Company previously released that it would present at 11:00 a.m. EST. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at h... 
01/03/2006Express Scripts to Present at the JP Morgan Healthcare Conference
ST. LOUIS, Jan. 3 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the 24th Annual JP Morgan Healthcare Conference on January 9, 2006 at 11:00 a.m. EST at The Westin St. Francis in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Player is needed to listen ... 
12/15/2005Express Scripts Recognized for Outstanding Web Site Designs
ST. LOUIS, Dec 15, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- eHealthcare Strategy and Trends recently awarded Express Scripts (Nasdaq: ESRX) a Platinum 2005 eHealthcare Leadership Award for Best Site Design (express-scripts.com) in its category. Express Scripts also received a Gold award for Best Overall Internet Site (express-scripts.com) and a Silver award for Best Health/Healthcare content (drugdigest.org). The intense competition included 1200 entries in 17 classificatio... 
11/28/2005Express Scripts Provides 2006 Earnings Guidance
ST. LOUIS, Nov. 28 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced today that it expects its 2006 diluted earnings per share will be in the range of $3.10 to $3.22, which includes $0.10 per diluted share in stock option expense as Financial Accounting Standard No. 123R - "Share Based Payment" will be adopted in 2006. The Company said that it expects its financial performance will continue to benefit from growth in generic utilization and home delivery, including spe... 
11/22/2005Express Scripts, Inc. Announces 2006 Earnings Guidance Conference Call
ST. LOUIS, Nov 22, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its 2006 earnings guidance on Monday, November 28, 2005 after market close and hold a conference call on this day to discuss this guidance at 3:30 p.m. Central (4:30 p.m. Eastern). This call is being webcast and can be accessed at Express Scripts' web site at htt... 
11/10/2005Express Scripts to Present at Investor Conferences
ST. LOUIS, Nov. 10 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Credit Suisse First Boston Health Care Conference on November 17, 2005 at 8:00 a.m. MST (10:00 a.m. EST) at The Arizona Biltmore Hotel in Phoenix, Arizona. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . Merril... 
10/26/2005Express Scripts Reports Record Third Quarter Earnings
Earnings Guidance Increased for 2005ST. LOUIS, Oct 26, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income of $101.7 million, or $0.68 per diluted share, compared to $0.40 per diluted share reported for the same quarter last year. Excluding non-recurring items in both quarters that are discussed below, diluted earnings per share in the third quarter was $0.67, a 34 percent increase over $0.50 per diluted share last ... 
10/25/2005Study Reveals $20 Billion in Untapped Generic Drug Savings
- Generics Use Varies by State: Massachusetts, Oregon and New Mexico Have Highest Usage; New Jersey and New York Have Lowest - ST. LOUIS, Oct. 25 /PRNewswire-FirstCall/ -- U.S. consumers could have saved $20 billion in 2004 and even more during this and future years by using more generic drugs, according to a new report by Express Scripts, Inc. Projectable to the U.S. commercially insured population, the study examined six major drug-therapy classes and was based on a ra... 
10/14/2005Express Scripts Completes the Acquisition of Priority Healthcare
Acquisition Will Grow Specialty Revenues to Over $3 Billion ST. LOUIS, Oct. 14 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), a leading pharmacy benefit management company, announced today it has completed the acquisition of Priority Healthcare Corporation ("Priority") (Nasdaq: PHCC) in a cash transaction for $28 per share, or a total of approximately $1.3 billion. Priority, headquartered near Orlando, Fla., is one of the nation's largest biopharmaceutical ph... 
09/21/2005Express Scripts, Inc. Announces Third Quarter 2005 Earnings Conference Call
ST. LOUIS, Sept 21, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Wednesday, October 26, 2005 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss third quarter results on Thursday, October 27, 2005, 8:30 a.m. Central Time. This call is being webc... 
09/08/2005Express Scripts to Build New Headquarters at University of Missouri-St. Louis
- Expansion Will Strengthen Company and Support Growth - ST. LOUIS, Sept. 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the nation's leading managers of pharmacy benefit plans, announced today that the company will build its new corporate headquarters on the campus of the University of Missouri-St. Louis (UMSL). The company will break ground on the new headquarters later this year, with occupancy expected in March 2007. Express Scripts will be the highest... 
09/06/2005Express Scripts to Present at Investor Conferences
ST. LOUIS, Sept 06, 2005 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Bear Stearns 18th Annual Global Healthcare Conference on September 13, 2005 at 3:00 p.m. EDT at the Grand Hyatt New York. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com... 
08/29/2005Defense Department Recognizes Express Scripts for Saving $100 Million on TRICARE Pharmacy Drug Expenditures
ST. LOUIS, Aug. 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that the Department of Defense (DoD) has recognized Express Scripts for its performance under the contract for the TRICARE Retail Pharmacy (TRRx) program serving about 9.1 million eligible TRICARE beneficiaries. This recognition resulted from saving the DoD more than $100 million by exceeding the contractual prescription drug price guarantee during the period of June 2004 through May 20... 
08/24/2005Study Finds Patient Education Drives Greater Use of Cost Saving Drugs
-- Consumer Involvement in Prescription Decision Making Process Helps Curtail Rising Drug Expenditures -- ST. LOUIS, Aug. 24 /PRNewswire-FirstCall/ -- Express Scripts today announced findings from a study indicating that patient education and involvement can strongly impact the use of cost saving drugs included in preferred drug lists called formularies. The Patient Formulary Change Notification Study was conducted in collaboration with a large national hea... 
07/27/2005Express Scripts Reports Record Second Quarter Earnings
Earnings Guidance Increased for 2005 ST. LOUIS, July 27 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter net income of $102.0 million, or $0.68 per diluted share, compared to $0.42 per diluted share reported for the same quarter last year. Excluding non-recurring items in both quarters that are discussed below, diluted earnings per share in the second quarter was $0.60, a 30 percent increase over $0.46 per diluted share last ... 
07/21/2005Express Scripts Announces Agreement to Acquire Priority Healthcare
Transaction Will Enhance CuraScript's Rapid Growth ST. LOUIS, July 21 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today the signing of a definitive agreement to acquire Priority Healthcare Corporation ("Priority") (Nasdaq: PHCC) in a cash transaction for $28 per share, or $1.3 billion. Priority, headquartered near Orlando, Fla., is among the nation's largest specialty pharmacy and distribution companies. The transaction is expected to close in the fourt... 
06/27/2005Express Scripts, Inc. Announces Second Quarter 2005 Earnings Conference Call
ST. LOUIS, June 27 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 27, 2005 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss second quarter results on Thursday, July 28, 2005 at 9:00 a.m. Central Time. This call is being webcast and can be accessed at E... 
06/24/2005Express Scripts Completes 2-For-1 Stock Split
ST. LOUIS, June 24, 2005—Express Scripts, Inc. (NASD: ESRX) announced that the previously disclosed two-for-one stock split was effected at the close of trading on June 24, 2005. The stock closed at a pre-split price of $101.20 and will commence trading on a post-split basis when the market opens on Monday, June 27, 2005. The stock split was for stockholders of record as of June 10, 2005. The split comes in the form of a stock dividend by issuing one additional share of stock for each share ... 
06/09/2005Express Scripts to Present at Investor Conferences
ST. LOUIS, June 9 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference on June 16, 2005 at 9:40 a.m. PDT (12:40 p.m. EDT) at the Ritz Carlton Laguna Niguel in Dana Point, California. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site... 
06/07/2005Zero Increase in Prescription Drug Spending With Generic Promotion Programs
ST. LOUIS, June 7 /PRNewswire-FirstCall/ -- Prescription drug spending stopped its upward trend in 2004, with no year-to-year increase, for sponsors of drug benefit programs that adopted two or more cost-management programs, according to the 2004 Express Scripts Drug Trend Report released today. The cost-management programs adopted by clients of pharmacy benefit manager Express Scripts typically required consumers in their drug-benefit plans to use a low-cost, equally effective gener... 
05/25/2005Express Scripts Declares 2-For-1 Stock Split
ST. LOUIS, May 25 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that its Board of Directors has approved a two- for-one stock split to be effected in the form of a stock dividend. The stock split is for shareholders of record as of June 10, 2005, and will be effective on or about June 24, 2005. "The stock split reflects the successful execution of our business model, which is built around the alignment of interests with our clients and members," sta... 
05/12/2005Express Scripts to Present at Banc of America Securities Health Care Conference
ST. LOUIS, May 12 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Banc of America Securities Health Care Conference on Thursday, May 19, 2005 at 8:40 a.m. PDT (11:40 a.m. EDT) at The Four Seasons Hotel in Las Vegas, Nevada The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Pl... 
05/11/2005Express Scripts Research Paper Receives Award for Excellence
ST. LOUIS, May 11 /PRNewswire-FirstCall/ -- For the second consecutive year, the Academy of Managed Care Pharmacy (AMCP) awarded its Award for Excellence to Express Scripts (Nasdaq: ESRX) for the best research paper published in the Journal of Managed Care Pharmacy. The award was presented at AMCP's 17th Annual Meeting. The paper, "Randomized Controlled Trial of a Dose Consolidation Program," examined the cost savings associated with convincing physicians to prescribe once-daily str... 
04/26/2005Express Scripts Reports Strong First Quarter Earnings
Record Generic Utilization of 54% Earnings Guidance Increased for 2005 ST. LOUIS, April 26 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $85.3 million, or $1.14 per diluted share, a 28% increase over $0.89 per diluted share reported for the same quarter last year. Excluding non-recurring items in both quarters that are discussed below, diluted earnings per share in the first qu... 
04/21/2005Express Scripts to Webcast Investor Conference
ST. LOUIS, April 21 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will webcast its investor conference beginning at 9:00 a.m. EDT on Thursday, April 28, 2005, at which management will make presentations regarding the Company followed by a tour of CuraScript Specialty Pharmacy. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . ... 
03/31/2005Express Scripts Receives Innovation Award for Generics Program
ST. LOUIS, March 31, 2005 /PRNewswire-FirstCall via COMTEX/ -- The Pharmacy Benefit Management Institute (PBMI) today awarded its 2005 Rx Benefit Innovation Award to Express Scripts (Nasdaq: ESRX) for its Zero Dollar Copay program, which promotes greater use of generic drugs. The annual award recognizes creative approaches to prescription-drug benefit program management. With Zero Dollar Copay, Express Scripts clients make it possible for covered employees to have their prescription co... 
03/24/2005Express Scripts to Present at Lehman Brothers Healthcare Conference
ST. LOUIS, March 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Lehman Brothers Eighth Annual Global Healthcare Conference on Friday, April 1, 2005 at 10:45 a.m. EST at the Loews Miami Beach Hotel. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Player is needed to lis... 
03/23/2005Express Scripts, Inc. Announces First Quarter 2005 Earnings Conference Call
ST. LOUIS, March 23 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Tuesday, April 26, 2005 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss first quarter results on Wednesday April 27, 2005 at 9:00 a.m. Central Time. This call is being webcast and can be accessed at Ex... 
03/09/2005Express Scripts CEO Adopts 10b-5 Plan
ST. LOUIS, March 9 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that Barrett Toan, the Company's chief executive officer, has adopted a prearranged trading plan in accordance with the guidelines specified by Rule 10b5-1 under the Securities and Exchange Act of 1934. Rule 10b5-1 permits officers and directors of public companies to adopt predetermined plans for selling specified amounts of stock. The plans may be entered into only when the director ... 
03/08/2005Express Scripts Web Site Recognized for User-Friendly Healthcare Content
ST. LOUIS, March 8, 2005 /PRNewswire-FirstCall via COMTEX/ -- A combination of user-friendly design, content and functionality earned Express-Scripts.com for Members a Best User Interface award in COR Health's third-annual Medicine on the Net Web Excellence Awards. The annual awards recognize outstanding healthcare Web sites from across the country, based on overall quality, user interface, design and content. Express Scripts, one of the nation's leading managers of pharmacy benefit p... 
03/07/2005Express Scripts Contributes $160,000 to Red Cross for Tsunami Relief
ST. LOUIS, March 7, 2005 /PRNewswire-FirstCall via COMTEX/ -- In less than one month, 813 employees of Express Scripts (Nasdaq: ESRX) raised $80,437 in donations to support Red Cross tsunami relief efforts. Express Scripts is matching employee donations dollar-for-dollar for a total of $160,874. The donations were raised at 13 Express Scripts locations in the U.S. and Canada. Some locations held special "Dollars for Denim" days, where employees making donations could wear casual clothe... 
03/02/2005Express Scripts Reports Strong Fourth Quarter Earnings
Record Cash Flow From Operations of $193 million Gross Profit up 13% ST. LOUIS, March 2 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced fourth quarter net income of $80.9 million, or $1.07 per diluted share, a 24 percent increase over $0.86 per diluted share reported for the same quarter last year. For the year, the Company reported net income of $278.2 million, or $3.59 per diluted share, compared to $249.6 millio... 
03/01/2005Express Scripts to Present at Investor Conferences
ST. LOUIS, March 1, 2005 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: -- Raymond James & Associates 2005 Institutional Investors Conference on March 8, 2005 at 9:15 a.m. EST at the Hyatt Regency Grand Cypress in Orlando, Florida. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web sit... 
02/03/2005Express Scripts, Inc. Announces Fourth Quarter 2004 Earnings Conference Call
ST. LOUIS, Feb. 3 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Wednesday, March 2, 2005 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss fourth quarter results on Thursday, March 3, 2005 at 9:00 a.m. Central Time. This call is being webcast and can be accessed at Ex... 
01/25/2005Express Scripts Commends Release of Medicare Drug Benefit Regulations Affirming Value of Pharmacy Benefit Management Tools
ST. LOUIS, Jan. 25 /PRNewswire-FirstCall/ -- Express Scripts, Inc. today commended the Centers for Medicare and Medicaid Services (CMS) upon the release of final regulations for implementation of Part D of the Medicare Modernization Act, which affirm the value of pharmacy benefit management tools. "Critical to the success of Part D will be the deployment of pharmacy benefit management tools already proven effective in safely managing drug costs in the commercial sector. We strongly... 
01/14/2005Georgia Medicaid Program Saves $20 Million by Controlling Use of Anti-Ulcer Drugs
ST. LOUIS, Jan. 14 /PRNewswire-FirstCall/ -- The Georgia Medicaid program reduced its prescription-drug costs by $20.6 million over a one-year period by requiring enrollees to get permission before filling prescriptions for anti-ulcer medications called proton pump inhibitors (PPIs). The savings were reported in a study published today in the American Journal of Managed Care by researchers at Express Scripts, the pharmacy benefit manager serving the Georgia Medicaid program. In 200... 
01/04/2005Express Scripts to Present at JP Morgan Healthcare Conference
ST. LOUIS, Jan. 4 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the JP Morgan Healthcare Conference on Monday, January 10, 2005 at 8:00 a.m. PST (11:00 am EST) at The Westin St. Francis Hotel in San Francisco. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Player is needed ... 
12/16/2004Express Scripts Names George Paz Chief Executive Officer Effective April 1, 2005
Barrett Toan Will Continue as Chairman of the Board ST. LOUIS, Dec 16, 2004 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today the appointment of George Paz as Chief Executive Officer effective April 1, 2005. Mr. Paz will succeed Chairman and CEO Barrett Toan, who will continue to serve as Chairman of the Company's Board of Directors. Mr. Paz, 49, has been President of Express Scripts since 2003 after joining the Company as Chief Financial Officer i... 
12/13/2004Plan Sponsors Save Money, Members Get Lower Copayments With New Express Scripts Generic Promotion Program
ST. LOUIS, Dec 13, 2004 /PRNewswire-FirstCall via COMTEX/ -- Members of Express Scripts' clients who switch from using a higher-cost branded drug to a lower-cost generic for certain therapy classes can now have their prescription copayment waived by their plan sponsor for six months with the Zero Dollar Copay program, a new generic promotion program available from Express Scripts. With Zero Dollar Copay, prescription plan sponsors can give members using nonformulary brand drugs a signi... 
12/06/2004Generic Drug Use Varies Widely by State, Study Reveals
ST. LOUIS, Dec 6, 2004 /PRNewswire-FirstCall via COMTEX/ -- Generic drug use varies widely by state, according to a new Express Scripts study that measured per capita generic drug utilization in 2003, using a random sample of approximately 3 million pharmacy benefit plan members age 18 to 64. The study revealed that Massachusetts had the highest generic dispensing rate, at 51%, followed by New Mexico and Oregon, with generic dispensing rates of approximately 50%. Eastern states, s... 
11/29/2004Express Scripts Recognized for Web Site Design, Healthcare Content
ST. LOUIS, Nov 29, 2004 /PRNewswire-FirstCall via COMTEX/ -- Health Care Communications, publisher of eHealthcare Strategy and Trends, awarded Express-Scripts.com for Members Platinum and Gold Awards for Best Overall Internet Site and Best Health/Healthcare Content in the fifth-annual eHealthcare Leadership Awards. The awards recognize the best health information Web sites for consumers and professionals. Express Scripts, one of the nation's leading managers of pharmacy benefit plans,... 
11/24/2004Express Scripts to Present at Merrill Lynch Health Care Conference
ST. LOUIS, Nov. 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Merrill Lynch Health Services and Investor Conference on Wednesday, December 1, 2004 at 12:15 p.m. EST at The Waldorf Astoria Hotel in New York. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Player is nee... 
11/24/2004Express Scripts Provides 2005 Earnings Guidance
ST. LOUIS, Nov. 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it believes its financial performance will continue to benefit from the growth in mail and retail prescriptions, further increases in generic utilization, growth in its specialty pharmacy offering, increased productivity and other cost management initiatives, and capital structure improvements. The Company believes that its 2005 diluted earnings per share will be in the range of $4.50 to... 
11/22/2004Express Scripts, Inc. Announces 2005 Earnings Guidance Conference Call
ST. LOUIS, Nov 22, 2004 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its 2005 earnings guidance on Wednesday, November 24, 2004 and hold a conference call on this day to discuss this guidance at 8:00 a.m. Central Time. This call is being webcast and can be accessed at Express Scripts' web site at http://www.express-scripts.com/ in the Inves... 
11/16/2004REVISED TIME: Express Scripts to Present at CSFB Health Care Conference
ST. LOUIS, Nov. 16 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Credit Suisse First Boston Health Care Conference on Wednesday, November 17, 2004 at 12:30 p.m. MST (2:30 p.m. EST) at The Arizona Biltmore Hotel in Phoenix, Arizona. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windo... 
11/12/2004Express Scripts to Present at CSFB Health Care Conference
ST. LOUIS, Nov. 12 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Credit Suisse First Boston Health Care Conference on Wednesday, November 17, 2004 at 12:30 p.m. PDT (3:30 p.m. EDT) at The Arizona Biltmore Hotel in Phoenix, Arizona. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windo... 
11/10/2004Organizations Announce Support for Rx Outreach and Challenge Americans to Help Inform Those Who Will Benefit
New program gives more than 108 million people an easy and affordable way to get prescription medicines WASHINGTON, Nov 10, 2004 /PRNewswire-FirstCall via COMTEX/ -- Organizations representing healthcare groups, providers, and consumers, announced their support today for Rx Outreach, the country's first prescription drug assistance program for generic medications. The program offers more than 50 different FDA-approved generic medications for health problems such as diabetes, asthma, high... 
11/10/2004Press Conference Today: Rx Outreach, the Country's First Prescription Drug Assistance Program for Generics
Supporters to issue national challenge to close the prescription access gap What: More than 108 million lower-income adults and children to gain access to Rx Outreach, the country's first prescription drug assistance program for generics. More than 50 percent of prescriptions in the U.S. are filled with generic medicines, but until today, there have been no assistance programs available to people who... 
11/10/2004New Program to Give More Than 108 Million People an Easy and Affordable Way to Get Prescription Medicines
Supporters Issue National Challenge to Close the Prescription Access Gap WASHINGTON, Nov 10, 2004 (PRNewswire-FirstCall via COMTEX) -- Starting today, more than 108 million lower-income adults and children will have access to Rx Outreach, a new and easy way to get more affordable medications. Rx Outreach, the country's first prescription drug assistance program for generic drugs, offers more than 50 different FDA-approved generic medications for health problems such as diabetes, asthma, high... 
11/03/2004Express Scripts Reports Third Quarter Earnings
Mail Pharmacy and Generic Utilization Set Records Gross Profit Up 14% ST. LOUIS, Nov. 3 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income of $62.0 million, or $0.80 per diluted share, which includes a charge of $0.20 per diluted share to increase reserves for legal defense costs. For the same quarter last year, the Company reported net income of $64.5 million, or $0.81 per diluted sh... 
10/27/2004'Seven Steps' are Key to Safety in Prescription Drug Use
ST. LOUIS, Oct. 27 /PRNewswire-FirstCall/ -- Prescription plan sponsors can provide patients with tools and information to evaluate their level of risk for adverse drug interactions using the "Seven Steps to Safety" checklist and several interactive tools now available at http://www.express-scripts.com. The "Seven Steps to Safety" checklist introduces basic safety concepts and empowers patients to make informed decisions regarding their routine use of prescription drugs. According t... 
10/06/2004Express Scripts, Inc. Announces Third Quarter 2004 Earnings Conference Call
ST. LOUIS, Oct 6 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Wednesday, November 3, 2004 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss third quarter results on Thursday, November 4, 2004, 10 a.m. Central Time. This call is being webcast and can be accessed at Ex... 
09/30/2004Information Week Recognizes Express Scripts for IT Innovations
ST. LOUIS, Sept. 30 /PRNewswire-FirstCall/ -- For the third consecutive year, Express Scripts was named to the Information Week 500, a ranking of the country's most technologically progressive companies. At 69th on the list, Express Scripts is the only pharmacy benefit manager ranked among the top 100. The Information Week 500 tracks the technology practices of the nation's largest and most innovative companies. The study documents the business- technology strategies, investments, ... 
09/23/2004Study Findings Call Into Question Claims of Significant Savings From Pharmacy Dose Consolidation Programs
ST. LOUIS, Sept. 23 /PRNewswire-FirstCall/ -- Previously published research suggests that programs encouraging physicians to prescribe once-daily strength tablets instead of two lower-strength tablets when the per tablet cost is the same -- thus doubling the cost -- would save money. However, in a study published today by the Journal of Managed Care Pharmacy, while savings opportunities from these programs were found, the savings may not be enough to justify the costs plan sponsors w... 
09/07/2004Express Scripts to Present at Investor Conferences
ST. LOUIS, Sept. 7 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Bear Stearns 17th Annual Healthcare Conference on Monday, September 13, 2004 at 2:45 p.m. Eastern Time at The Plaza Hotel in New York. The presentation will also be broadcast via the Internet and can be accessed at: http://customer.talkpoint.com/BEAR002/091304a_cy/default.asp?entity=expressscr ipts Banc of America Securities 34th Annua... 
08/25/2004Maura Breen Elected to Express Scripts' Board of Directors
ST. LOUIS, Aug. 25 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced that its Board of Directors has elected Maura C. Breen to fill a position on the Board. Ms. Breen is senior vice president - Support Services at Verizon, where she is responsible for the Network Services Group operation's staff functions, with additional accountability for corporate sourcing, logistics, and Broadband Operations. "As a very successful leader in the telecommunications industry,... 
08/05/2004Younger Men Lead Surge in Viagra Use, Study Reveals
ST. LOUIS, Aug. 5 /PRNewswire-FirstCall/ -- The use of Viagra(R) (sildenafil) has grown more than three-fold among younger men since it entered the market, according to a study published today in the International Journal of Impotence Research. The study is the first to profile trends in the use of Viagra using prescription claim information from a random, nationwide sample. The study by Express Scripts examined Viagra use among more than 5 million commercially insured adult benefic... 
08/04/2004Record of Strong Performance and Cost Savings by Express Scripts Refute New York Attorney General's Claims
ST. LOUIS, Aug 4, 2004 /PRNewswire-FirstCall via COMTEX/ -- The attorney general in the State of New York today filed a lawsuit concerning the management of the New York State employee pharmacy benefit program. Express Scripts (Nasdaq: ESRX) strongly denies the assertions in this contract dispute. The company will defend itself vigorously in court. Express Scripts has saved the State of New York more than $2 billion in drug costs since 1998. During the contract, the state got all reb... 
07/29/2004Express Scripts Clarifies Statement Made on Conference Call
New Earnings Guidance Was Not Provided ST. LOUIS, July 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today reaffirmed that its 2004 diluted earnings per share will be between $3.84 and $3.92, excluding non-recurring items that were detailed in yesterday's second quarter earnings release. During its conference call to discuss these earnings, chairman and chief executive officer, Barrett Toan, commented on some of the Company's long-term growth drivers in a respons... 
07/28/2004Express Scripts Reports Second Quarter Earnings
Company Expands Share Repurchase Program by 4 Million Shares ST. LOUIS, Jul 28, 2004 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter net income of $65.4 million, or $0.83 per diluted share, which includes charges of $0.10 per diluted share resulting from the early retirement of debt, and $0.01 per diluted share pertaining to the implementation of the TRICARE Retail Pharmacy ("TRICARE") program for the Department of Defense ("DoD"). For th... 
07/21/2004Study Finds Plan Sponsors Save with Step Therapy
ST. LOUIS, Jul 21, 2004 /PRNewswire via COMTEX/ -- An employer that implemented savings programs promoting the use of generic and lower-cost brand drugs for three drug therapy classes reduced total costs for the therapy classes by 38%, according to a study reported in the July issue of the American Journal of Managed Care. This is the first study of its kind to examine plan sponsor savings from programs that provide for trying a lower cost generic drug as a first step before using a b... 
07/08/2004Express Scripts, Inc. Announces Second Quarter 2004 Earnings Conference Call
ST. LOUIS, July 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 28, 2004 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss second quarter results on Thursday, July 29, 2004, 9 a.m. Central Time. This call is being webcast and can be accessed at Express... 
07/08/2004Express Scripts Tops in Online Customer Experience for Second Consecutive Year
ST. LOUIS, July 8 /PRNewswire-FirstCall/ -- For the second consecutive year, Express Scripts provided the best online customer experience among 36 leading healthcare organizations surveyed by The Customer Respect Group, a firm that studies how corporations treat their customers online. Express Scripts, one of the nation's leading managers of pharmacy benefit plans, serves more than 50 million consumers. Express Scripts, along with one other firm, scored 7.3 of a possible 10 based o... 
06/17/2004Express Scripts to Present at the William Blair Twenty-Fourth Annual Growth Stock Conference
ST. LOUIS, June 17 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the William Blair & Company Twenty-Fourth Annual Growth Stock Conference on Thursday, June 24, 2004 at 8:30 a.m. CDT (9:30 a.m. EDT) at the Four Seasons Hotel in Chicago, Illinois. The presentation will also be broadcast via the Internet and can be accessed at: http://wsw.com/webcast/blair3/esrx . RealPlayer or Windows Media Player is needed to listen to the Webc... 
06/14/2004Study Finds Over Half of Patients on COX-2 Therapy Take Aspirin, Possibly Negating the Gastrointestinal Benefits Afforded by COX-2's
ST. LOUIS, Jun 14, 2004 /PRNewswire-FirstCall via COMTEX/ -- Findings reported in a study published today in the Archives of Internal Medicine found that over half of patients within a predominantly retiree population taking COX-2 anti-inflammatory drugs on a long-term basis were also taking aspirin therapy for its cardio-protective benefit. Previously published clinical research has shown that using aspirin along with COX-2 therapies can negate the gastrointestinal (GI) benefit of usi... 
06/08/2004Express Scripts Promotes Generics, Low-Cost Brand Drugs With GenericsWork(SM)
ST. LOUIS, June 8 /PRNewswire-FirstCall/ -- With generic drugs now available in most therapy classes, Express Scripts has developed GenericsWork(SM), a new program that helps prescription benefit plan sponsors to save even more money through even greater generic drug utilization without shifting costs to consumer members of their plans. GenericsWork is built around Express Scripts' High Performance Formulary, a generics-based formulary that promotes generics and low-cost brands. The... 
06/08/2004Generics Slow Rising Cost of Prescription Drugs in 2003
ST. LOUIS, June 8 /PRNewswire-FirstCall/ -- Higher generic drug use in 2003 slowed the rising cost per prescription to a 7.9% increase -- from $51.76 to $55.86. This rate of increase was significantly less than the 13.1% increase from 2001 to 2002, and the lowest rate in the past four years. Generic drug use increased to a record 48% among Express Scripts' 50 million members during 2003, spurred by the use of several prominent new generics, fluoxetine, omeprazole and lisinopril. Th... 
06/03/2004Express Scripts to Present at the Goldman Sachs Twenty Fifth Annual Healthcare Conference
ST. LOUIS, Jun 3, 2004 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Goldman Sachs Twenty Fifth Annual Healthcare Conference on Thursday, June 10, 2004 at 7:40 a.m. Pacific Time (10:40 a.m. Eastern Time) at the Ritz Carlton Laguna Niguel in Dana Point, California. The presentation will also be broadcast via the Internet and can be accessed at: http://customer.talkpoint.com/GOLD006/060704a_mk/default.asp?entity=express ... 
05/18/2004Express Scripts Research Papers Receive Awards for Excellence
ST. LOUIS, May 18 /PRNewswire-FirstCall/ -- Two Express Scripts research studies have received Awards of Excellence for examining the validity of pharmacoeconomic models used in healthcare decision-making and treatment recommendations. Emily Cox, PhD, Doug Mager, and Brenda Motheral, PhD, were awarded the 2004 "Research Excellence Award" by the International Society for Pharmacoeconomics and Outcomes Research for a study that examined the validity of assumptions made in cost-effecti... 
05/11/2004Express Scripts to Present at Banc of America Securities Health Care Conference
ST. LOUIS, May 11 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Banc of America Securities Health Care Conference on Wednesday, May 19, 2004 at 10:40 a.m. PDT (1:40 p.m. EDT) at The Four Seasons Hotel in Las Vegas, Nevada The presentation will also be broadcast via the Internet and can be accessed at: http://www.veracast.com/webcasts/bas/healthcare-2004/id22105266.cfm . RealPlayer or Windows Media Player is needed to liste... 
04/28/2004Express Scripts Reports Strong First Quarter Earnings
Record Level of Mail and Generic Drug Utilization ST. LOUIS, April 28 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $70.0 million, or $0.89 per diluted share, a 20 percent increase over $0.74 per diluted share reported for the same quarter of 2003. The Company generated $97.8 million of cash flow from operations in the first quarter compared with $94.4 million in the same quarter last year. "We are pleased by our strong s... 
04/19/2004Express Scripts, Inc. Announces First Quarter 2004 Earnings Conference Call
ST. LOUIS, April 19 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Wednesday, April 28, 2004 after 3:00 p.m. CDT. In addition, management will hold its quarterly conference call to discuss first quarter results on Thursday, April 29, 2004, at 10:00 a.m. Eastern Time (9 a.m. Central Time). This call is being webcast and can... 
04/02/2004Preschoolers Lead Growth of Antidepressant Use, Study Reveals
ST. LOUIS--(BUSINESS WIRE)--April 2, 2004--The use of paroxetine and other antidepressant medications continues to grow by about 10% annually among children and adolescents, according to a study published in the April issue of Psychiatric Services. The study profiles trends of prescription antidepressant use in children and adolescents using prescription claim information from a random, nationwide sample. The study by Express Scripts examined antidepressant use among approximately ... 
03/25/2004Express Scripts Names Edward J. Stiften Chief Financial Officer
ST. LOUIS, March 25 /PRNewswire-FirstCall/ -- Express Scripts, Inc. today announced that Edward J. Stiften will join the company as Senior Vice President and Chief Financial Officer. He will succeed George Paz, who was named President of the company in October 2003. Mr. Stiften comes to Express Scripts from BJC HealthCare, where he has been Vice President and Chief Financial Officer since 1998. BJC HealthCare operates 13 hospitals and about 100 primary care and home health faciliti... 
02/26/2004Express Scripts to Present at Healthcare Conferences
ST. LOUIS, Feb 26, 2004 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following healthcare conferences: Lehman Brothers Seventh Annual Healthcare Conference on Friday, March 5, 2004 at 10:45 a.m. EST at the Loews Hotel in Miami Beach, Florida. The presentation will also be broadcast via the Internet and can be accessed at: www.lehman.com/conferences/200403Healthcare SG Cowen 24th Annual Health Care Conference on Tue... 
02/24/2004Express Scripts Reports Strong Fourth Quarter Earnings
Record Cash Flow From Operations of $177 Million ST. LOUIS, Feb. 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced net income of $67.4 million, or $0.86 per diluted share for the fourth quarter, and $249.6 million, or $3.16 per diluted share for 2003. This compares with net income of $56.7 million, or $0.72 per diluted share for the fourth quarter of 2002, and $202.8 million, or $2.55 per diluted share for 2002. This represents increases of 19 percent and ... 
02/18/2004Express Scripts, Inc. Announces Fourth Quarter 2003 Earnings Conference Call
ST. LOUIS, Feb 18, 2004 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Tuesday, February 24, 2004 after 3:00 p.m. CST. In addition, management will hold its quarterly conference call to discuss fourth quarter results on Wednesday, February 25, 2004, at 9 a.m. Central Time (10:00 a.m. Eastern Time). This call is b... 
02/11/2004Samuel Skinner Elected to Express Scripts' Board of Directors; Former White House Chief of Staff, U.S. Transportation Secretary
ST. LOUIS--(BUSINESS WIRE)--Feb. 11, 2004--Express Scripts (Nasdaq:ESRX) announced today that its Board of Directors has elected Samuel K. Skinner to fill a vacancy on the Board. Express Scripts is one of the nation's largest pharmacy benefit management firms. Most recently the chairman, president and chief executive officer of USF Corporation until his May 2003 retirement, Mr. Skinner served in the administration of President George H.W. Bush as Secretary of the Department of Trans... 
01/30/2004Pharmacy Care Alliance Applies for Medicare Endorsement of National Prescription Drug Discount Card
40,000 Community Pharmacies Signal Participation in the Program ALEXANDRIA, Va., Jan. 30 /PRNewswire/ -- The Pharmacy Care Alliance, Inc., today submitted its application to the Centers for Medicare and Medicaid Services (CMS) seeking Medicare endorsement of its national prescription drug discount-card program. More than 40,000 chain and independent community pharmacies have already said they intend to participate in the Pharmacy Care Alliance network and that number is increasing d... 
01/30/2004Express Scripts Completes Acquisition of CuraScript
ST. LOUIS--(BUSINESS WIRE)--Jan. 30, 2004--Express Scripts, Inc. (Nasdaq:ESRX) announced today it has completed the acquisition of the capital stock of CuraScript Pharmacy, Inc. and CuraScript PBM Services, Inc., together comprising the business of CuraScript, which was announced in December 2003. CuraScript, headquartered in Orlando, Florida, is one of the nation's largest specialty pharmacy services companies. Serving over 175 managed care organizations, 30 Medicaid programs and ... 
01/28/2004Express Scripts Achieves Sixth Year on Forbes Honor Roll
ST. LOUIS, Jan 28, 2004 (BUSINESS WIRE) -- For the sixth consecutive year, Express Scripts (Nasdaq:ESRX) was named by Forbes magazine to their 2004 Platinum 400 Honor Roll of companies. Express Scripts is one of only 25 companies to make the list every year since the list's inception in 1999. The Forbes Platinum List consists of America's "best performing" corporations by industry, as selected by the magazine's editors and analytical tools. According to Forbes, the companies selected ... 
01/21/2004Express Scripts Earns Incentive Award from Department of Defense for High Beneficiary Satisfaction; Member Satisfaction Exceeded 96% in Latest Survey
ST. LOUIS--(BUSINESS WIRE)--Jan. 21, 2004--Express Scripts, Inc. (Nasdaq:ESRX) announced today that since the March 1, 2003 inception of its 5-year contract with the Department of Defense ("DoD") under the TRICARE Management Activity to provide mail pharmacy services to DoD beneficiaries, the Company has earned $1.5 million in quarterly incentive awards. This includes the most recent award of $1.0 million for exceeding 96 percent beneficiary satisfaction levels for the three months ended ... 
01/15/2004Medicare Discount Card to Emerge from New Retail Pharmacy, Benefit Manager Alliance
WASHINGTON, Jan. 15 /PRNewswire/ -- The National Association of Chain Drug Stores (NACDS) and pharmacy benefit manager (PBM) Express Scripts, Inc. (Nasdaq: ESRX) today announced that they will jointly seek endorsement of a national Medicare discount card from the Centers for Medicare and Medicaid Services (CMS). NACDS and Express Scripts said the application would be submitted by the Pharmacy Care Alliance, which is to be restructured to provide for equal control by both NACDS an... 
01/13/2004Medicare, Generics and Over the Counter Drugs Top 2003 Pharmaceutical Developments
ST. LOUIS, JANUARY 13, 2004 – Congressional passage of the Medicare bill, wrangling over Canadian drug reimportation, the over-the-counter (OTC) availability of Claritin and Prilosec, as well as the introduction of several new generic drugs were among the top pharmaceutical developments in 2003, according to Express Scripts' fifth annual year-end report on events and trends influencing prescription drug costs and utilization. Express Scripts is one of the nation's largest pharmacy benefit manag... 
01/05/2004Express Scripts to Present at the JP Morgan Healthcare Conference
ST. LOUIS--(BUSINESS WIRE)--Jan. 5, 2004--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the JP Morgan 22nd Annual Healthcare Conference on Monday, January 12, 2004 at 8:30 a.m. PST (11:30 a.m. EST) at the Westin St. Francis Hotel in San Francisco, California The presentation will also be broadcast via the Internet and can be accessed at: http://equityconferences.jpmorgan.com/. RealPlayer or Windows Media Player is needed to listen to the Webcast and ... 
12/22/2003Express Scripts and CuraScript Announce Acquisition Agreement; Specialty Pharmacy Will Enhance PBM Service Offering
ST. LOUIS--(BUSINESS WIRE)--Dec. 22, 2003--Express Scripts, Inc. (Nasdaq:ESRX) announced today it has signed a definitive agreement to acquire the capital stock of CuraScript Pharmacy, Inc. and CuraScript PBM Services, Inc., together comprising the business of CuraScript for $335 million. CuraScript, headquartered in Orlando, Florida, is one of the nation's largest specialty pharmacy services companies. This transaction is expected to close during the first quarter of 2004, subject to cus... 
12/12/2003Study Findings Question COX-2 Drug Cost Effectiveness
ST. LOUIS--(BUSINESS WIRE)--Dec. 12, 2003--Findings reported in a study published today by The American Journal of Managed Care call into question the cost effectiveness of the new, more expensive COX-2 anti-inflammatory drugs. Using data representing actual clinical practice, researchers sought to validate the rate of co-prescribing of agents used to protect the gastrointestinal tract -- a key assumption made in prior COX-2 cost-effectiveness studies. COX-2 drugs offer greater prot... 
11/14/2003Most New Users of Higher Cost COX-2s May Not Need Drugs' Gastrointestinal Protection
ST. LOUIS, Nov 14, 2003 (BUSINESS WIRE) -- Most patients given new prescriptions for the more expensive COX-2 anti-inflammatory drugs had no indication of being at risk for gastrointestinal events, according to a study published today by The American Journal of Managed Care. COX-2 drugs provide greater protection against gastrointestinal side effects than equally effective but lower cost treatments. Researchers at pharmacy benefit manager Express Scripts (Nasdaq:ESRX) examined new use... 
11/06/2003DrugDigest Alerts Consumers about Mixing Medications with Herbal Supplements
ST. LOUIS--(BUSINESS WIRE)--Nov. 6, 2003--Consumers now can use the DrugDigest(R) Interaction Checker to see if they may be taking a potentially harmful combination of herbal supplements, over-the-counter medications and prescription drugs. DrugDigest is Express Scripts' (Nasdaq: ESRX) consumer health and drug information Web site. By logging on to http://www.drugdigest.org/DD/Interaction/ChooseDrugs, consumers will find information on 11,500 potential interactions for more than 5,... 
11/05/2003Express Scripts to Present at Healthcare Conferences
ST. LOUIS--(BUSINESS WIRE)--Nov. 5, 2003--Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the following healthcare conferences: CIBC World Markets Fourteenth Annual Healthcare Conference on Wednesday, November 12, 2003 at 1:30 p.m. EST at the Plaza Hotel in New York. The presentation will also be broadcast via the Internet and can be accessed at: http://www.veracast.com/webcasts/cibcwm/healthcare03/38310146.cfm In addition, the presentation and slides wi... 
10/29/2003Express Scripts Reports Record Third Quarter Earnings; Strong Cash Flow from Operations of $161 Million
ST. LOUIS--(BUSINESS WIRE)--Oct. 29, 2003--Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income of $64.5 million, or $0.81 per diluted share, an increase of 21 percent over $0.67 per diluted share reported for the same quarter of 2002. The Company generated $160.8 million of cash flow from operations in the third quarter compared with $91.4 million in the same quarter last year. This increase in cash flow reflects improved operating results and working capital man... 
10/17/2003Express Scripts, Inc. Announces Third Quarter 2003 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--Oct. 17, 2003--Express Scripts, Inc. (NYSE: ESRX-News), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Wednesday, October 29, 2003 after 3:00 p.m. CST. In addition, management will hold its quarterly conference call to discuss third quarter results and general operations of the company on Thursday, October 30, 2003, at 10:00 a.m. Eastern Time (9 a.m. Central Time)... 
10/02/2003George Paz to Become President of Express Scripts
ST. LOUIS--(BUSINESS WIRE)--Oct. 2, 2003--Express Scripts, Inc. (Nasdaq: ESRX) announced today that Chief Financial Officer George Paz will assume the position of President immediately, filling the position vacated due to the resignation of Barbara Hill. "Barbara was instrumental in initiating important changes at Express Scripts," said Barrett Toan, Chief Executive Officer. "We are grateful for her contributions and wish her well. At the same time, George Paz's new position as Pres... 
09/30/2003Express Scripts' Member Web Site Wins Web Health Award
ST. LOUIS--(BUSINESS WIRE)--Sept. 30, 2003--The online experience that Express Scripts (Nasdaq: ESRX) provides its members is one of the best among 300 Web sites, according to the Health Information Resource Center (HIRC), a national clearinghouse for consumer health information programs and materials. HIRC awarded Express-Scripts.com for Members a Merit Award for health information in HIRC's Spring 2003 World Wide Web Health Awards program. The program recognizes the best health in... 
09/26/2003Express Scripts Awarded TRICARE Retail Pharmacy Contract
ST. LOUIS--(BUSINESS WIRE)--Sept. 26, 2003--The Department of Defense (DoD) announced today that it has awarded the contract for its TRICARE Retail Pharmacy (TRRx) program to Express Scripts, Inc., one of the nation's largest pharmacy benefit management firms. The contract term is for one year with four subsequent option years exercisable by DoD. The TRRx program will provide retail pharmacy services to the approximately 2.5 million DoD beneficiaries who currently utilize the retai... 
09/09/2003Drug Cost Effectiveness Evaluations Based on Faulty Assumptions
ST. LOUIS--(BUSINESS WIRE)--Sept. 9, 2003--Faulty assumptions in economic models used to evaluate the cost effectiveness of prescription drugs may incorrectly favor more expensive drugs, according to a new study published today in the Journal of Managed Care Pharmacy. In the study, researchers at Express Scripts (Nasdaq: ESRX) substituted actual data in place of model assumptions and discovered that economic models used to compare ulcer treatments overstated the cost-effectiveness ... 
09/08/2003Express Scripts to Present at Banc of America Securities Conference
ST. LOUIS--(BUSINESS WIRE)--Sept. 8, 2003--Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the Banc of America Securities 33rd Annual Investment Conference on Tuesday, September 16, 2003 at 10:00 a.m. PST (1:00 p.m. EST) at the Ritz-Carlton Hotel in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed at: http://www.veracast.com/webcasts/bas/33rd-annual-2003/id94107482.cfm RealPlayer or Windows Media Pla... 
07/30/2003Partial Prescriptions - Now Easier to Pay Only for What You Receive
ST. LOUIS--(BUSINESS WIRE)--July 30, 2003--In a first for pharmacy benefit managers, when a pharmacy partially fills a prescription, Express Scripts now processes claims for only the amount of medication dispensed. Previously, coping with temporary supply shortages, has been a challenge for both consumers and pharmacies. Express Scripts is the first PBM to process partial fill claims in this manner. Now, it is easier for the pharmacy to charge a benefit plan member a pro rated co-pa... 
07/28/2003Express Scripts Specialty PBM Improves Health and Lower Costs
ST. LOUIS--(BUSINESS WIRE)--July 28, 2003--New drugs emerging from the world's biotechnology labs hold great promise for patients, but at a price that's causing heartburn for the employers, unions, governments and health plans that provide pharmacy benefits to millions of Americans. Costs for individual therapies average approximately $15,000 annually, but can range up to $150,000 annually. And, spending on biotech and specialty injectable drugs is projected to grow 20 percent to 4... 
07/23/2003Express Scripts Reports Second Quarter Earnings; Debt and Stock Repurchases Exceed $100 Million
ST. LOUIS--(BUSINESS WIRE)--July 23, 2003--Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter net income of $59.0 million, or $0.74 per diluted share, which includes a charge of $4.9 million ($3.0 million net of tax), or $0.04 per diluted share, resulting from the early retirement of debt. This compares to $48.7 million, or $0.61 per diluted share, for the same quarter of 2002. "This quarter our strong performance was driven by increased mail pharmacy and generic utilizat... 
07/16/2003Express Scripts, Inc. Announces Second Quarter 2003 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--July 16, 2003--Express Scripts, Inc. (NYSE:ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 23, 2003 after 3:00 p.m. CST. In addition, management will hold its quarterly conference call to discuss second quarter results and general operations of the company on Thursday, July 24, 2003, at 10:00 a.m. Eastern Time (9 a.m. Central Time). T... 
07/03/2003Consumer Choice Comes to Pharmacy Benefit Plans
ST. LOUIS--(BUSINESS WIRE)--July 3, 2003--Having a choice among pharmacy benefit plans this year made one-and-a-half million consumers unique among the nearly 200 million currently receiving pharmacy benefits in the U.S. Using Express Choice(SM), from pharmacy benefit manager Express Scripts, pharmacy benefit plan sponsors are giving their members the option to select the plan that best fits their lifestyle and personal needs, weighing the relative importance of cost, comprehensiven... 
06/20/2003Express Scripts to Present at William Blair & Company Conference
ST. LOUIS--(BUSINESS WIRE)--June 20, 2003--Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the William Blair & Company 23rd Annual Growth Stock Conference on Thursday, June 26, 2003 at 7:30 a.m. CDT (8:30 a.m. EDT) at the Four Seasons Hotel in Chicago, Illionois. The presentation will also be broadcast via the Internet and can be accessed at: http://www.twst.com/econf/mm/blair2/esrx.html RealPlayer or Windows Media Player is needed to listen to the Webcast and... 
06/03/2003First Quarter Prescription Drug Spending: Generic Drugs Slow Upward Trend; Study Shows Physicians Welcoming, Acting On Drug Interaction Safety Warnings
ST. LOUIS--(BUSINESS WIRE)--June 2, 2003--Growth in prescription drug spending slowed to 11.3% during first quarter 2003 as consumers used more wallet-friendly generic drugs and, as a result of a mild flu season, fewer antihistamines and cough-cold remedies. Lower, too, was use of estrogen drugs because of safety concerns raised by studies published last year. According to pharmacy benefit manager Express Scripts, during the previous year first quarter, spending grew at a much faste... 
05/15/2003Blue Cross Blue Shield of Massachusetts and Express Scripts Partner with Retail to Answer Member Calls in Real Time
ST. LOUIS--(BUSINESS WIRE)--May 15, 2003--Blue Cross Blue Shield of Massachusetts (BCBSMA) pharmacy plan members now have answers to their pharmacy benefit questions at their fingertips, thanks to "Blue Phone," a new phone system piloted at five retail pharmacy locations in Massachusetts. Coordinated by Express Scripts (Nasdaq:ESRX), which provides pharmacy benefit management services to BCBSMA, the service is available at select Brooks and Stop & Shop stores. Members can pick up th... 
05/06/2003Express Scripts Tops in Online Customer Experience
ST. LOUIS, May 6, 2003 (BUSINESS WIRE) -- The online customer experience that Express Scripts (Nasdaq: ESRX) provides its Web site visitors is the best of 38 leading healthcare organizations surveyed by The Customer Respect Group, a firm that studies how corporations treat their customers online. Express Scripts, one of the nation's leading managers of pharmacy benefit plans, serves more than 50 million consumers. Express Scripts scored 8.6 of a possible 10 based on 25 Web site attri... 
04/30/2003Express Scripts to Present at Deutsche Bank 28th Annual Health Care Conference
ST. LOUIS--(BUSINESS WIRE)--April 30, 2003--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Deutsche Bank 28th Annual Health Care Conference on May 7, 2003 at 11:30 a.m. EDT at the Marriott Waterfront Hotel in Baltimore, Maryland. The presentation will also be broadcast via the Internet and can be accessed at: http://www.visualwebcaster.com/event.asp?id=14175 RealPlayer or Windows Media Player is needed to listen to the Webcast and free downloads of the... 
04/30/2003Multimedia Available: Drug Interaction Safety Tops Consumer Concerns
--(BUSINESS WIRE)-- When consumers search the Internet for information on prescription drugs, and visit DrugDigest.org, half are most concerned about potentially harmful interactions between drugs they are taking. DrugDigest(R) is Express Scripts' consumer health and drug information website. You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?9264 This multimedia news story is for free and unrestricted use on your news ... 
04/30/2003Drug Interaction Safety Tops Consumer Concerns
ST. LOUIS--(BUSINESS WIRE)--April 30, 2003--When consumers search the Internet for information on prescription drugs, and visit DrugDigest.org, half are most concerned about potentially harmful interactions between drugs they are taking. DrugDigest(R) is Express Scripts' (Nasdaq: ESRX) consumer health and drug information website. Approximately 425,000 page views, half of all page views of DrugDigest(R) interactive tools for 2002, were directed to the Drug Interaction Checker, an in... 
04/23/2003Multimedia Available: Record 47 Percent Generic Drug Utilization at Express Scripts in First Quarter
Apr 23, 2003 (BUSINESS WIRE) -- Generic drug utilization reached an all-time high of 47 percent of all prescriptions processed by Express Scripts during the first quarter of 2003, up from 45.9 percent in the fourth quarter of 2002 and 43 percent in the first quarter of 2002. You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?9193 This multimedia news story is for free and unrestricted use on your news information site (and for print or ... 
04/23/2003Record 47 Percent Generic Drug Utilization at Express Scripts in First Quarter
ST. LOUIS, Apr 23, 2003 (BUSINESS WIRE) -- Generic drug utilization reached an all-time high of 47 percent of all prescriptions processed by Express Scripts during the first quarter of 2003, up from 45.9 percent in the fourth quarter of 2002 and 43 percent in the first quarter of 2002. The company, one of the nation's largest managers of pharmacy benefit plans, attributed the increase to aggressive promotion of generic drugs, especially of generic versions of several heavily used bra... 
04/23/2003Express Scripts Reports 35% Increase in Diluted Earnings Per Share; Cash Flow from Operations of $94 Million
ST. LOUIS--(BUSINESS WIRE)--April 23, 2003--Express Scripts, Inc. (Nasdaq: ESRX) announced net income of $58.6 million, or $0.74 per diluted share for the first quarter, an increase of 35 percent over the same quarter of 2002. The first quarter earnings include a change in accounting principle relating to the adoption of FAS 143, "Accounting for Asset Retirement Obligations," which reduced net income by $1.0 million, or $0.01 per diluted share. Express Scripts generated $94.4 millio... 
04/16/2003Express Scripts, Inc. Announces First Quarter 2003 Earnings Conference Call
CLARENCE, N.Y.--(BUSINESS WIRE)--April 16, 2003--Express Scripts, Inc. (NYSE:ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Wednesday, April 23, 2003 after 3:00 p.m. CST. In addition, management will hold its quarterly conference call to discuss first quarter results and general operations of the company on Thursday, April 24, 2003, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).... 
03/17/2003Express Scripts Issues Client Pledge and Publicizes Pharmacy Benefit Management Business Principles
ST. LOUIS, Mar 17, 2003 (BUSINESS WIRE) -- Express Scripts today announced publication of a seven point client pledge and a set of pharmacy benefit management business principles. "As we enter an era of increased business accountability, the Express Scripts Client Pledge manifests our open and sustainable business model and reiterates for our clients and their members that we are unequivocally on their side in making the use of prescription drugs safer and much more affordable," said B... 
03/13/2003Express Scripts to Present at Investor Conferences
ST. LOUIS, Mar 13, 2003 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: -- SG Cowen 23rd Annual Health Care Conference on March 20, 2003 at 8:00 a.m. and 9:00 a.m. EST at the Marriott Copley Place Hotel in Boston, MA. The presentation will also be broadcast via the Internet and can be accessed at: http://www.visualwebcaster.com/event.asp?id=12755 -- Banc of America Securities Healthcare Conference on March 27, 2003 at... 
03/12/2003Express Scripts Mail Pharmacy Hits One Hundred Million Prescription Mark
ST. LOUIS, Mar 12, 2003 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX), today announced that it has dispensed its 100 millionth mail pharmacy prescription. The company is one of the nation's largest pharmacy benefit management firms and serves more than 50 million consumers in the United States and Canada. The mail milestone, reached early this month, coincided with the company's start up of a new mail facility in Tempe, AZ. It also came as Express Scripts began dispensing up t... 
02/25/2003Express Scripts to Present at Investor Conferences
ST. LOUIS, Feb 25, 2003 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the following conferences: Lehman Brothers 6th Annual Global Healthcare Conference on March 4, 2003 at 10:45 a.m. EST at the Loews Miami Beach Hotel in Miami Beach, Florida. The presentation will also be broadcast via the Internet and can be accessed at: http:// customer.ibeam.com/LEHM002/030303a_byRFD/default.asp?entity=express. Raymond James & Associates 2... 
02/12/2003Express Scripts Reports Strong Fourth Quarter Earnings; $139 Million of Cash From Operations
ST. LOUIS, Feb 12, 2003 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced net income of $56.7 million, or $0.72 per diluted share for the fourth quarter, and $202.8 million, or $2.55 per diluted share for 2002. This compares with net income of $40.9 million, or $0.52 per diluted share for the fourth quarter of 2001, and $151.0 million, or $1.89 per diluted share for 2001, excluding the amortization of goodwill. This represents increases of 38 percent and 35 percent in per sh... 
02/03/2003Children's Use of Stimulant Medications Vary Widely by State
ST. LOUIS, Feb 3, 2003 (BUSINESS WIRE) -- America's children are getting stimulant medications for attention deficit/hyperactivity disorder (ADHD) at rates that vary widely between states, with a fourfold difference between the highest rate, in Louisiana, and the lowest rate, in the District of Columbia. The study also found that higher stimulant use among children is primarily concentrated in the South and Midwest regions of the country, and in higher-income communities. The drugs ... 
01/28/2003Express Scripts, Inc. Announces Fourth Quarter 2002 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--Jan. 28, 2003--Express Scripts, Inc. (NYSE:ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Wednesday, February 12, 2003 after 3:00 p.m. CST. In addition, management will hold its quarterly conference call to discuss fourth quarter results and general operations of the company on Thursday, February 13, 2003, at 2:00 p.m. Eastern Time (1 p.m. Ce... 
01/23/2003JAMA Letter: Consumers Save on Lower Cost Drugs, Too
ST. LOUIS--(BUSINESS WIRE)--Jan. 23, 2003--Consumers and their pharmacy benefit plans both save when less expensive drugs have lower consumer copayments and a lower cost drug - like a generic - is selected, contended Express Scripts researchers Brenda Motheral, PhD, and Jagat Sheth, PhD, in a letter published by the Journal of the American Medical Association (JAMA) in this week's issue. They were commenting on an October JAMA article, "Employer Drug Benefit Plans ... 
01/09/2003Many Women Stop Combination Hormone Replacement - HRT - Therapy But 57 Percent Continue HRT Following Health Risk Reports
ST. LOUIS--(BUSINESS WIRE)--Jan. 9, 2003--A report issued today by pharmacy benefit manager Express Scripts (NASDAQ:ESRX) provides new information on the difficult choices women and their physicians began facing after the Journal of the American Medical Association (JAMA) published two studies questioning the relative safety of combination estrogen/progestin hormone replacement therapy (HRT) products. In the four months following the July 2002 publication of the studies, 3... 
12/30/2002Express Scripts to Present at JPMorgan H&Q Healthcare Conference
JPMorgan H&Q Healthcare Conference ST. LOUIS--(BUSINESS WIRE)--Dec. 30, 2002--Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the JPMorgan H&Q Healthcare Conference on Monday, January 6, 2003 at 1:30 p.m. PST (4:30 p.m. EST) at the Westin St. Francis Hotel in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed at: http://www.mapdigital.com/jpmorgan/healthcare03. RealPlayer or Windows Media... 
12/27/2002More Generics, Over the Counter Loratadine/Claritin Top 2002 Pharmaceutical Developments
ST. LOUIS--(BUSINESS WIRE)--Dec. 27, 2002--An all time high generic drug market share of 45.2 percent and over the counter availability of the non-sedating antihistamine Claritin(R) were among the top pharmaceutical developments in 2002, according to Express Scripts' fourth annual year-end report on events and trends influencing prescription drug costs and utilization this year. Express Scripts (Nasdaq:ESRX) is one of the nation's largest pharmacy benefit managers. ... 
11/08/2002Express Scripts to Present at Credit Suisse First Boston Health Care Conference
2002 Credit Suisse First Boston Health Care Conference ST. LOUIS--(BUSINESS WIRE)--Nov. 8, 2002--Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the 2002 Credit Suisse First Boston Health Care Conference on Thursday, November 14, 2002 at 12:30 p.m. EST at the Arizona Biltmore Resort and Spa in Phoenix, Ariz. The presentation will be webcast in the investor relations section on Express Scripts' Web site and can be accessed at: http:/... 
11/01/2002Express Scripts Welcomes Generic Version of Prilosec(R)
ST. LOUIS, Nov 1, 2002 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts issued the following statement regarding today's announcement by three generic drug makers on their planned introduction of a generic version of the gastrointestinal drug Prilosec(R): "Express Scripts welcomes today's announcement by Andrx, Genpharm and KUDCo that they will cooperate on introducing a generic version of Prilosec(R). Assuming all legal and regulatory hurdles are cleared, this is good news for our ... 
10/31/2002Express Scripts Saves Payers, Consumers $161 Million on Three New Generic Drugs
ST. LOUIS, Oct. 31 /PRNewswire/ -- Express Scripts, one of the nation's largest pharmacy benefit management (PBM) firms, today announced that it has saved clients and consumer-members $161.6 million by expanding use of three new generic drugs introduced within the last 14 months. The savings are from that same time period. For Express Scripts members, this translates into lower copayments, saving the people who used 799,000 of these medications in September 2002 an... 
10/23/2002Express Scripts Reports Record Third Quarter Earnings
ST. LOUIS--(BUSINESS WIRE)--Oct. 23, 2002--Express Scripts, Inc. (Nasdaq:ESRX) announced third quarter net income before extraordinary items of $53.9 million, or 68 cents per diluted share, an increase of 39 percent over the same quarter of 2001, excluding the amortization of goodwill. Express Scripts generated $115.3 million of cash flow from operations in the third quarter compared with $72.5 million in the same quarter last year. During the quarter, the company repaid $... 
10/21/2002Express Scripts to Present at Salomon Smith Barney 2002 Global Health Care Conference
ST. LOUIS, Oct 21, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the 2002 Salomon Smith Barney Health Care Conference on Wednesday, October 30, 2002 at 11:45 a.m. EST at the Plaza Hotel in New York, New York. The presentation will also be broadcast via the Internet and can be accessed at: http://www.veracast.com/ssb/2002/healthcare/53308214.cfm RealPlayer or Windows Media Player is needed to listen to the Webcast and free downloads of thes... 
10/10/2002Express Scripts Provides Increased Earnings Guidance
ST. LOUIS, Oct 10, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced today that it expects its third quarter 2002 diluted earnings per share will be in the $0.67 to $0.69 range, while full-year 2002 diluted earnings per share is expected to be in the $2.53 to $2.56 range. "We are still in the process of closing our books and reviewing our results, but it is obvious that our earnings for the quarter will exceed our prior guidance," stated Barrett Toan, chairman and ch... 
09/19/2002Express Scripts to Present at Banc of America Securities Annual Investment Conference
The presentation will also be broadcast via the Internet and can be accessed at: http://www.veracast.com/webcasts/BAS/32nd-annual-2002/id74404441.cfm RealPlayer or Windows Media Player is needed to listen to the Webcast and free downloads of these players are available at the Webcast site. The Webcast will be archived and available for replay for 14 days. In addition, the presentation and slides will be available on the investor relations section of the Express Scripts' Web site at www.e... 
08/22/2002Orphan Medical Names Express Scripts Exclusive Distributor of Xyrem
ST. LOUIS & MINNETONKA, Minn., Aug 22, 2002 (BUSINESS WIRE) -- SDS Subsidiary Will Manage Unique Distribution System for Cataplexy Medication Express Scripts (NASDAQ:ESRX) and Orphan Medical, Inc. today announced that Express Scripts will be the sole distributor of Orphan Medical's Xyrem(R) (sodium oxybate) oral solution through its Specialty Distribution Services (SDS) subsidiary. The U.S. Food and Drug Administration (FDA) approved Xyrem(R) on July 17, 2002 for the treatment of catap... 
08/14/2002Express Scripts Receives Subpoena from HHS OIG Relating to Relationship with Premier, Inc.
ST. LOUIS, Aug 14, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that on August 13, 2002, the company received a subpoena duces tecum issued by the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services. The subpoena seeks information on stock options, warrants, shares of stock or other items of value given by the company to Richard Norling, chairman and chief executive officer of Premier, Inc. or to other persons affiliated with Premi... 
08/14/2002Express Scripts Announces Investor Conference Call
ST. LOUIS--(BUSINESS WIRE)--Aug. 14, 2002--Express Scripts, Inc. (Nasdaq:ESRX) announced that it will hold an investor conference call today at 1:00 p.m. CST (2:00 p.m. EST) to discuss recent events. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Investor Relations section of Express Scripts' website at http://www.express-scripts.com. Express Scripts, Inc. is one of the largest pharmacy ben... 
07/24/2002Express Scripts Reports Record Second Quarter Earnings; Board Expands Stock Repurchase Program
ST. LOUIS, Jul 24, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced second quarter net income of $48.7 million, or 61 cents per diluted share, an increase of 33 percent over the same quarter of 2001, excluding the amortization of goodwill. Express Scripts generated $170.7 million of cash flow from operations in the second quarter compared with $45.5 million in the same quarter last year. During the quarter, the company repurchased 400,000 shares of common stock for ... 
07/17/2002Express Scripts Announces Second Quarter Earnings Release Date July 24, 2002
ST. LOUIS, Jul 17, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (NASD:ESRX) announced today its intention to release its second quarter earnings on July 24, 2002 after 3 P.M. CST. In addition, management will hold an investor conference call on July 25, 2002 at 12:00 P.M. CST to discuss the quarterly results and general operations of the Company. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Investor Relations section ... 
06/20/2002Express Scripts to Present at William Blair & Co. 22nd Annual Growth Stock Conference
ST. LOUIS, Jun 20, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the William Blair & Co. 22nd Annual Growth Stock Conference on Wednesday, June 26, 2002 at 1:00 p.m. CDT (2:00 p.m. EDT) at the Four Seasons Hotel in Chicago, IL. The presentation will also be broadcast via the Internet and can be accessed at http://www.twst.com/econf/mm/blair/esrx.html. RealPlayer or Windows Media Player is needed to listen to the Webcast and free downlo... 
06/18/2002Deltec Selects Express Scripts' Specialty Distribution Services to Help Launch New Insulin Pump
Click here for printer-friendly format ST. LOUIS, Jun 18, 2002 (BUSINESS WIRE) -- Agreement Marks Expansion Into New Market for Pharmacy Benefit Manager Subsidiary Express Scripts (NASDAQ:ESRX) announced today that medical-device manufacturer Deltec, Inc. has selected the company to manage the launch of its new insulin pump later this year. Specialty Distribution Services (SDS), an Express Scripts subsidiary, will handle the launch. SDS will also provide ongoing clinical and ... 
06/11/2002Express Scripts to Host Analyst Meeting on June 18th
ST. LOUIS, Jun 11, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (NASD:ESRX) today announced that it will host an analyst meeting on Tuesday, June 18, 2002 beginning at 12:00 p.m. EST (11:00 a.m. CST) at NASDAQ MarketSite in New York. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of the Express Scripts' Web site at www.express-scripts.com. Express Scripts, Inc. is one of the largest pharmacy benefit management (PBM) compani... 
06/05/2002Express Scripts to Present at Goldman, Sachs & Co. 23rd Annual Global Healthcare Conference
ST. LOUIS, Jun 5, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Goldman, Sachs & Co. 23rd Annual Global Healthcare Conference on Wednesday, June 12, 2002 at 7:40 a.m. PDT (10:40 a.m. EDT) at the Ritz-Carlton Laguna Niguel in Dana Point, California. The presentation will also be broadcast via the Internet and can be accessed at https://www.gs.com/ir/conf . Use the following login information for the webcast (user name and password a... 
06/04/2002First Quarter 2002 Prescription Drug Spending: Higher Again, but Rate of Increase Drops
ST. LOUIS, Jun 4, 2002 /PRNewswire via COMTEX/ -- Consumers Expect to Pay More Out of Their Own Pockets New Findings Challenge COX-2 Cost-Effectiveness, Show Wide Use for Short-Term Pain Relief The nation's rapid upward trend in prescription drug spending continued during first quarter 2002, but at a slightly lower rate of 19.3 percent compared to 19.8 percent in first quarter 2001. For the entire year 2001, spending increased 16.9 percent according to the "2001 Express Scripts Drug... 
05/02/2002Express Scripts Announces Conference Call
ST. LOUIS--(BUSINESS WIRE)--May 2, 2002--Express Scripts, Inc. (Nasdaq:ESRX) announced today that it will hold a conference call at 3:00 P.M. CST to discuss the 8K it filed today. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Investor Relations section of Express Scripts' website at http://www.express-scripts.com. Express Scripts, Inc. is one of the largest pharmacy benefit management (PB... 
05/01/2002Express Scripts to Present at Deutsche Banc Alex. Brown Healthcare Conference
ST. LOUIS, May 1, 2002 (BUSINESS WIRE) -- Express Scripts Inc. (Nasdaq:ESRX) announced that it will present at the Deutsche Banc Alex. Brown Healthcare Conference on Wednesday, May 8, 2002, at 4:30 p.m. EST at the Waterfront Marriott in Baltimore, Md. The presentation will also be broadcast via the Internet and can be accessed at: http://www.visualwebcaster.com/event.asp?id=4863 RealPlayer or Windows Media Player is needed to listen to the Webcast and free downloads of these players... 
04/18/2002Express Scripts Appoints Barbara Hill President; Extensive Healthcare, Insurance Background Complements Senior Leadership
ST. LOUIS, Apr 18, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has named Barbara Hill, to fill the position of president, effective immediately. Hill will report to chairman and CEO, Barrett Toan. Most recently, Hill served as senior Vice President, Operations for CIGNA Healthcare. Previously, Hill served on Express Scripts' Board of Directors from 2000 to 2001. "The company's board and our senior leadership are extremely pleased to welcome Barb... 
04/17/2002Express Scripts Reports First Quarter Earnings; Earnings Guidance Increased for 2002 and 2003
ST. LOUIS, Apr 17, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $44.0 million, or 55 cents per diluted share, an increase of 28 percent over the same quarter of 2001. All per share amounts reflect the 2-for-1 stock split which was effective June 22, 2001. In addition, the 2001 earnings have been adjusted to eliminate the amortization of goodwill. "Our strong earnings reflect our success in executing all phases of our strategic busin... 
04/12/2002Express Scripts Completes Acquisition of National Prescription Administrators
ST. LOUIS, Apr 12, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced today that it completed its acquisition of National Prescription Administrators, Inc. (NPA), which was announced in February. Headquartered in East Hanover, New Jersey, NPA was the largest privately held full-service pharmacy benefit manager. NPA manages approximately $2.5 billion in annual drug spend primarily for union and government groups in the northeast. "We're very pleased to welcome NPA into... 
04/10/2002Express Scripts Announces First Quarter Earnings Release Date April 17, 2002
ST. LOUIS, Apr 10, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (NASD:ESRX) announced today its intention to release its first quarter earnings on April 17, 2002 after 3 P.M. CST. In addition, management will hold an investor conference call on April 18, 2002 at 10:00 A.M. CST to discuss the quarterly results and general operations of the Company. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Investor Relations section... 
03/28/2002Express Scripts to Present at Banc of America Securities Healthcare Conference
ST. LOUIS, Mar 28, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the Banc of America Securities Healthcare Conference on Thursday, April 4, 2002 at 9:10 a.m. PST (12:10 p.m. EST) at the Four Seasons Hotel in Las Vegas, Nevada. The presentation will also be broadcast via the Internet and can be accessed at: http://www.veracast.com/webcasts/BAS/healthcare-2002/id42303421.cfm RealPlayer or Windows Media Player is needed to listen to the Webca... 
03/26/2002Express Scripts is Upgraded by Standard & Poor's to Investment Grade
ST. LOUIS, Mar 26, 2002 (BUSINESS WIRE) -- Express Scripts, Inc. (NASD:ESRX) announced today that Standard & Poor's (S&P) raised the credit ratings on the company's debt to BBB- from a BB+, and indicated that the outlook remains stable. S&P noted that the investment-grade ratings on Express Scripts reflect the company's strong position in the expanding pharmaceutical benefit management industry, continued solid operating performance, and growing cash flows. S&P indicated that PBMs shou... 
03/25/2002WV Governor's Multistate Drug Purchasing Effort a Reality
CHARLESTON, W.Va., Mar 25, 2002 (BUSINESS WIRE) -- Gov. Bob Wise today announced that Express Scripts of St. Louis, Mo. (NASDAQ:ESRX) is the winning Pharmacy Benefits Manager for PEIA and the RXIS group. "The rising costs of prescription drugs, especially for our seniors, continue to climb," Wise said. "This problem must be solved, and this project shows the benefits of a united effort." During the past year, PEIA Director Tom Susman has been working with several other states on the... 
03/25/2002RxHub Announces The Publication of Electronic Prescribing Specifications
Specifications Available at RxHub's New Web Site, www.rxhub.net ST. PAUL, MINNESOTA, MARCH 25, 2002 – RxHub, a health care services company focused on accelerating the adoption of electronic prescribing, announced today that it has created and published a set of industry-wide specifications open for comment from all participants in the prescription creation and delivery process. Prior to publication, RxHub solicited input from members of the industry representing pharmacies, PBMs and point... 
02/25/2002Express Scripts Completes Acquisition of Phoenix Marketing Group, Inc
ST. LOUIS, Feb. 25 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has completed the acquisition of the assets of Phoenix Marketing Group (Holdings), Inc. ("Phoenix") from Access Worldwide Communications, Inc. (OTC Bulletin Board: AWWC) for $33 million in cash. "We're pleased to announce the completion of this acquisition," stated Barrett Toan, chairman and chief executive officer. "Phoenix is well-positioned to assume a greater s... 
02/06/2002Express Scripts Reports 30 Percent Increase in Fourth Quarter Diluted EPS;
ST. LOUIS, Feb 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- Tenth Consecutive Year of Record Cash Flow From Operations Express Scripts, Inc. (Nasdaq: ESRX) announced fourth quarter net income of $34.2 million, or 43 cents per diluted share, and 2001 net income of $124.7 million, or $1.56 per diluted share. This compares with fourth quarter 2000 net income of $26.0 million, or 33 cents per diluted share, and 2000 net income of $94.1 million, or $1.21 per share, excluding non-recurring i... 
02/06/2002Express Scripts and National Prescription Administrators Announce Acquisition Agreement
ST. LOUIS, Feb 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today it has signed a definitive agreement to acquire the capital stock of National Prescription Administrators, Inc., Central Fill Inc., CFI of New Jersey, Inc., NPA NY IPA, Inc., and certain real estate and equipment owned by a limited partnership, together comprising the business of NPA for a net purchase price of $515 million. NPA, headquartered in East Hanover, New Jersey, is the... 
01/11/2002Medicine Access, Safety and Affordability Lead Year's Top Pharmaceutical Developments
ST. LOUIS, Jan 11, 2002 /PRNewswire via COMTEX/ -- Express Scripts Issues Third Annual Pharmaceutical Developments Report Can Americans get the medicines they need, safely and affordably? That's the question behind most of 2001's top pharmaceutical developments, according to a report issued today by Express Scripts, Inc., (Nasdaq: ESRX) one of the nation's leading pharmacy benefit management firms. "We have looked closely at the events of the year and identified those we believe mo... 
01/07/2002Prescription Drug Use Varies Widely Between States for Adults and Children
ST. LOUIS, Jan. 7 /PRNewswire/ -- Until now, your age and gender were among the best indicators of how you might use prescription drugs. With today's release by Express Scripts of the first comprehensive state-by-state study of prescription drug use, where you live also can say a lot about which and how many medications you use. According to the study, the percentage of adult beneficiaries obtaining at least one prescription in 2000 ranged from a high of 71 percent in K... 
12/20/2001No Increase in Emergency Room Visits or Hospitalizations From Three-Tier Prescription Benefit Copayment Structures
ST. LOUIS, Dec. 20 /PRNewswire/ -- In the first study of its kind, researchers have found that adding a third, higher-cost pharmacy benefit copayment level did not result in unintended consequences, such as higher emergency room visits or inpatient hospitalizations. There had been some concern, now shown to be unfounded, that patients might stop taking necessary medications because of higher copayments under a three-tier pharmacy benefit. Between 1998 and 2000, the avai... 
12/19/2001Express Scripts Enters Into Agreement to Acquire Phoenix Marketing Group, Inc.
ST. LOUIS, Dec 19, 2001 /PRNewswire via COMTEX/ -- Pharmacy Benefit Manager to Enhance Distribution Services With Medication Sampling to Physicians Express Scripts, Inc. (Nasdaq: ESRX) announced today it has signed a definitive agreement to acquire the assets of Phoenix Marketing Group (Holdings), Inc. ("Phoenix") from Access Worldwide Communications, Inc. (OTC Bulletin Board: AWWC) for $33 million in cash. Phoenix is one of the largest prescription drug sample fulfillment companies in... 
12/17/2001Express Scripts Joins Nasdaq-100 Index
ST. LOUIS, Dec 17, 2001 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) reached another milestone today by being added to the Nasdaq-100 Index(R) effective with the beginning of trading Monday, December 24, 2001. The Index includes the top 100 non-financial Nasdaq-listed companies based on market capitalization. Express Scripts will also be included in the Nasdaq-100 Index Tracking Stock (SM) (Amex: QQQ) which represents ownership in the Nasdaq-100 Trust. "We are please... 
11/01/2001Express Scripts to Present at the CIBC World Markets Health Care Conference On November 7, 2001
ST. LOUIS, Nov 1, 2001 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will present at the CIBC World Markets Health Care Conference on November 7, 2001 at 11:00 a.m. EST at the Plaza Hotel in New York. The presentation will also be broadcast via the Internet and can be accessed at: http://webcast.talkpoint.com/starthere.asp?pres=16096&template=cibc&exit=http: //www.express-scripts.com The Webcast will be archived and available for 30 days fol... 
10/25/2001Express Scripts to Present at the Salomon Smith Barney Health Care Conference On October 30, 2001
ST. LOUIS, Oct 25, 2001 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will present at the Salomon Smith Barney Health Care Conference on Tuesday, October 30, 2001 at 11:15 a.m. EST at the Plaza Hotel in New York. The presentation will also be broadcast via the Internet and can be accessed at http://www.veracast.com/clientaccess/ssb/healthcare-2001/33207194.cfm . The Webcast will be archived and available for 30 days following the presentation. ... 
10/18/2001Express Scripts Provides Updated Guidance
ST. LOUIS, Oct 18, 2001 /PRNewswire via COMTEX/ -- Express Scripts, Inc. (Nasdaq: ESRX) responded to the impact of today's announcement that WellPoint Health Networks, Inc. and RightCHOICE Managed Care, Inc. have signed a definitive agreement to merge. RightCHOICE is a client of Express Scripts representing approximately 600,000 members. Express Scripts has not received a notice of termination from RightCHOICE, which has a contract scheduled to expire in the second quarter of 2002, but Exp... 
10/16/2001Express Scripts Reports Third Quarter Earnings; EPS Grew 33
ST. LOUIS, Oct. 16 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income of $32.2 million, or 40 cents per diluted share. This represents a 35 percent increase in net income and a 33 percent increase in diluted earnings per share compared with the $23.9 million, or 30 cents per diluted share for the same quarter last year. All per share amounts reflect the 2-for-1 stock split, which was effective June 22, 2001. Express Scripts generat... 
10/09/2001Express Scripts Announces Third Quarter Earnings Release Date October 17, 2001
ST. LOUIS, Oct 9, 2001 (BW HealthWire) -- Express Scripts, Inc. (NASD:ESRX) announced today its intention to release its third quarter earnings on October 17, 2001 after 3 P.M. CST. In addition, management will hold an investor conference call on October 18, 2001 at 10:00 a.m. CST to discuss the quarterly results and general operations of the Company. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Investor Relations sect... 
09/17/2001Express Scripts Reiterates Earnings Guidance
ST. LOUIS, Sep 17, 2001 (BW HealthWire) -- Express Scripts, Inc. (NASDAQ: ESRX) today announced that it is comfortable with First Call earnings estimates for the third quarter and full year 2001. Express Scripts' mail order and claims administration services were not materially impacted by the events of last week. "We continue to see strong business fundamentals, which gives us confidence that we can successfully accomplish our business plans," stated Barrett Toan, chairman and chief execu... 
09/07/2001Express Scripts to Present at the Banc of America Securities Conference On September 13, 2001
ST. LOUIS, Sep 7, 2001 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will present at the Banc of America Securities 31st Annual Investment Conference on Thursday, September 13, 2001 at 9:30 a.m. PDT (12:30 p.m. EDT) at the Ritz-Carlton in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed at http://www.veracast.com/webcasts/BAS/31st-annual-2001/id44405225.cfm . In addition, Express Scripts will conduct a... 
08/03/2001Corporate Profile for Express Scripts, dated Friday, August 3
Aug 03, 2001 (BUSINESS WIRE) -- The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. Published Date: Friday, August 3, 2001 Company Name: Express Scripts Address: 13900 Riverport Dr. Maryland Heights, MO 63043 Main Telephone Number: 314/770-1666 Interne... 
07/25/2001Express Scripts Adopts Stockholder Rights Plan
ST. LOUIS, July 25 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that its board of directors has adopted a Stockholder Rights Plan. In the face of a rapidly evolving health care industry, the adoption of the Rights Plan provides protection against coercive or unfair takeover tactics, and should encourage anyone seeking to acquire the company to negotiate with the board first. The Rights Plan is similar to plans adopted by many public companies and other he... 
07/18/2001Express Scripts Reports Second Quarter Earnings
ST. LOUIS, Jul 18, 2001 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter net income of $30.2 million, or 38 cents per diluted share. This represents a 32 percent increase in net income and a 27 percent increase in diluted earnings per share compared with the $22.9 million, or 30 cents per diluted share for the same quarter last year, excluding a non-recurring charge in 2000 discussed below. All per share amounts reflect the 2-for-1 stock split, which was effect... 
07/12/2001Express Scripts Supports Administration's Prescription Discount Card Initiative for Seniors
ST LOUIS, Jul 12, 2001 /PRNewswire/ -- Pharmacy Benefit Manager Joins Administration Officials in Rose Garden Announcement Express Scripts (Nasdaq: ESRX), one of the nation's largest pharmacy benefit managers (PBMs), announced its support for the Medicare Prescription Discount Card initiative unveiled today by President George W. Bush. "Our participation in the White House announcement was a demonstration of our strong support for improving Medicare recipients' access to affordable ... 
07/11/2001Express Scripts Announces Second Quarter Earnings Release Date July 18, 2001
ST. LOUIS, July 11 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today its intention to release its second quarter earnings on July 18, 2001 after 3 P.M. CST. In addition, management will hold an investor conference call on July 19, 2001 at 10:00 A.M. CST to discuss the quarterly results and general operations of the Company. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Investor Relati... 
07/02/2001RxHub Names James Bradley as CEO to Guide Future of Prescription Connectivity
“This is an opportunity to apply my understanding of business, technology and the Internet in a way that significantly contributes to quality care.” New York, July 2, 2001 – RxHub, a new venture that will operate as a connectivity hub that enables doctors, pharmacies, health plans and pharmacy benefit managers to exchange prescription information and process electronic prescriptions, today named James P. Bradley as its chief executive officer. Formerly a senior business development e... 
06/22/2001Express Scripts Completes 2-For-1 Stock Split
ST. LOUIS, June 22 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that the previously disclosed two-for-one stock split was effected at the close of trading on June 22, 2001. The stock closed at a pre-split price of $107.31 and will commence trading on a post-split basis when the market opens on Monday, June 25, 2001. The stock split was for stockholders of record as of June 8, 2001. The split comes in the form of a stock dividend by issuing one additio... 
06/19/2001Prescription Drug Use Patterns Complicated by Wide Regional Variation; ''Total Drug Spending Up Again in 2000, Fastest Prescription Cost Increase for Children's Medications''
ST. LOUIS, Jun 19, 2001 (BW HealthWire) -- California and New York may be the nation's most populous states, but they and other big states like Florida, New Jersey, Minnesota, and Massachusetts, placed at or near the bottom when Express Scripts (Nasdaq:ESRX) measured per capita prescription drug use across the nation, using a random sample of commercially insured members (age 18 to 64) of its pharmacy benefit plans. New York's drug utilization rate was 7.7 prescriptions per year, as wer... 
06/13/2001Express Scripts Sells Home Infusion Subsidiary Branch Offices: Will Focus on Chronic Biotech and Injectable Drugs
ST. LOUIS, Jun 12, 2001 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has agreed to sell the branch offices of its IVTx home infusion subsidiary to Option Care, Inc. (Nasdaq: OPTN) for an undisclosed amount. Barrett Toan, chairman and CEO stated, "The sale of these assets reflects a change in our business model to focus on chronic biotech and injectable drugs, which we can distribute through a centralized location. Branch offices are not needed to support... 
06/06/2001Express Scripts to Present at Goldman Sachs Healthcare Conference on June 12, 2001
ST. LOUIS, June 6 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will present at the Goldman Sachs' 22nd Annual Healthcare Conference on Tuesday, June 12, 2001 at 10:20 a.m. PST (1:20 p.m. EST) at the Ritz-Carlton Laguna Niguel in Dana Point, CA. The presentation will also be broadcast via the Internet and can be accessed at the investor relations section of Express Scripts' web site at: http://www.express-scripts.com . The following inform... 
05/30/2001Novartis Selects Express Scripts as Patient Assistance Program Provider For Newly Approved Gleevec™, Oral Leukemia Drug
ST. LOUIS, May 30 /PRNewswire/ -- Express Scripts, Inc., (Nasdaq: ESRX) announced today that it has been selected by Novartis Pharmaceuticals Corporation to be the exclusive patient assistance program service provider for Gleevec™, an oral anti-leukemia drug. The Food and Drug Administration (FDA) recently gave fast-track approval to Gleevec for treatment of patients with chronic myeloid leukemia (CML) in three stages: blast crisis, accelerated phase, and chronic phase after fail... 
05/25/2001Express Scripts Study Says Prescription Drug Coverage for Seniors May Cost Three to Four Times More Than Coverage for Those Under 65
ST. LOUIS, May 25 /PRNewswire/ -- A new study released today by Express Scripts (Nasdaq: ESRX), one of the nation's leading pharmacy benefit managers (PBMs), examines the unique patterns of prescription drug usage among a commercially insured senior population, defined as those age 65 or older. Through original research involving analysis of millions of prescription claims, the study documents high levels of prescription drug consumption among this population. The findings hold si... 
05/23/2001Express Scripts Declares 2-For-1 Stock Split; Increases Earnings Guidance
ST. LOUIS, May 23 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that its board of directors has approved a two-for-one stock split to be effected in the form of a stock dividend. The stock split is for shareholders of record as of June 8, 2001, and will be effective on or about June 22, 2001. Based on strong business fundamentals, including membership growth, continued cross-selling of additional services, development of new products, increased p... 
05/11/2001Express Scripts Comments on FDA Panel Recommendation
ST. LOUIS, May 11 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) has issued a comment on today's recommendation by a Food and Drug Administration (FDA) advisory panel that the allergy drugs Claritin, Allegra and Zyrtec be made available over-the-counter without supervision by a doctor. Express Scripts believes that if the FDA commissioners adopt the recommendation that these drugs be available without a prescription, there will be no material impact on the co... 
05/04/2001Express Scripts to Present at Deutsche Banc Alex. Brown Health Care Conference on May 9th
ST. LOUIS, May 4 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will present at the Deutsche Banc Alex. Brown 2001 Health Care Conference on Wednesday, May 9, 2001 at 4:00 p.m. EST at the Marriott Waterfront Hotel in Baltimore, Maryland. The presentation will also be broadcast via the Internet and can be accessed at: www.db.com/conferences . A replay of the presentation will be available by the end of the day and will be archived for 7... 
05/01/2001Express Scripts to Host Analyst Meeting on May 4th
ST. LOUIS, May 1 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will host an analyst meeting on Friday, May 4, 2001 beginning at 9:30 a.m. CST (10:30 a.m. EST) at the company's corporate headquarters in St. Louis, Missouri. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of the Express Scripts' Web site at http://www.express-scripts.com . Express Scripts, Inc. is one of the... 
04/19/2001UnitedHealth Group Awards Contract to Express Scripts to Provide Pharmacy Services to AARP Members
ST. LOUIS, April 19 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has signed a five-year contract with UnitedHealth Group (NYSE: UNH) to make available comprehensive mail, retail network, and other pharmacy services to members of AARP. Effective June 1, 2001, Express Scripts will provide pharmacy mail services, network management, and claims processing to members currently using the AARP Pharmacy Service. The company will also support and collabora... 
04/18/2001Express Scripts Reports First Quarter Earnings; Diluted Earnings Per Share Up 29
ST. LOUIS, April 18 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $28.1 million, or 71 cents per diluted share. This is a 31 percent increase in net income and a 29 percent increase in diluted earnings per share compared with $21.4 million, or 55 cents, in the first quarter of 2000. The company generated $50.1 million of cash flow from operations in the first quarter. Express Scripts' ratio of debt to total capitalization has declin... 
04/10/2001Express Scripts Announces First Quarter Earnings Release Date April 18, 2001
ST. LOUIS, April 10 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today its intention to release its first quarter earnings on April 18, 2001 after 3 P.M. CST. In addition, management will hold an investor conference call on April 19, 2001 at 10:00 A.M. CST to discuss the quarterly results and general operations of the Company. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Investor Rela... 
04/05/2001Express Scripts to Present at The Robinson-Humphrey 30th Annual Institutional Conference on April 9, 2001
ST. LOUIS, April 5 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will present at the Robinson-Humphrey 30th Annual Institutional Conference on Monday, April 9, 2001 at 12:50 p.m. EST at the Ritz-Carlton, Buckhead in Atlanta. The presentation will also be broadcast via the Internet and can be accessed at: http://webcast.talkpoint.com/starthere.asp?pres=13286&template=rh&exit=http. RealPlayer or Windows Media Player is needed to listen to th... 
03/28/2001Express Scripts and Choicelinx Announce Strategic Alliance
ST. LOUIS, and MANCHESTER, N.H., March 28 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX), one of the nation's largest pharmacy benefit managers (PBMs), and Choicelinx Corporation, a benefits technology and services company specializing in a new generation of customer-designed products, today announced a three-year joint marketing deal. Under the agreement, the two companies will co-market a combination of Web-based products that will allow employees of participating organizations... 
03/27/2001Express Scripts to Present at Banc of America Securities Health Care Conference on March 29th
ST. LOUIS, March 27 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will present at the Banc of America Securities Health Care Conference on Thursday, March 29, 2001 at 12:15 p.m. PST (3:15 p.m. EST) at the Four Seasons Hotel in Las Vegas, Nevada. The presentation will also be broadcast via the Internet and can be accessed at: http://www.veracast.com/bas_healthcare2001/webcasts/id01308222.cfm RealPlayer or Windows Media Player is needed to l... 
03/19/2001Express Scripts Names LabCorp's Thomas Mac Mahon to Board of Directors
ST. LOUIS, March 19 /PRNewswire/ -- Express Scripts Inc. (Nasdaq: ESRX), one of the nation's largest pharmacy benefit managers, today announced the appointment of Thomas P. Mac Mahon, chairman, president and CEO of Laboratory Corporation of America Holdings™ (LabCorp) (NYSE: LH), to its Board of Directors. "The addition of Tom Mac Mahon to the Board signals our commitment to building a strong governing body that understands our business," said Barrett Toan, Express Scri... 
03/08/2001Express Scripts Discusses Capitalized Software
ST. LOUIS, March 8 /PRNewswire/ -- Investors and analysts have recently asked questions regarding Express Scripts, Inc. (Nasdaq: ESRX) reported capitalized software development costs for 2000. Under Regulation FD, the company is issuing this press release to insure full public dissemination of this information in response to these inquiries. As reported in our 2000 Form 10-K, capitalized software rose to $37 million from $16 million in 1999 and $10 million in 1998. ... 
03/02/2001Express Scripts Canadian Subsidiary Closes on CAPSS Acquisition
ST. LOUIS, March 2 /PRNewswire/ -- ESI Canada, a subsidiary of Express Scripts, Inc. (Nasdaq: ESRX), has completed the acquisition of Centre d'autorisation et de paiement des services de sante (CAPSS) Inc. The transaction brings together the second and third largest Canadian health benefit management companies. The purchase price was $25 million (CAD), or approximately $16.5 million (US). ESI Canada gains an additional 1.5 million members and its first Quebec opera... 
03/01/2001Express Scripts Is Upgraded By Standard & Poor's
ST. LOUIS, March 1 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that Standard & Poor's (S&P) raised its credit ratings on the company's debt to BB+ from a BB, and noted the outlook is stable. S&P indicated the upgrade reflects Express Scripts' continued solid operating performance and improved balance sheet. S&P also noted Express Scripts' strong cash flows, which have enabled the company to pay down its acquisition-related debt aggressively. ... 
02/22/2001Express Scripts Joins Leading PBM's in Forming RxHub
ST. LOUIS, Feb. 22 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX), AdvancePCS (Nasdaq: ADVP) and Merck-Medco have signed an agreement, announced earlier today, to form RxHub LLC. Each of the founding partners will own one-third of RxHub, and each has committed to invest up to $20 million over the next five years, with approximately $6 million anticipated for 2001. Express Scripts will record its investment in the joint venture under the equity method of accounting, which re... 
02/14/2001Pharmacy Landscape Developments in 2000 Signal Still Higher Costs Ahead
ST. LOUIS, Feb. 14 /PRNewswire/ -- In its second annual report on events most influencing the pharmaceutical landscape, Express Scripts (Nasdaq: ESRX), one of the nation's largest pharmacy benefit managers, says last year's developments have increased plan sponsors' "urgency to find ways to manage costs." "Our 'Top Developments on the Pharmaceutical Landscape 2000' takes a close look at the year past, and it tells us much about what may lie ahead," said Express Scripts ... 
02/07/2001Express Scripts Reports Ninth Consecutive Year of Record Cash From Operations; 2000 Diluted EPS up 36 Percent, Excluding Non-Recurring Items
ST. LOUIS, Feb. 7 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced fourth quarter net income of $26.0 million, or 66 cents per diluted share, and 2000 net income of $94.1 million, or $2.41 per diluted share, excluding non-recurring charges discussed below. This compares with fourth quarter 1999 net income of $19.6 million, or 50 cents per diluted share, and 1999 net income of $67.3 million, or $1.77 per diluted share, excluding the effect of temporary debt and non-recurri... 
01/31/2001Express Scripts Announces Fourth Quarter Earnings Release Date February 7, 2001
ST. LOUIS, Jan. 31 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today its intention to release its fourth quarter earnings on February 7, 2001 after 3 P.M. CST. In addition, management will hold an investor conference call on February 8, 2001 at 10:00 A.M. CST to discuss the quarterly results and general operations of the Company. The call will be broadcast live as well as replayed through the Internet. The webcast can be accessed through the Invest... 
12/18/2000Express Scripts Board of Directors Names Barrett Toan Chairman
ST. LOUIS, Dec. 18 /PRNewswire/ -- Express Scripts Inc. (Nasdaq: ESRX), one of the nation's largest pharmacy benefit managers (PBMs), today announced the election of Barrett Toan as chairman of the company's Board of Directors. Toan will continue in his current roles of president and CEO of Express Scripts. He has been a member of the Board of Directors since the company went public in 1992. "Express Scripts is leading the pharmacy benefit industry into an era that ... 
12/15/2000Seniors Who Reach Prescription Benefit Caps More Likely to Leave Medicare HMOs, Say Express Scripts Researchers
Study Suggests Prescription Drug Benefit Should Enter Into Seniors' Healthcare Decisions ST. LOUIS, Dec. 15 /PRNewswire/ -- Reaching prescription benefit caps, or spending limits, may lead some seniors to drop out of their Medicare HMOs. This relationship was confirmed by a new study conducted by Express Scripts Inc. (Nasdaq: ESRX - news), one of the nation's largest pharmacy benefit managers. A synopsis of the study by lead author Emily R. Cox, Ph.D., and her colleagues at Express Scripts was... 
11/02/2000Express Scripts Completes Secondary Common Stock Offering
ST. LOUIS, Nov. 2 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has completed a secondary public offering of 6 million shares of Express Scripts Class A Common Stock owned by NYLIFE, L.L.C. ("NYLIFE"), a subsidiary of New York Life Insurance Company, at $69 per share. Concurrently, a closed-end investment company, known as the Express Scripts Automatic Exchange Security Trust (the "Trust"), completed a primary public offering of 3 mi... 
10/16/2000Express Scripts Reports Strong Third Quarter Earnings; Membership Grows To 41.5 Million and $135 Million of Debt Repaid
ST. LOUIS, Oct. 16 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income of $23.9 million, or 61 cents per diluted share. These results include one-time items (extraordinary loss and non-recurring gain), which mostly offset each other and are more fully described below. This compares to net income of $17.0 million, or 43 cents per diluted share for the same period last year, which includes a $0.6 million after-tax, or two cents per diluted share, e... 
10/06/2000Express Scripts Files Secondary Common Stock Offering
ST. LOUIS, Oct. 6 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has filed a registration statement with the Securities and Exchange Commission relating to a secondary public offering of 6 million shares of Express Scripts' Class A Common Stock owned by NYLIFE HealthCare Management, Inc. (NYLIFE), a subsidiary of New York Life Insurance Company, and 3 million shares of Express Scripts' Class A Common Stock, also owned by NYLIFE, that may subsequent... 
09/26/2000Express Scripts, First Major Pharmacy Benefit Manager to Oversee a Medicaid Pharmacy Program
ST. LOUIS, Sept. 26 /PRNewswire/ -- The Georgia Department of Community Health and Express Scripts, one of the nation's largest independent pharmacy benefit management (PBM) companies, have announced a contractual agreement under which Express Scripts will manage pharmacy services for 1.8 million Georgians. The agreement also marks the first instance of a PBM being retained to manage the fee-for-service pharmacy component of a state Medicaid program. The program will b... 
08/30/2000Fortune Magazine Ranks Express Scripts as One of the 100 Fastest-Growing Companies in America
ST. LOUIS, Aug. 30 /PRNewswire/ -- Express Scripts, Inc., (Nasdaq: ESRX) has been ranked for the first time among the 100 fastest-growing companies in the United States by Fortune Magazine, published in the September 4th issue. Fortune considered companies for the ranking if they achieved a 30 percent annual growth rate for three years in both revenue and earnings per share and had positive earnings in the latest quarter. Express Scripts was also included earlier this year in the... 
08/09/2000TriWest and Express Scripts First to Implement New Pharmaceutical Screening Service for Military Personnel and Family Members
PHOENIX and ST. LOUIS, Aug. 9 /PRNewswire/ -- TriWest Healthcare Alliance, a managed-care support contractor for the Department of Defense (DoD), and Express Scripts, Inc. (Nasdaq: ESRX), one of the nation's largest independent pharmacy benefit managers, today jointly announced the first successful implementation of the military's new Pharmacy Data Transaction Service (PDTS). Approved under the FY 2000 Defense Authorization Act and developed under the auspices of the Office of the Se... 
07/19/2000Express Scripts Second Quarter Pro Forma Net Income Up 38 Percent; Membership Exceeds 40 Million
ST. LOUIS, July 19 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter 2000 pro forma net income of $22.9 million, or 59 cents per diluted share. The pro forma calculation excludes the previously announced $97.0 million non-cash, after-tax write-down of the company's 19.8 percent ownership interest in PlanetRx.com, Inc. Pro forma net income and diluted earnings per share for the second quarter increased 37.9 percent and 40.5 percent, respectively, from the... 
06/28/2000New Evidence About Positive Three-Tier Co-Pay Performance Presented At Express Scripts 2000 Outcomes Conference
Researcher First to Study and Report on Prescription Drug Benefit Tool ST. LOUIS, June 28 /PRNewswire/ -- Researcher Brenda Motheral, PhD, told participants of the fourth annual Express Scripts (Nasdaq: ESRX - news ) Outcomes Conference, held in St. Louis, that recent data indicates three-tier co-pay prescription programs have enjoyed a great deal of success since their inception two years ago. Motheral, the author of numerous articles in the area of outcomes research, claims data... 
06/27/2000Express Scripts 1999 Drug Trend Report: Seniors Hit Hardest By Record 17.4-Percent Prescription Drug Spending Increase
ST. LOUIS, June 27 /PRNewswire/ -- Spending on prescription drugs increased a record 17.4 percent last year, with senior citizens 70 years or older seeing the biggest cost increases per prescription. Higher prescription costs and greater drug utilization drove the spending increase, which was less for plan sponsors that actively managed their pharmacy benefits. These are among the findings included in the 1999 Drug Trend Report, released today by Express Scripts Inc. (Nasd... 
06/22/2000Express Scripts, PocketScript Partner to Roll Out Electronic Prescribing Solution to 15,000 Physicians
ST. LOUIS, Mo. and CINCINNATI, Ohio--(BUSINESS WIRE)-- June 22, 2000--Express Scripts, Inc. (Nasdaq: ESRX) and PocketScript, Inc., today announced an agreement to bring PocketScript's wireless, handheld e-prescribing system to more than 15,000 Express Scripts' physicians. Under the agreement, Express Scripts will provide PocketScript's device, which includes formulary information and potential drug interactions, to approximately 15,000 physicians at the point of care. PocketScr... 
06/19/2000Express Scripts Restructures PlanetRx Relationship
ST. LOUIS, June 19 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX), today announced that it has restructured its relationship with PlanetRx.com , Inc. Members of health plans using Express Scripts' online pharmacy service will continue to be able to access PlanetRx.com for their prescription medications through Express Scripts' and PlanetRx.com's websites. Under the restructured agreement, which is scheduled to take effect on July 5, 2000, Express Scripts will retain ... 
05/24/2000Ceres Health Care Selects Express Scripts to Provide Full Service Pharmacy Benefit Management Services
ST. LOUIS, May 24 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it is implementing a program to provide pharmacy benefit management (PBM) services for Ceres Health Care, Inc., a subsidiary of Ceres Group, Inc. (Nasdaq: CERG). As part of the contract, Express Scripts will provide prescription benefits through retail, mail and Internet pharmacy services. Express Scripts will provide Internet pharmacy services through its exclusive online pharmacy... 
05/09/2000Express Scripts Authorizes Repurchase of Up to 2.5 Million Shares
ST. LOUIS, May 9 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that the Executive Committee of its Board of Directors authorized a modification to the terms of the Company's previously-announced stock repurchase program to permit the Company to repurchase up to 2.5 million shares of the Company's Class A common stock. To date, the Company has repurchased approximately 1,255,000 shares of its Class A common stock under the program. The Company currently has ap... 
04/26/2000Express Scripts Selects Allscripts to Expand Electronic Prescribing Nationwide
Prescription Drug Ordering and Processing Made Easier for Physicians, Patients, Health Plans ST. LOUIS and CHICAGO, April 26, 2000 -- Express Scripts, Inc. (Nasdaq: ESRX), and Allscripts, Inc. (Nasdaq: MDRX) today announced an agreement intended to accelerate physician adoption of the TouchScript® electronic prescribing solution. Express Scripts will provide physicians who use Allscripts' TouchScript® Personal Prescriber™ real-time access to current formulary and clinical in... 
04/19/2000Express Scripts First Quarter Net Income Up 58 Percent; Diluted EPS Rises 38 Percent Cash Flow from Operations Grows to $61 Million
ST. LOUIS, April 19 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter 2000 net income of $21.4 million, or 55 cents per diluted share. This is a 58 percent increase in net income and a 38 percent increase in diluted earnings per share compared with $13.5 million, or 40 cents, in the first quarter of 1999. During the quarter, Express Scripts generated $60.7 million in cash flow from operations, compared with the use of ($3.8) million in cash for t... 
04/17/2000Humana Selects Practice Patterns Science to Develop Integrated Clinical Database
ST. LOUIS and LOUISVILLE, Ky., April 17 /PRNewswire/ -- Practice Patterns Science, Inc. (PPS) a subsidiary of Express Scripts, Inc. (NASD: ESRX), the nation's largest independent pharmacy benefit management firm, announced today that it has signed a contract with Humana Inc. (NYSE: HUM) to provide advanced decision-support technology that will significantly enhance Humana's population health program and provide network information systems capabilities. By integrating Human... 
04/12/2000Express Scripts Ranked by Fortune and Forbes
ST. LOUIS, April 12 /PRNewswire/ -- Express Scripts, Inc., (Nasdaq: ESRX) has been ranked for the first time among the top 500 companies in the United States by both Fortune and Forbes magazines, published this month. Express Scripts was also included earlier this year in the Forbes Platinum List, and was one of 25 companies featured in the "Platinum Profiles." In the Fortune 500 list, Express Scripts ranked #371 based on revenues. The Forbes 500s ranked Express Scripts #3... 
04/12/2000Express Scripts Corrects Dow Jones Report
ST. LOUIS, April 12 /PRNewswire/ -- Express Scripts, Inc., (Nasdaq: ESRX) will announce its first quarter financial results at the close of market on Wednesday, April 19, 2000. The management conference call for investors will be held on Thursday, April 20, 2000 at 10:00 a.m. central. The call can be accessed via the Express Scripts website at http://www.express-scripts.com . Earlier today, Dow Jones inadvertently reported Express Scripts' fourth quarter 1999 earnings as ... 
03/08/2000Express Scripts Online Forum on Drug Formulary Development and Manufacturer Discounts
ST. LOUIS, March 8 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) has scheduled an informational forum for investors. CEO Barrett Toan and CFO George Paz will host the forum, which will be broadcast live via the Internet: Wednesday, March 8, 2000 4 p.m. Central (5 p.m. Eastern) www.express-scripts.com Select "Investor Relations" from the main menu and click on "Live Audio Link." The purpose of the forum is... 
03/03/2000Express Scripts Calls 1st Quarter Outlook 'Achievable'
(Copyright (c) 2000, Dow Jones & Company, Inc.) By Desiree J. Hanford (This repeats an article originally published late Thursday.) ST. LOUIS (Dow Jones)--Based on the company's performance so far this quarter, Express Scripts Inc. (ESRX) thinks Wall Street's outlook for the first quarter is "achievable," President and Chief Executive Barrett Toan told Dow Jones Newswires. The first-quarter consensus estimate of 13 analysts polled by First Call/Thompson Financial is 53 cents ... 
02/16/2000Pharmacy Market Heading for Major Reorganization
New Drugs, Empowered Consumers, Aging Baby Boomers Set the Stage ST. LOUIS, Feb. 16 /PRNewswire/ -- New prescription drugs, empowered consumers and aging baby boomers led the top ten developments on the pharmaceutical landscape in 1999, according to a report issued by Express Scripts (Nasdaq: ESRX - news), the nation's largest independent pharmacy benefit management firm. The Express Scripts Top Ten was compiled by a multidisciplinary team of Express Scripts pharmacists, physicians and pharmacy... 
02/09/2000Express Scripts Announces 65% Increase in Fourth Quarter Pro Forma Net Income
ST. LOUIS, Feb. 9 /PRNewswire/ -- 2000-Express Scripts, Inc. (Nasdaq: ESRX) announced pro forma fourth quarter 1999 net income of $19.6 million, or 50 cents per diluted share, and year-to-date 1999 pro forma net income of $67.3 million, or $1.77 per diluted share. This compares with net income of $11.9 million, or 35 cents per diluted share, in the fourth quarter of 1998 and pro forma net income of $43.7 million, or $1.30 per diluted share, in the year ended December 31, 1998. Pro forma ... 
01/26/2000Express Scripts Names Five Members to Board of Directors Appointees Combine Extensive Industry and Corporate Finance Experience
ST. LOUIS, Jan. 26 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced the election of five members to its board of directors. Frank J. Borelli, Barbara B. Hill, Stuart L. Bascomb, Gary G. Benanav and Gary E. Wendlandt will assume their directorships effective Jan. 26, 2000, at the Express Scripts board meeting. "These exceptional individuals have consistently demonstrated innovation and leadership in their own careers, and we look forward to their contribut... 
11/01/1999Express Scripts Reaffirms Strong Results and Positive Outlook
ST. LOUIS, Nov. 1 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today reaffirmed its positive business outlook, based on strong operating results and proven business strategy. Barrett Toan, Express Scripts president and chief executive officer, stated, "We have recently announced record net income, reported the completion of our exclusive Internet pharmacy agreement with PlanetRx.com, and reviewed our success in gaining new business." "Our outlook moving ... 
10/29/1999Blue Shield of California Selects Express Scripts to Provide Mail Pharmacy Services for Its 1.6 Million Members
ST. LOUIS, Oct. 29 /PRNewswire/ -- Express Scripts, Inc. announced today that it has signed a contract with Blue Shield of California to provide mail pharmacy services and Internet refill services to the plan's 1.6 million members. "We're excited to have the opportunity to partner with one of California's leading health care companies," said Barrett Toan, president and chief executive officer of Express Scripts. "We look forward to using our expertise, technology and extensive Inter... 
10/20/1999Express Scripts Announces Third Quarter Results
Achieves Record Net Income ST. LOUIS, Oct. 20 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX - news ) announced third quarter 1999 net income of $17.5 million, or 45 cents per diluted share, excluding an after-tax extraordinary charge associated with the payoff of the company's Term B debt of $0.5 million, or 2 cents per share. This compares with $11.3 million, or 34 cents per diluted share in the same period of 1998. Third quarter net income on a reported basis, including th... 
10/18/1999Express Scripts, Inc. Announces Amendments to the Indenture Governing its 9 5/8% Senior Notes Due 2009 Have Become Effective
ST. LOUIS, Oct. 18 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that amendments to the Indenture, under which its 9-5/8% Senior Notes due 2009 (the "Notes") were issued, became effective on October 13, 1999. The amendments to the Indenture allowed the Company to sell assets of yourPharmacy.com, Inc., a wholly-owned subsidiary of Express Scripts, Inc., without restriction under the Asset Sale Covenant of the Indenture. Further, the amendments allowed the receipt of consi... 
10/14/1999PlanetRx.com and Express Scripts Today Complete Acquisition Transaction
PlanetRx.com Becomes Exclusive Online Pharmacy for Express Scripts' 36 Million Members SOUTH SAN FRANCISCO, Calif. and ST. LOUIS, Oct. 14 /PRNewswire/ -- PlanetRx.com, Inc. (Nasdaq: PLRX) and Express Scripts, Inc. (Nasdaq: ESRX) today announced that PlanetRx.com has completed the acquisition of Express Scripts' e-commerce pharmacy, making PlanetRx.com (www.planetrx.com) the exclusive online pharmacy for Express Scripts and its 36 million ... 
10/08/1999Express Scripts, Inc. Announces Amendments to the Indenture Governing its 9 5/8% Senior Notes due 2009
Express Scripts, Inc. Announces Amendments to the Indenture Governing its 9 5/8% Senior Notes due 2009 ST. LOUIS, Oct. 8 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it has entered into amendments to the Indenture under which its 9 5/8% Senior Notes due 2009 were issued. The amendments to the Indenture allow the Company to sell assets of YourPharmacy.com, Inc., a wholly-owned subsidiary of the Company, without restriction under ... 
10/06/1999Express Scripts, Inc. Announces Completion of its Consent Solicitation
ST. LOUIS, Oct. 5 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX - news ) announced that it successfully completed its previously announced consent solicitation with respect to its 9 5/8% Senior Notes due 2009 (the ``Securities''). As set forth in the Consent Solicitation, amendments to the Indenture under which the Securities were issued will become effective and the Company will pay consent fees to holders who delivered a valid consent, immediately prior to the contribution o... 
09/21/1999Express Scripts, Inc. Completes Exchange Offer; Company will Exchange Notes Today
ST. LOUIS, Sept. 21 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that, as of 5 p.m. on Sept. 14, 1999, the expiration date of its exchange offer, $250 million, or 100 percent, of its outstanding 9-5/8% Senior Notes due 2009 had been tendered in its offer to exchange $250 million of its 9-5/8% Series B Senior Notes due 2009. These Series B Senior Notes were registered under the Securities Act of 1933, as amended. The date of acceptance for exchange of the No... 
09/17/1999Express Scripts Commences Consent Solicitation
Express Scripts Commences Consent Solicitation ST. LOUIS, Sept. 17 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX), the nation's largest independent pharmacy benefit management firm, today announced that it has commenced a consent solicitation with respect to proposed amendments to the Indenture governing its $250 million 9-5/8% Senior Notes due 2009 (CUSIP Nos. 302182 AA 8 and 302182 AB6). The amendments are intended to facilitate the proposed contribut... 
09/09/1999Express Scripts, Inc. Announces Extension of Exchange Offer
ST. LOUIS, Sept. 9 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has elected to extend its offer to exchange $250,000,000 of its outstanding 9 5/8% Senior Notes due 2009 for an equal amount of notes which have been registered with the Securities and Exchange Commission and have the same terms as the outstanding notes. As of Sept. 8, 1999, approximately $249,400,000 of the outstanding notes had been tendered. Express Scripts, Inc. is extend... 
08/31/1999Express Scripts and PlanetRx.com Announce Internet Pharmacy Agreement
Express Scripts and PlanetRx.com Announce Internet Pharmacy Agreement Combined Strengths Significantly Accelerate Express Scripts' Online Capabilities ST. LOUIS, Aug. 31 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX), the nation's largest independent pharmacy benefit management firm, today announced a definitive agreement with PlanetRx.com, Inc. The agreement will give Express Scripts a 19.9 percent ownership s... 
07/21/1999Express Scripts Announces Second Quarter Results
ST. LOUIS, July 21 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter 1999 pro forma net income of $16.6 million, or 42 cents per diluted share. The pro forma calculation is before one-time charges and assumes that the company's equity and debt offering took place on April 1, 1999. This compares with $10.6 million, or 31 cents per diluted share, before one-time charges in the same period of 1998. Second quarter net income on a reported basis, before one-time c... 
06/29/1999Medication Prescribing Patterns Vary Widely Between, Within States and Therapy Classes
ST. LOUIS, June 29 /PRNewswire/ -- Where you live plays a big role in how many and which medicines you take according to a study of regional prescription use presented here today by University of Arizona researcher Brenda Motheral, Ph.D., at a national conference of health plans and benefits managers. Conference and study sponsor Express Scripts, Inc. (Nasdaq: ESRX), is the nation's largest independent pharmacy benefit manager. According to Motheral, some states have consistently higher or... 
06/29/1999Depression-Treating Drugs Lead Record-Setting Pharmacy Benefit Cost Rise
ST. LOUIS, June 29 /PRNewswire/ -- America's growing use of depression- treating drugs like Prozac, Zoloft and Paxil made antidepressants the biggest contributors to a record-setting pharmacy benefit cost increase of 16.8 percent last year, according to a study by the country's largest independent pharmacy benefit manager, Express Scripts, Inc. (Nasdaq: ESRX). Not everyone was hit by the full cost increase. ``Plan sponsors that successfully navigated the challenging pharmacy landscape were... 
06/28/1999Express Scripts, Inc. Invites You to Join Its Outcomes Conference Call On The Web
ST. LOUIS, June 28 /PRNewswire/ -- Barrett Toan, president and chief executive officer of Express Scripts, hosts a media teleconference to discuss the company's 1998 Drug Trend Report. Also participating will be Fred Teitelbaum, Ph.D., principal author of the report; conference keynoter Arthur Caplan, Ph.D., Director for Bioethics, University of Pennsylvania; and conference speaker Brenda Motheral, Ph.D., an expert in geographic variations in prescribing patterns. What: Express... 
06/24/1999Express Scripts Underwriters Exercise Common Stock Overallotment
ST. LOUIS, June 24 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that underwriters of its recent 4,500,000 share Class A Common Stock offering exercised their overallotment option and purchased 675,000 shares of Class A Common Stock from the company at $61.00 per share. The company will use the net proceeds of approximately $39.6 million to reduce indebtedness incurred in connection with its acquisition of Diversified Pharmaceutical Services, Inc. (``DPS''), completed... 
06/11/1999Express Scripts Completes Debt Offering
ST. LOUIS, June 11 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it has completed the sale of $250 million of 9-5/8% Senior Notes Due 2009 through a private placement to qualified institutional buyers. The notes are not registered under the Securities Act and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements under the Act. The company will use the net proceeds of approximately $243.... 
06/10/1999Express Scripts Completes Stock Offering
ST. LOUIS, June 10 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it has completed its offering of 4,500,000 shares of its Class A Common Stock at $61.00 per share. The company has granted the underwriters a maximum of 675,000 shares to cover over-allotments of shares. The company will use the net proceeds of approximately $264.2 million to reduce indebtedness incurred in connection with its acquisition of Diversified Pharmaceutical Services, Inc. (``DPS''), comp... 
05/24/1999Express Scripts Plans $200 Million Senior Note Offering
ST. LOUIS, May 24 /PRNewswire/-- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it plans to offer $200 million in unsecured senior notes due in 2009, through a private placement to qualified institutional buyers. The notes will not be registered under the Securities Act and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements under the Act. Express Scripts, Inc., is the nation's leading independent full... 
04/21/1999Express Scripts First Quarter EPS Increases 38 Percent
ST. LOUIS, April 21 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today reported net income of $13.5 million for the three months ended March 31, 1999, a 37 percent increase over $9.9 million in the same period of 1998. The company earned 40 cents per share on a diluted basis, a 38 percent increase compared with 29 cents per share on a diluted basis in the same period of 1998. In the first quarter of 1999, net revenues were $899.1 million, a 142 percent increase over $371.4 million... 
04/01/1999Express Scripts Completes Acquisition of Diversified Pharmaceutical Services
ST. LOUIS, APRIL 1, 1999 -- Express Scripts, Inc. (NASDAQ: ESRX) announced today that it has completed the acquisition of Diversified Pharmaceutical Services (DPS) from SmithKline Beecham Corporation (NYSE: SBH). "We’re pleased to announce the completion of the DPS acquisition just seven weeks after the agreement was announced, and exactly one year since we compl... 
03/29/1999Express Scripts, Inc. Unveils Plans For Online Pharmacy and Drug Information Site
St. Louis, Mo., March 29, 1999 - Express Scripts, Inc. (NASDAQ: ESRX), the nation’s leading independent full-service pharmacy benefit manager (PBM), announced today plans for a dual online effort targeted to an initial customer base of more than 36.5 million people. The company has formed a subsidiary to launch one site, YourPharmacy.com , that will ser... 
03/18/1999Express Scripts Files $350 Million Primary Common Stock Offering
ST. LOUIS, MARCH 18, 1999 - Express Scripts, Inc. (NASD: ESRX) today announced an offering for approximately 4,500,000 primary shares, or approximately $350 million, of its Class A Common Stock. The offering is being managed by Credit Suisse First Boston, BT Alex. Brown and Morgan Keegan & Company, Inc. The company plans to use the net proceeds of the offering to reduce indebtedness to be incurred in connection with its pending acq... 
02/16/1999Express Scripts Fourth Quarter EPS Rises 30 Percent
  ValueRx Integration Goals Achieved as Company Prepares to Add DPS ST. LOUIS, FEBRUARY 16, 1999—Express Scripts, Inc. (NASD: ESRX) today reported that fourth quarter 1998 net income grew by 31.8 percent to $11.9 million from $9.0 million in the fourth quarter of 1997, and earnings per share rose 29.6 percent, to 35 cents per share from 27 cents per share, on a diluted basis. For the year ended December 31, 1998, Express Scripts earned $43.7 million or $1.30 per sh... 
02/09/1999Express Scripts To Acquire Diversified Pharmaceutical Services
ST. LOUIS, February 9, 1999 -- Express Scripts, Inc. (NASDAQ: ESRX), one of the nation’s largest pharmacy benefit management (PBM) firms, announced today that it has signed a definitive agreement to acquire Diversified Pharmaceutical Services (DPS), a subsidiary of SmithKline Beecham (NYSE: SBH). Express Scripts will pay SmithKline $700 million in cash. The tr... 
02/01/1999Blue Cross and Blue Shield of Massachusetts Selects Express Scripts/ValueRX to Manage Pharmacy Benefits
BOSTON and ST. LOUIS, February 1, 1999 -- Blue Cross and Blue Shield of Massachusetts (BCBSMA) members will soon have their pharmacy benefits managed through Express Scripts, one of the nation’s largest pharmacy benefit management firms, the two firms announced today. The three-and-a-half-year contract between the two companies will cover appro... 
11/01/1998Express Scripts, Inc. Completes 2-For-1 Stock Split
ST. LOUIS, November 1, 1998— Express Scripts, Inc. (NASD: ESRX) announced today that the previously disclosed two-for-one stock split of its Class A and Class B common stock was effective at the close of trading Oct. 30. The stock closed at a pre-split price of 97.69. The Class A common stock will commence trading on a post-split basis when the market opens on Monday, Nov. 2. The ... 
10/21/1998Express Scripts Reports Continued Strong Revenue and Income Growth
Net Income Increased 31 Percent In Third Quarter; ValueRx Integration Continues On Track ST. LOUIS, October 21, 1998—Express Scripts, Inc. (NASD: ESRX) today reported net income grew by 31.2 percent to $11.3 million from $8.6 million in the prior year, and rose 28.9 percent on a diluted per share bas... 
10/12/1998Express Scripts, Inc. Declares 2-For-1 Stock Split
ST. LOUIS, October 12, 1998—Express Scripts, Inc. (NASD: ESRX) today announced that its board of directors has approved a two-for-one stock split of its Class A and Class B common stock to be effected in the form of a stock dividend. The stock split is for shareholders of record as of Oct. 20, 1998, and will be effective on or about Oct. 30, 1998. The split will be effected in the form of a dividend by issuance of one additional share of Class A common stock for each share of Clas... 
08/20/1998Express Scripts, Inc. Announces Expansion of Riverport Facility
New Building to House Company’s Corporate Headquarters St. Louis (August 20, 1998) – Express Scripts, Inc. has announced it is breaking ground on a new building adjacent to its existing facility located in Maryland Heights, Mo. The future three-story building will sit on 11.4 acres in the Riverport Business Center and will be ... 
07/28/1998Express Scripts Reports Strong Revenue and Income Growth
168.7 Percent Revenue Gain and Operating Profit Growth Reflect Success with Integration of ValueRx ST. LOUIS, July 28, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today reported second quarter 1998 revenues increased 168.7 percent to $807.4 million compared with $300.5 million for the period one year ago. Excluding a previously announced one-time, pre-tax charge of $1.7 ... 
07/09/1998Express Scripts/ValueRx Report Identifies Reasons for the Rapid Increase in Pharmacy Expenses
1997 Drug Trend Report Analyzes Prescription Drug Costs and Trends St. Louis (July 1, 1998) – America’s increasing consumption of prescription drugs and its fondness for new drugs are among the trends that drove prescription drug costs to a record 16.1 percent increase in 1997, according to a new Express Script... 
06/17/1998Express Scripts Announces Alliance with Cole Managed Vision
ST. LOUIS, June 17, 1998—Express Scripts, Inc. (NASDAQ:ESRX) announced today that it will close its PhyNet vision care subsidiary and transfer certain functions of its Express Scripts Vision Corporation unit to Cole Managed Vision, a subsidiary of Cole National Corporation (NYSE:CNJ). "Our alliance with Cole Managed Vision is a win-win situation for Express Scripts an... 
04/23/1998Express Scripts Reports Strong Gains in Revenue and Income for First Quarter
Net Income Up 29.3 Percent on Revenue Growth of 41.8 Percent ST. LOUIS, April 23, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today announced that revenues for first quarter 1998 increased 41.8 percent to a record $371.4 million from $262.0 million for the period in 1997. Net income for the first quarter of 1998 rose 29.3 percent to $9.9 million fr... 
04/01/1998Express Scripts Completes Acquisition of ValueRx from Columbia/HCA
ST. LOUIS, April 1, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today announced that it has completed the acquisition of ValueRx from Columbia/HCA Healthcare Corporation approximately six weeks after signing the definitive acquisition agreement. The purchase makes Express Scripts the nation’s largest pharmacy benefit manager not controlled by a drug manufacturer. "We are pleased that we have been able to mov... 
03/16/1998Express Scripts Announces Long-Term Agreement with NYLCare Health Plans
ST. LOUIS, March 16, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today announced that it has reached agreement with NYLCare Health Plans, Inc., a subsidiary of New York Life Insurance Company, for an extension of its agreements to provide members of NYLCare’s HMO with pharmacy benefit management and infusion therapy services. As part of the definitive agreement announced by Aetna U.S. He... 
02/20/1998Express Scripts Announces Agreement to Purchase ValueRx from Columbia/HCA
$445 Million Transaction Will Create Largest Independent PBM Managing More Than $4.0 Billion in Drug Claims ST. LOUIS, February 20, 1998 – Express Scripts, Inc. (NASDAQ:ESRX) today announced that it has executed a definitive agreement to purchase ValueRx, the pharmacy benefit management (PBM) subsidiary of Columbia/HCA Healt... 
02/10/1998Express Scripts Names Novak as Vice President, Healthcare Services Sales and Palmer as Vice President, Commercial Sales
ST. LOUIS (February 10, 1998) --- Express Scripts, Inc. (NASDAQ: ESRX) announced today the appointment of two senior sales executives. Tim Novak has been named to the position of Vice President, healthcare services sales, and Marc Palmer has been named Vice President, commercial sales. As Vice President, healthcare services sales, Mr. Novak will head a newly created sa... 
02/10/1998Express Scripts Reports Record Revenues and Income for Fourth Quarter and Full Year in 1997
Annual Revenues Grow 59.1 Percent to $1.2 Billion; Net Income Rises 27.9 Percent ST. LOUIS, Feb. 10, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today reported that revenues for 1997 reached a record $1.2 billion, up 59.1 percent from $773.6 million in 1996. Net income for the year increased 27.9 perc... 
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet